Quality of life in pancreatic cancer : differences in perception between health professionals and patients. by Fitzsimmons, D. et al.
Gut 1997; 40 (suppl 1)
Stomach and duodenum TU1-TU6
TUl TU3
TU4TU2
D)EiGREIEI OF SUPPRESSION OF GASTRIC ACII) SECRETION BY
OME^:PRAZOI.E IS REI,ATEI) TO H. PYLORI STATUS. 1). Gillen.
A. Wirz, K.l;.l. McColl. University Dept. of Medicine & Therapeutics,
Western Infirmary. Glasgow. U.K.
Iltroduction: Proton pump inhibitors (PPIs) are very commonly used
drugs. Recent data indicate that they cause more marked elevation of
intragastric pH in H.P-infected individuals. It is not clear whether this is
due to a neutralising effect of ammonia produced by H. pylori urease or to
a more marked inhibition of acid secretion.
Am: To assess the effet of H. pylori status on acid secretion during PPI
therapy.
Subjects and Methods: I8 H.P -ve and I) H.P.+ve healthy volunteers
were studied. H. pylori status was confirmed by the 14C-urea breath test.
Prior to commencing the PPI therapy, basal acid output, acid output to
gastrin releasing peptide (40pmoUkg/h) (GRP) and maximal acid output to
Gastrin-17 (MAO) were measured on separate days. Omeprazole
40mg/day was then taken in the morning daily for eight weeks. On
separate mornings in the last two weeks ol this course, the acid secretion













3.4 0.3* 82%9 3.2 0.0 100%.
9.6 3.8* 64t1 14.2 0.0 100%
MAO(;. (nmoVl/h) 36.0 18.2* 5290 34.6 7.1 80%
Values are mediarms. *Indica(es difference fr(wn H.P+ve at p<0.05.
1,ifi-ion and Conclusions: This study indicates that the inhibition of
gastric tcid secretion produced by PPI therapy is much more profound in
H.P+ve individuals. The magnitude of this effect cannot be explained by
the neutralising effect Of bactcrial ammonia. It may be explained by the
body gastritis which develops in H.P.+vc subjects during PPI therapy
impairing acid secrctory function and.thus augmenting the effect of the
drug. This profound suppression of acid secretion may have deleterious
effects by facilitating gastric bactcrial colonisation and consequently
predisposing to gastric carcinoma. Eradication of H. pylori may be
appropriate prior to long-tcrm PPI therapy, but this may reducc the efficacy
of PPI therapy in reflux disease.
USE (,F SELF EXPANDABLE STENTS INTHETREATMENT OF
BENIGN PEPTIC OESOPHAGEAL STRICTURES IN THE
ELDERLY.
DR D R FOSTER, DEPARTMENTS OF RADIOLOGY AND
ENDOSCOPY, PRINCESS OF WALES HOSPITAL, BRIDGEND,
SOUTH WALES, U.K.
The use of self-expandable stents in the management of malignant
oesophageal strictures has become well established. The majority of
benign peptic oesophageal strictures can be successfully managed using
endoscopic o0 fluoroscopically guided balloon oesophageal dilatation
combined with long term drug therapy, particularly using Proton pump
inhibitors. Although endoscopic oesophageal dilatation can be
performed on an outpatient basis it requires repeated hospital visits.
There is a small risk of oesophageal perforation whilst cardio-
respiratory complications may be encountered during the use of
intravenous sedation in elderly patients. Self-expandable Strecker
oesophageal stents (Boston Scientific Corporation, Boston) were used
in three elderly female patients aged 91, 98 and 100 years
respectively. All patients had previously required repeated endoscopic
oesophageal dilatations over a 5 year period despite the use of long
term Omeprazole therapy. Self-expandable stents were inserted in all
patients under mild sedation following preliminary stricture dilatation.
All patients have obtained excellent relief of symptoms following stent
insertion and have now been followed up for approximately 12
months. They are able to swallow normally and have continued on
long term maintenance Omeprazole therapy. There is a theoretical
risk of developing an additional peptic stricture above the stent but this
is unlikely to be a signiFican' problem in these patients with the use
of long term Omeprazole therapy and their likely life expectancy.
THE EFFECTS OF NaMETHYLHISTAMINE ON GASTRIC ACID
SECRETION IN HUMAN VOLUNTEERS
Bliss PW. and Calam I
Departqmt of Gastoentrology, Royal Postgraduate Medical School,
Ha s Hospital, London UK
Background: Helicobacferpylori (Hp) produces Na Methyl Histamine.
(NaMH). Ih effects ofthis substance on the physiolo ofthe human
stonach is unknown. NaMH is an agonist ofboth H2 and H3 receptors. Its
histamine H3 agonist effect is expected to inhibit n ol -like cells
which might decreas acid secretion. However we find that it simulates rabbit
paietal cells via hisam H2-receptors, and also releases gastin from rabbit
G-cells. Therefore we investgated the oveUrall effect of lumenal NaMH on
acid secretion and gastrin releas in human volunteers.
Methods: Volunteers fasted ovemight. Terfenadine, 120mg, was given 1 hour
before the study to block hisamie Hi-receptor effects. A nasogstric tube
was passed and connected to an automated syringe device to ensure adequate
mixing ofthe gastric contents. Gastric acid output was measured by
continuous intra-pstric tition ofa 5.8% glucose solution to pH 5.0. The
intragastric solution was changed every 30 min. NaMH was added at 104M,
l1-1 M, and l06 M, with basal periods before each dose. Blood was collected
for gastrin assay. Hp status was deermined by '4C Urea breath test.
Resuls: Elven volunteers took part; 5 female and 6 male. Four were infected
with Hp. In the Hp neptive group NaMH stimulated acid output from a basal
value of 3.8 ± 1.3 (mnwl/h mean + SEM), to 5.2 ± 2.1 at l0-6M (NSD) and
6.0 ± 1.7 at lO-' M (P<0.05 vs. basal). NaMH 10-4 M produced no further
rise. By way of cotast, inital results in the Hp positive group showed a
higher basal acid output; 7.5 ± 2.7 (P<0.05 vs. uninfcted) and no response to
NaMH; 5.1 ± 1.9 at IO-' M. Fasting plasma gastrin concentatons were 7.5 ±
1.5 pmol/l in uninfrtd subjects compared to 30.5 ± 7.9 pmol/l in infected
subjects(P<0.05). NaMH had no significant eflct on plasma gastrin levels.
Coodusion: The H. pylon product NaMH stimulated acid socretion in Hp
negative subjects when infiLsed into the gastric lumen. No effect was seen on
gastrin relase. By corast Hp postive patients had higher basal acid output
and did not respond to NaMH. Thus NcxMH may contribute to the elevated
basal acid output seen in H. pyloni infection.
NEW, INTERNATIONALLY APPLICABLE, POLYMERASE
CHAIN REACTION-BASED TYPING OF Helicobacter pyloyi vacA.
JC Atherton, RJ Twells, CJ Hawkey, RM Peek Jr.*,TL Cover*, MJ
Blaser*. Div.Gastroenterology and Institute of Inections and Immunity,
University of Nottingham, Nottingham NG7 2UH, *Div. Infectious
Diseases, Vanderbilt University and VAMC, Nashville, USA.
Typing H. pylon vacA is important because, in the US, vacA structure
has been associated with gastric epithelial damage and ulceration. A
previous PCR-based typing system successfully classified all U.S. strains
tested, but failed to classify vacA mid-regions of Japanese and various
other strains. We sought to investigate the extent of vacA mid-region
diversity between US strains and strains from other countries, and to
devise an internationally applicable typing system.
Methods and Results: We studied 78 H. pylori isolates of which
13/13 Japanese, 2/6 Chinese, 3/9 Thai, 1/8 Peruvian and 0/42 US
isolates had vacA mid-regions we could not previously classify. We
PCR-amplified, cloned and sequenced, extended (1.7Kb) vacA mid-
regions of 1-2 untypeable strains from each country. All proved to be
type ml variants except one Chinese strain which was ml proximally and
m2 distally with a clear crossover site. Annealing sites for the
unsuccessful ml primers had up to 3/19 and 7/20 non-complementary
bases. vacA sequence comparisons using these strains, m2 strains from
the same populations, and other published strains, showed that diversity
was greater among ml strains (1-12% nucleotide differences over 294bp)
than m2 (0-6%), but that differences were most marked between ml and
m2 strains (22-27%). Next, we devised two new PCR-based typing
strategies. The first used conserved primers spanning a 75bp imperfect
repeat found only in m2 strains, and differentiated products by size. The
second used four primers in a single reaction: two new ml primers and
two previously described m2 primers. We applied both strategies to all
78 isolates. Results agreed entirely with previous vacA typing, except
that for both strategies all previously untypeable strains were ml. As
expected, the Chinese ml/m2 strain appeared ml by strategy 1 and gave
a uniquely sized product (of the predicted size) using strategy 2.
Cclusions: Despite variability in the vacA mid-region, all strains can
be typed as ml or m2. Finding an intermediate ml/m2 type implies in
vivo recombination between strains. This typing system will aid studies
linking vacA genotype with disease in countries other than the US.
Al
Results:
Gut 1997; 40 (suppl 1)
Stomach and duodenum W7-W32
W7TUS
TU6 W8
VIRULENT HELICOBACTER PYLORI (HP) IN PATIENTS WITH
GASTRIC AND OESOPHAGEAL ADENOCARCINOMA.
CE Grinley, DE Loft, AG Morris, CU Nwokolo.
Department of Gastroenterology, Walsgrave Hospital, Coventry, UK.
Introduction Gastric carcinogenesis can be explained by a model based on
HP-mediated inflammation facilitating progression from gastritis to atrophy,
dysplasia and cancer. Mucosal inflammation which occurs when HP colonises
the stomach is more severe when the strains express CagA and VacA. IfHP-
mediated inflammation is the main pathogenetic factor in gastric carcinogenesis,
then virulent proinflammatory strains ofHP should be over represented among
patients with gastric cancer when compared to other disease groups in which
HP inflammation is not a factor.
Method: In an unselected series ofpatients with gastric (GA) or oesophageal
(OA) adenocarcinoma, HP status was determined by serology/'3C-UBT/CLO-
test/histology. CagA and VacA status ofthe colonising HP was determined
indirectly by deteing antibodies to these proteins in patients sera by an
immunoblot assay. Using a novel virulence scoring system, a putative HP
virulence load was assigned to each patient depending on whether they were
colonised by HP and whether the TP strain they harboured expressed either
CagA or VacA or both virulence factors. Virulence load increased in a stepwise
fashion: - patients scored 0 ifHP-ve, 1 if HP+ve and -ve for CagA and VacA, 2
ifHP+ve and ako-+ve for either CagA or VacA and 3 ifHP+ve and also +ve
for CagA and VacA.
Results : GA (n=26) OA (n=26), median age were 74 and 67 respectively. In
the GA group 21/26 patients were HP+ve and 19/21 harboured strains which
were +ve for CagA or/and VacA. In the OA group 14/26 were HP+ve and only
7/14 harboured strains +ve for CagA or/and VacA. When our virulence scoring
system was used to assign virulence/inflammatory load, patients with GA
scored a median of 2 (range 0-3) compared with OA patients who scored I
(range 0-3), p=0.0016 Mann-Whitney U Test.
Conclusion : Compared to an OA control group, the majority ofpatients with
GA are colonised by virulent pro-infammatory strains ofHP. This study
supports the HP inflammatory model for gastric carcinogenesis. An altemative
interpretation could be that colonisation by virulent BP protects against
oesoplsageal adenocarcinoma.
VALUE OF THE HELISAL TEST IN SCREENING DYSPEPTIC
PATIENTS FOR H.PYLORI INFECTION-. A.inha, C.Treharne,
L.Murray, D.W.Williams, M.J.Dew, Prince Philip Hospital, Llanelli.
Introduction: H.Pylori antibody seropositivity as determined by
laboratory based ELISA tests or ELISA kits has been proposed as a
screening test for H.Pylori infection in dyspeptic patients without
sinister symptoms, especially those below 45 years, with diagnostic
endoscopy offered to only the seropositive group. The Helisal test
(Cortecs diagnostics), which is one such Rapid Whole Blood Test, is
increasingly being used in general practice for this purpose. This study
assesses the reliability ofthis approach.
Aim: To assess the value of the Helisal test in screening dyspeptic
patients for H.Pylori infection.
Methods: 207 consecutive patients (102 male, 105 female) referred
for Open Access endoscopy were tested immediately before endoscopy.
Serum samples were obtained for a reference laboratory based ELISA
test for H.Pylori antibodies. Infection was confirmed ifCLO test at 24
hours and microscopic visualisation ofthe organism on biopsy were
both positive, and excluded if both were negative.
Results:. H.Pylori infection found in 69/187 (36.9%) patients [Age <
45 - 13/39 (33.3%); Age >= 45 - 56/138 (40.58%)]. The Helisal test
had a sensitivity of 0.84, but a specificity of only 0.46 [ Positive
predictive value (PPV) 0.43, Negative predictive value (NPV)
0.75,False positive rate (FPR) 0.54, False negative rate (FNR) 0.16,
Likelihood ratio (LR) 1.56]. The laboratory ELISA test had a
sensitivity 0.84, but the specificity was 0.79 [ PPV 0.62 NPV 0.82, FPR
0.21, FNR 0.16, LR 4]. Correlation of Helisal test with Laboratory
based ELISA test was poor. Both tests performed similarly in the <45
group and the >45 group.
Conclusion: Ofthe 122 patients that had a positive Helisal test in this
study, 64 (52.46%) were falsely positive. Reliance on a negative Helisal
result to restrict endoscopy would have resulted in 16% (11/69) cases of
H. Pylori infection being missed. The poor performance of this test
makes it unsuitable for use in screening for H.Pylori infection.
THE PROLIFERATIVE STATUS OF ENTEROCHROMAFFIN-LIKE(ECL) CELLS IN THE GASTRIC MUCOSA; THE PLOT THICKENS
Neema M Rashid, Irvin Modlin, Laura Tang and Nicholas A Wrijht,Department of Histopathology RPMS, Hammersmith Hospital, London
and Gastric Pathobiology Research Group, West Haven VAMC and Yale.
There has been considerable interest in ECL cell hyperplasia, in recent
years, mainly because of concern that powerful antisecretory therapy may
lead to the development of ECL cell carcinoids. The mechanism of
development of ECL cell hyperplasia in chronic atrophic gastritis, whether
or not the patient is on antisecretory therapy, has been assumed to be due
to proliferation of the ECL cells themselves; this is because of findings in
experimental animals that indicate that the ECL cell lineage is a self-
renewing population. There is little or no direct experimental evidence,
however, on the proliferative status of this important lineage in the human
stomach.
Consequently, we have examined the fundic gastric mucosa of normal
humans, patients on long-term antisecretory therapy, and patients with
atrophic gastritis showing diffuse, linear and micronodular hyperplasia,
and with ECL cell carcinoids. In addition, we evaluated fundic mucosa
from Mastomys, an important animal model for ECL cell hyperplasia and
neoplasia: control animals, animals with ECL cell hyperplasia and ECL
cell carcinoids induced by loxtidine were available. All tissues were
double-immunostained using chromogranin A as an endocrine cell
marker, and PCNA and MIB- I as proliferative markers.
We were unable to demonstrate double-labelled cells in normal human
corpus or in patients with diffuse, linear or micronodular hyperplasia,
despite counting in excess of 20,000 chromogranin A positive cells in
each group. However, ECL cell carcinoids in humans contain numbers of
double-labelled cells (up to 0.15%). However, Mastomys corpus contains
proliferative ECL cells, as previously reported, and we demonstrated that
up to 3% of chromogranin positive cells were double-stained in ECL cell
hyperplasia, and 4% in ECL cell carcinoids.
We conclude that (i) as assessed by chromogranin A, neither normal nor
hyperplastic ECL cells in the human stomach appear to have proliferative
potential; (ii) Mastomys ECL cells form a renewing population and
undergo hyperplasia after loxtidine-induction which involves cell division,
which may reflect different rates of cell tumover in each species. These
rindings indicate (a) that the mechanism of ECL cell hyperplasia in the
human stomach does not involve proliferation of ECL cells themselves,
although neoplastic ECL cells themselves can divide, and (b) that lineage
relationships in the human and animal stomach differ. The mastomys
model thus apears appropriate for studies of ECL cell proliferation.
One year follow-up of a randonused trial of pre endoscopy screening
for H. pyloA in the management of dyspepsia.
MA Asante M Mendall, P Patel, L Ballamn and TC Northfield.
Dept. ofMedicine, St. George's Hospital Medical School, London. UK.
Background: The safety and savings in endoscopy derived from not endoscoping H.
pylori seronegative dyspeptic patients has been demonstrated in short term studies of
six month duration. The long term outcome of such a management strategy is not clear
what. We report the final 12 month follow-up in a prospective randomised trial. for
which we reported Interim results of this study has already been presented to the
society. Design: 417 patients under the age of 45 years referred to a direct access
endoscopy service were screened with a validated questionnaire and H. pylori serology(Helico-G ELISA). A cut off level of 6.3u/ml had been previously determined to be
suitable for screening. 154 patients (56% male) had serology titres below 6.3u/ml and
were randomised to have either endoscopy or no endoscopy. All patients were
returned to their GPs for further management. Patients with a history of weight loss of
more than 1/2 stone in 6 months, dysphagia, anaemia or persistent vomiting or on
regular NSAIDs were excluded. Six and twelve month assessment was carried out by
postal questionnaire.
Reslts: 120/154 (79%) and 82/154 (53%) questionnaires were returned at 6 and 12
monthsrespectively. Table shows results at 12 months expressed as medians.
Endoscopy (43) No Endoscopy (39) P
Symptomscore I I NS
Disability score 0 I NS
Days off work 0 0 NS
GP visit 0 0 NS
Prescriptions score 0 NS
Self medications score 0 1 0.05
Specialist referral 6/38 (16%) 13/34 (38%) 0.06
Endoscopy referral (n) 6/39 (15%)
Summary: There were no significant differences in symptoms, disability, GP visits
and prescriptions between the two groups. 46%(6/13) of the non endoscoped group
referred for specialist consultations were endoscoped. At one year 85% of
endoscopies were saved.
Conclusions: It is safe and more cost effective in the long term to manage young
H. pylori negative dyspeptic patients without endoscopy.
A2
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MARKED REBOUND ACID HYPERSECRETION FOLLOWING
OMEPRAZOLE THERAPY IN H. PYLORI NEGATIVE
SUBJECTS. D. Gillen, A. Win, K.E.L. McColl. Univ. Dept. of
Medicine & Therapeutics, Western Infirmary, Glasgow, U.K.
Introduction: Rebound hypersecretion of gastric acid is a well
established class effect of H2-antagonists. Previous studies have
suggested that this phenomenon does not occur with proton pump
inhibitors (PPIs). However, the effect may have been masked by PPI
induced H. pylon body gastritis.
Aims: To establish whether rebound acid hypersecretion occurs
with PPIs when subjects are stratified by H. pylon (H.P.) status.
Subjects and Methods: 11 H.P.-ve and 7 H.P.+ve healthy
volunteers were examined. Their H.P. status was determined by the
14C-urea breath test. Their basal acid output (BAO) and G17
stimulated maximal acid output (MAOG17) and maximal acid output in
response to gastrin releasing peptide (MAOoRP) were measured before and 2
weeks after completing a 2 month course of omeprazole 40mg/day.
Results and Discussion:
H.P negative H.P positive
Pre-omep. Post-omep. % change Pre-omep. Post-omep. % change
(n=l 1) (n= 1) (n=7) (n=7)
BAO 4.6 7.5* +63.0% 4.9 4.8 -2.0%
(mmol/h)
MAOG17 31.6 41.2* +30.4% 32.5 39.3 +21%
(mmol/h)
MAOGRP 9.8 15.5* +58.2% 15.2 12.1 -20%
(mmol/h)
All values are means. *Indicates significantly higher than pre-mep. at p<0.01.
In the H.P.-ve subjects there was marked rebound hypersecretion of
acid following omeprazole therapy apparent with each of the 3 acid
secretion tests. There was no rebound hypersecretion of acid in the
H.P.+ve subjects and this may be due to the body gastritis occurring
in H.P.+ve subjects during omeprazole therapy impairing gastric acid
secretion and thus masking the rebound phenomenon.
Conclusion: There is marked rebound hypersecretion of gastric
acid following PPI therapy in H. pylori-negative, but not H.
pylori-positive subjects.
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RANITIDINE TREATMENT INDUCES DYSPEPSIA IN
PREVIOUSLY ASYMPTOMATIC HEALTHY VOLUNTEERS.
A.Smith, D. Gillen, K. Cochran, E. El-Omar, K.E.L. McColl.
University Dept. of Medicine & Therapeutics, Western Infirmary &
Victoria Infirmary, Glasgow, Scotland.
Background: Dyspeptic symptoms frequently rapidly recur
following cessation of H receptor antagonist therapy. We have
previously shown that in A. pylori +ve healthy volunteers basal and
gastrin releasing peptide (GRP) stimulated acid secretion are
increased by 96% and 56% respectively 3 days after completing a
two month course of ranitidine 300mg nocte compared to
pre-treatment values (Am. J. Gastroenterol., 1996; 91: 355-359). It is
unknown whether this rebound acid hypersecretion causes dyspeptic
symptoms.
Aim: To determine whether cessation of H2 antagonist treatment
results in the de novo development and/or aggravation of dyspepsia.
Subjects and Methods: Thirty H. pylori positive healthy volunteers
were randomised in a double blind fashion to receive either ranitidine
300mg nocte or placebo tablets for two months. All subjects had H.
pylori infection confirmed using serology and 13C-urea breath test.
The two groups were matched for age, sex, body weight, smoking
and alcohol consumption. Dyspeptic symptoms were measured using
a validated questionnaire. Symptoms were scored for one week prior
to entry into the study and for the 10 days following cessation of the
treatment.
Results: Compliance was similar in the two groups (active 95%,
placebo 98%, p=NS). The mean dyspepsia score before treatment
was 0.86 in the active group and 0.53 in the placebo group (p=NS).
The mean dyspepsia score for the 10 days after stopping treatment
was 5.4 (range 0-30) in the active group and 0.93 (range: 0-9) in the
placebe group (p<0.03). 53% experienced dyspepsia in the 10 day
period following active therapy versus 13% following placebo.
Conclusions: These results indicate that a two month course of
ranitidine 300mg nocte is followed by the development of new
dyspeptic symptoms in H. pyloA positive healthy volunteers. This
finding indicates that rebound acid hypersecretion following
withdrawal of H2 antagonist therapy is of clinical significance. It is
now important to determine whether the dyspepsia is due to the
rebound acid hypersecretion causing acute peptic ulceration.
REFLUX SYMPTOMS IN THE LONG TERM FOLLOW UP OF
PATIENTS AFTER HELICOBACTER PYLORI ERADICATION
AE Griffiths, MR Thursz, D Pryce, MM Walker. Departments of
Gastroenterology and Histopathology, Imperial College School of
Medicine at St Mary's, Norfolk Place, London W2.
Background Symptomatic relapse after H. pylon (Hp) eradication in
duodenal ulcer (DU) patients is common and is only rarely due to proven
ulcer recurrence. Recent reports suggest that eradication ofHp is
associated with the onset of gastro-oesophageal reflux disease (GORD)
one to two years later.
Methods A questionnaire was sent to 85 individuals who had completed a
similar questionnaire 2 years previously, just prior to Hp eradication. This
included questions about symptomatology, medication, weight and
smoking and alcohol history. Eradication was confirmed by 13C urea
breath test at follow up.
Results 45 patients returned the questionnaire (53% response). 32 were
from patients known to have cleared Hp; 20 ofthese had DU originally,
19 were male and median age was 55 (range 25-79). The remaining 13
replies were from patients who had not cleared Hp (5 patients) or in
whom a breath test result was unavailable (8 patients); 3 had DU, 5 were
male and median age was 57 (range 32-82). In the Hp eradicated group
with DU 9/20 (45%) had heartbumJreflux symptoms at 2 years follow up.
However 17 (85%) had these symptoms prior to treatment. In the non-
DU, Hp eradicated patients the figures were similar with 75% having
heartburn pre-treatment and 42% at 2 years. In the non-eradicated group
the corresponding frequencies of heartburn were 54% initially and 380/o at
2 years. No individual in any group developed heartbum/reflux symptoms
during 2 years of follow up. Other findings were that 65% of 32
successfully treated patients remained symptomatic at follow up, with
53% still requiring medication, chiefly antacids. 9% stated that their
symptoms are worse now than they were before treatment. Changes in
weight or in alcohol consumption had no bearing on current symptoms
though increased cigarette smoking was associated with fewer symptoms.
Conclusions Contrary to previous reports we have found no evidence of
new symptoms ofGORD in the long-term follow up of patients
undergoing Hp eradication for DU or for other Hp related conditions.
REGULATION OF CORPUS MUCOSAL FUNCTION IN H.P.
INFECTED DU PATIENTS VERSUS HEALTHY VOLUNTEERS.
D. Gil. E. El-Omar, A. Wirz, J.E.S. Ardill, KE.L. McColl. Univ. Dept.
of Medicine & Therapeutics, Western Infirmary, Glasgow, U.K.
Introduction: We have demonstrated a two-fold greater acid response to
gastrin in DU patients compared to H.P+ve healthy volunteers (H.1V).
Aim: To determine wher the increased acid response in DU patients is
due to difference in (1) parietal cell mass (PCM), (2) sensitivity to gastrin,
(3) inhibitory control or (4) combination of these.
Subjects and Methods: 34 H.P-ve HVs, 19 H.P.+ve HVs and 18
H.P.+ve DU patients were examined. On separate mornings, after a 30
minute basal acid collection, either 7, 20, 60, 180 and 800pmolKg-'h'1 of
Gastrinl7 or 7, 20, 60 and 120pmolKg1lh-1 of CCK8 were infused
intravenously over 30 minute periods with corresponding acid collections.
Plasma for gastrin estimation was collected at the end of each infusion
period. Plasma gastrin was then plotted against acid output by computer
generated Langmuir Plot to give the D5o (sensitivity to gastrin) and E-max
(PCM). CCK simultaneously stimulates acid secretion via the gastrin
(CCKB) receptor and inhibits it by stimulating somatostatin release via the
CCKA receptor on D cells in body mucosa. The maximal acid output
(MAO) to CCK8 as percentage of MAO to G17 is thus a measure of
somatostatin mediated inhibitory control.
Results: HP-ve HVs HP+ve HVs HP+ve DUs
E-max 35.3 38.5 47.3*(mmolb'1) (21.3-67.3) (17.2-65.0) (18.2-73.7)
D50 75.1 164.0** 69.8(ngL') (17.7410) (44.8-368) (26.2-142)
MAOccK 26.2% 16.2%*** 36.6%
MAOG17 (5.9 - 85.8) (0-46.9) (21.5-58.2)
Values are medians with ranges in parenthesis. *Indicltes different from
H.P-ve HV at p<0.05. ** Indicates different from H.P-ve HV at p<0.001.
*** Indicates different from H.R+ve DU at p<0.02.
The higher acid response to gastrin in H.P.+ve DU patients versus
infected d.V is predominantly due to a reduced sensitivity to gastrin in the
infected HVs when compared with both DU patients and uninfected HVs
(i.e. true normals). This reduced sensitivity to gastrin in the infected
non-ulcer subjects may be due to H. pylon body gastritis. The DU patients
also had a slightly increased PCM. There was no evidence of impaired
CCK mediated inhibitory control of body function in the DU patients. The
apparently enhanced inhibitory control in the H.P+ve HV can be explained
by their lesser sensitivity to gastrin.
Conclusion: The two-fold difference in acid response to gastrin
stimulation in the H.P.+ve DU patients versus H.P.+ve HV is
predominantly due to impaired sensitivity to gastrin in the infected HVs.
A3
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NON-STEROIDAL ANTI-INFLAMMKATORY DRUGS AND THE NATURAL HISTORY OF NON-NSAID GASTRC ULCER
HELI'COBACERPYLORIIAS INDEPENDENT RISK FACTORS FOR DISEASE FOLLOWVING H. PYLOR! ERADICATION: A ONE
PEPTC ULCE-R BLEEDING GM Hawkey, S Everitt, GM Pearson, NA YEAR FOLLOW-UP STUDY IN THE AFRICAN SETTING.
ltaLCJHawkey. GI Trial Service, Division of Gastroenterology, University 1JA ntu, AK Cariem, TA Winter, W Osle, W Lucke and
Hospital, Nottingham NG7 2UH, UK. IN Marks. Gastrointestinal Clinic and Department of Medicine,Universty of Cape Town and Groote Schuur Hospital.
INTRODUCTION: Non-steroidal anti-inflammatory drugs (NSAIDs) and icto of H. ylon has been shown to prevent duodenal
Helicobacterpylori both cause peptic ulcer and its complications. Indirect ule eas.Th feto rdiaino h atrlhsoyo
and retrospective data, however, suggest that these two factors may act patic ule dieaea bee lessdiwellodocmnthed evena hithough it
independently. TheNottingham "NSAID or Helicobacter Outcomes as Peptic is now accepted that the majority of non-NSAID dpnetgastric
Emergency Referral" Study is a large ongoing investigation of the interaction ulcers are H. plnrelated. This study was done to determine the
ofNSAIDs and H.pylorn in peptic ulcer bleeding. effect ofr H. plneaitonon gastric ulcer recurrence rates
METHODS: Drug history (structured interview) and H. pylori serologic-al following heln,i an environment with a high "background"
statu (Premier ELISA) were established prospectively in consecutive patients prevalence of H. pln
and hospital controls. The controls were matched forage and sex and selected PATIENT'S AND ETHODS: Patients with endoscopically
tvoiditorionofackroud ppultio NSID sag. W reortdat Poven, H. pyloni positive gastric ulcers, without a history offrom thei firstotn256 sbjects.ud sglaiorNAIuag.cantprtdaasalicylate or NSAID use, were elbigbe for study.
R teSULTS:5Csubesadcotros. wrwelmthdfrae(be)ndsxPtitswere endoscoped at entry to study, following 4 and 8HEpyLoS:infeto andcntrAlD usre waslsiniiantlye highrinecTabl)adsesxha weeks of theray (if not healed at four weeks), four weekscontylrol Thfeseiosubect wereDmore laigiikeyt caveanetl history (PHcsstand following docunented healing and 6 and 12 months later, orcotrbThsesujeto eradis on. kl ohv as i P)adt whenever symptoms sugested a relaps. H. pyloyi status wasreportap oradmissieterinedoynhstoly (2atal de body biopsies) and RUTMeam Age Hp+~ NSAIOD PH Pain (antral biopsy).Qudatcbose weretae from the ulcer edge
Controls 68 48.1% 28.3% 13.5% 21.7% for hitlgcl vlain.Ptet were treated with omeprazole,
Case 66 77.8%** 53.8% 24.8%* 62.1%*** 20mng b o month and received amxcli, lg bd during the
*p<0.05, **p<0.Ol, **p<O.OOl first or second two weekcs of ompaoetherapy. Patients not
ABO blood group did not differ significantly between cases and controls. healed after four weeks of tretment reevda further four weeks
Twenty-thre perent of patients positive by serology had a negative CLO Of ompaoeand were not eligible for study if thiey were not
test, not explained by recet drug use. Halfof the NSAID usage in both cases haeatigtweeks.
and controls was aspirin, often as low dose cardiovascular prophylaxis. RSL :Fitonpaetswretrd. Of thes, 13 did not
Logistic regression analysis identified H. pylori and NSAIDs as the main qualfy for suy 3=.pln egtv,3=gastric carcinoma,
determining factors. The relatve risk associated with NSAID usage was 4.23 reie andt1h=defalt atfoe3vptents couldri behanae lysed.o
(95% CI 1.47-12.15,p=0.01), with H.pylori2.78(0.98-7.97p=0.06) and for the reiwanIdfal. Data 38 painscudb pW sd
interaction O.1I8(0.02-1.48,p'=O.I 1). Eaicated: 22 2 (9%)*
CONCLUSIONS: NSAID expoure remains high, is now often due to aspirin Not erdcted: 16 8 (50%) <0.01, Fishers exact
and causes substantial ulcer morbidity. H. pylori is a significant risk factor *One used salicylates for interurret problem. One of 22 subjects
which may be under-diagnosed by CLO test in bleeding patients but which was found to be re-,infected at the 6 month endoscopy.
shows no evidence of positive synergy with NSAID usage. CONCLUSION: H. pylon raiato protect against gastric
ulcer relapse in patients not taking sahicylates or NSAID)s, even in
an environment of a high background prevalence of H. pyloni.
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ULCER, DEVELOPMENT IN LONG TERM NSAID USERS IN THE LOW GASTROINESTINAL TOXICITY OF MELOXICAM, A
PRESENCE OR ABSENCE OF GASTRIC NEUTROPHILS. A DOUBLE- SELECTIVE INHIBIOR OF THE INUCIBLE CYCLOOX'YGENASE
BLIND PLACEBO-CONTROLLED STUDY. AS Taha, S Dahill,C Morra, (COX-2) ENZYMOE CJiHawkey., Division of Gastroenterology, UniversityN Hudson,C J Hawkey,F D Lee,R D Sturrock,R I Russell. Deparmnents of Hospital, Nottinghamn NG7 2UH, UK, for the International MELISSA StudyGastroenterology,Pathology,and Rheumatology,Royal Infirmary,Glasgow,and Group.
Univesity Hospital ,Nottingham,U.K.
RO:EDDU.Cn.NRecognition of two cyclooxygenase (COX) isoformns has
The link betwee gastric neutrohils and NSAID ulcers reimais unclear in stimulated development of selective inhibitors of COX-2 (induced in
humans, particularlythe long term users ofNSAID.To investigate the effect of inflammation and responsible for arthritic symptoms), which leave gastro
base-line gastric mucosal neutrophils on fuiture ulcer developmnt in such protective COX-lI prostaglandin synthesis unimnpaired. We compared
painsgsrcantral biopsies were taken from 120 patients using NSAIDs,for meloxicam a selective COX-2 inhibitor with diclofenac for efficacy and
a minimum of4 wieekcswho had no ulcers at base-line endoscopy.Patients were safety.
followed up with regular endoscopies for 6 months after beingrnoie,MEI-iQIDS: Patients with oesteoarthritis requiring pain relief were
under double-blnd conditims,to receive placebofamnotidine 20 or 40mg bid for randomised to receive meloxicam 7.5mg daily (n=4628) or diclofenac SR
ulcer prophylaxis.Biopsies,carrying code numbers,were analysed for neutrophils (n=4685) 100mng, both given once daily under double blind conditions for
count(0-3/field)aoher inlmaoycells and feature,and for Hpyloni (by one month. Comparative efficacy was assessed by visual analogue scale, and
histology,culture,an.d urease activity), other measures. All adverse events, including perforations, ulcers, bleeds
ks:laibe ulcer incidece atthe completion ofthe study,in the. (PUBs) and hospitalisations were rated for severity and relationship to drug.
absence(NEUT=O) orpresence(NEUT>0) of neutrophils,was as follows: BESLILI: Both drugs were equally effective (visual analogue scale for pain
Placebo Famotidine 20mg Famotidine 40mg on active movement 30.3 ± 27m1 meloxicam vs 32.5 ± 26m1d for diclofenac)
NEUT=O. Ulcer incidence 7.7% 12.5% 0.0% but meloxicam caused fewer adverse events.
95% confidence 0.0%.1622.2% 0.20/6-32.0%/1 0.00/.-20.6% Meloxicam Diclofenac
intervals All adverse events 27% 32%**
Patientswith ulcers 1/14 2/16 0/13 Gastrointestinaladverse events 13%19*
Withdrawal, lack of efficacy 1.7% 1.0%
NEUT>O. Ulcer incidence 47.4%/(*) 12.6% 13.0%/ Witdxrawal, GI adverse events 2.7% 59*
95% cmfidence 28.50/6.66.2% 0.0%/-26.00% 2.8%/-33.6% PUBs (n) 5 7
btervals ~~~~~~~~~~~~~~~~**p<0.001
Patients witi ulcers 13/28 3/26 3/23 There was significanly less dyspepsia, abdominal pain, nausea/vomiting and
diarrhoea with meloxicam.
(*):P<o.00l,log rank test.P=0.017,adjusted for treatment differences. NCLUSINS: Meloxicam a selective COX-2 inhibitor, is as effective in
Eight of46(8/46.17/) iDts who Hvon had utric oesteo arthritis as diclofenac but associated with fewer GI adverse events..,rr~ yr-, -DO
nmqb ,pare d widi 6974 (93%) witi both Hpyloni and neutrophils
p<.OOl).
C d the presenc of gastric nucosal n phiw or withoutH
pylon,sigificandy incrass the risk of fitu ulceaon in long term NSAID
users.However,neu ophils are more likely to exit in the presence ofHpylon
ps.ii
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RESISTANCE OF HELICOBACTER PYLORI TO METRONIDAZOLE:
AN IMAGINARY PROBLEM?
BATESON, M.C., WINN, G. 6 AHMAD, F.
GENERAL HOSPITAL, BISHOP AUCKLAND, UK.
Concern has been raised that H. pylori might exhibit
both primary and secondary resistance to nitro-
imidazoles, making these drugs less useful in therapy.
In 1992/3 102 unselected patients not on antibiotics for
at least 2 months had gastric antral forceps biopsy taken
at gastroscopy. These were sent in transport medium for
micro-aerophilic culture for 5-7 days, and then sub-
cultured with antimicrobial discs for 3 days to test
sensitivity. None were resistant to amoxycillin or
tetracycline, 2 were resistant to erythromycin and
clarithromycin, and 19 were resistant to metronidazole.
In 1996 94 patients had gastric antral forceps biopsies
cultured. Antimicrobial sensitivity was assessed using
E-test strips. Metronidazole sensitivity was tested with
a 24 hour preliminary anaerobic culture. None were
resistant to amoxycillin, 1 to tetracycline, 2 to
clarithromycinfiand only 2 to metronidazole.
RESULTS OF E-TESTING
(n = 94 patients)
ANTIBIOTIC SENSITIVITY MIC (mg/1)
mode (range)
Amoxycillin 100% 0.016 (<0.016-0.64)
Tetracycline 99% 0.016 (<0.016-0.5)
Clarithromycin 98% <0.016 (C0.016-0.016)
Metronidazole 98% 0.032 (0.002-6)
Because of the discrepancy 37 cultures were tested
for metronidazole sensitivity using both micro-aerophilic
disc culture and E-testing with preliminary anaerobic
culture. Eight cultures showed apparent resistance to
metronidazole on disc testing (MIC > 5 mg/l), but were
all sensitive on E-testing (MIC 0.002-0.5 mg/1).
CONCLUSION - Metronidazole resistance to micro-
aerophilic disc testing is a laboratory artefact, not
reflecting true insensitivity to therapy.
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HlELCOBACTER PYLORI ERADICATION THERAPY
COMPARED WITH RANITlDINE MANTENANCE THERAPY
IN PATIENTS WITH CHRONIC DUODENAL ULCER DISEASE:
A PROSPECTIVE PHARMACOECONOMIC EVALUATION. A T
Prach' M Malek2, D Hopwood3, B W Senior4, F E Murri
University Departments of Clinical Pharmacology', Pathology3 and
Medical Microbiology4, Ninewells Hospital, Dundee and Department
of Management2, University of St Andrews.
Although eradicating Helicobacter pylori (Hp) infection in duodenal
ulcer (DU) disease is widely practised, there are few prospective studies
evaluating the cost-effectiveness of this approach. The aim of this study
was to compare the health care costs over one year in two groups of
patients with chronic DU who received either Hp eradication therapy or
maintenance therapy using ranitidine. Methods. Patients with active Hp
infection were randomised to receive either 150mg ranitidine, daily [n =
58] or, Hp eradication [n = 61] using OAM (omeprazole 40mg/d,
amoxycillin 2G/d, metronidazole 1.2G/d; for 14 days), or OC
(omeprazole 40mg/d, clarithromycin 1.5G/d; for 14 days), if penicillin-
allergic. Eradication patients underwent 13C urea breath testing to
confirm success. Patients in both groups were managed according to
good clinical practice and investigated if symptoms worsened. Health
care costs in each group were quantified. Results. Hp eradication rates:-
Per protocol Intention-to-treat
Eradication rate 95% CI Eradication rate 95% CI
OAM 58/58 (100%) 0.92-1.00 56/59 (94.9%) 0.85-0.99
OC 2/2 (100%) 0.20-1.00 2/2 (100%) 0.20-1.00
Overall 60/60 (100%) 0.92-1.00 58/61 (95.1%) 0.85-0.99
Two patients failed eradication therapy because of side-effects (and
withdrew). Another did not attend for breath testing and was lost to
follow-up. At one year, of those randomised to eradication therapy,
49/61(80.3%; CI 0.68-0.89) no longer took ulcer-healing drugs. The
mean annual per patient health care costs were: £249 for maintenance
therapy and £217 for eradication therapy. Conclusion. Hp eradication
saved £32 in the first year of treatment. The saving in subsequent years is
likely to be much greater because of reduced ulcer-healing drug
prescribing and investigation costs.
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THE OPTIMUM S DAY THERAPY AGAINST
HELICOBACTER PYLORI. P Moavedi H Langworthy*,
DS Tompkins**, N Mapstone, DM Chalmers, ATR Axon. Centre for
Digestive Diseases, General Infirmary at Leeds, *Lederle
Laboratories, Hampshire, **Dept. Public Health Medicine, Leeds, UK
Introduction: H pylori therapy is usually given for at least 7
days. A shorter regimen would be cheaper and better tolerated. We
have investigated the optimum 5 day therapy with various
combinations of lansoprazole 30 mg bd (L), clarithromycin 250 mg
bd (C), amoxycillin 1 g bd (A) and metronidazole 400 mg bd (M).
Methods: Patients attending the dyspepsia clinic who were H pylori
positive as assessed by histology, rapid urease test, microbiology and
'3C-urea breath test ("C-UBT) were randomised to receive 5 days of
either LCM, LAC or LACM. The investigator was blinded to the
treatment group. Success of treatment was evaluated by '3C-UBT at
least 4 weeks after completion of therapy. Results: 143 patients
were recruited to the study (mean age 53 ± 14 years, range 21-80,
52% male). Culture was successful 84% of cases with 51%
harbouring metronidazole resistant strains. There was no statistical
difference in age, gender or smoking between the 3 groups.
Eradication rates were higher in the LCM group (38/45 - 84%) than
the LAC group (29/47 - 62%; p=0.02 Fisher's exact test). LCM was
less effective against metronidazole resistant organisms (eradication
rate 13/19-68%) than sensitive organisms (13/14 - 93%). Treatment
was successful in 46/51 (90%) patients taking LACM. There was a
trend towards adverse events being more common in the LACM
group (50%) than the LCM or LAC groups (36%) but this did not
reach statistical significance (p=0.2 x2). Conclusions: LCM is more
effective than LAC in eradicating H pylori. Adding amoxycillin to
LCM may improve efficacy but increase adverse events. Five days
of LCM appears as efficacious as 7 day regimens for metronidazole
sensitive strains of H pylori but is less effective against resistant
organisms.
RANITIDINE BISMIUTH CITRATE PLUS CLARITHROMYCIN
AND TETRACYCLINE: A SEVEN-DAY HELICOBACTER
PYLORI ERADICATION REGIMEN. M Williams. J Sercombe, R E
Pounder, Royal Free Hospital School ofMedicine, London NW3 2QG.
Introduction: The ideal regimen for treating Helicobacter pylori (H.
pylon) infection needs to be simple, short duration and well tolerated. It
should give reproducible and high levels of eradication on an
"intention-to-treat" basis. Dual therapy with ranitidine bismuth citrate
plus clarithromycin for fourteen days is a highly effective regimen for
eradicating H. pylori infection.
Aim: To determine whether, with the addition of a second antibiotic,
it may be possible to reduce the duration of treatment with ranitidine
bismuth citrate to seven days and yet maintain a high eradication rate.
Methods: A total of 48 dyspeptic patients were enrolled to this open
treatment study. All were infected with H. pylon, as determined by 3C
urea breath test +/- a rapid urease test at endoscopy. Patients were
treated with twice daily ranitidine bismuth citrate 400mg,
clarithromycin 500mg and tetracycline hydrochloride 50mng, all for 7
days. H. pylon eradication was assessed by 13C urea breath test at least
28 days after the completion oftreatment. Adverse events were assessed
by patient interview with all events mentioned, either sponteneously or
on direct questioning, considered significant.
Results: Successful eradication of H.pylori was achieved in 43/48
(90%/6). Compliance was >90%h in 47/48 (98%): 1 patient stopped
treatment after 2 days due to vomiting. Minor adverse events were
reported by 24 of the remaining 47 patients (51%) - these were loose
stools (31%), nausea (17%), taste disturbance (10%), vomiting (2%),
sore mouth (2%) and vaginal candida (2%).
Conclusion: Triple therapy with ranitidine bismuth citrate 400mg,
clarithromycin 500mg and tebtacycline 500mg, all twice daily for seven
days, is a safe well-tolerated treatment regimen that eradicates H. pylon
infection in 900/o ofpatients on a strict intention-to-treat analysis.
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EFFECT OF H. PYLORI, ASPIRIN & ANOXIA ON ANTIBIQTIC
PERMEABILITY IN THE RAT STOMACH. AF Goddard, PO Erah,
JC Atherton, PN Shaw, DA Barrett & RC Spiller. Division of
Gastroenterology, University Hospital, Nottingham. UK.
Background The flux of amoxycillin (AMO) across normal gastric
mucosa in vivo and in vitro is 10% that of metronidazole (MET). The
effect of gastric mucosal injury (as in H. pylori (Hp) gastritis) on the
flux of either antibiotic is unknown.
Aims To study the effect of mucosal injury caused by toxigenic and
non-toxigenic Hp strains on the gastric mucosal flux of MET and
AMO and compare this with the effect of aspirin and anoxia.
Methods Gastric mucosal flux (nmol.hrl1.cm2 ) was assessed using a
previously validated Ussing chamber method. Serosal to mucosal flux
from 1mM solution of antibiotic was measured over 60 min under
baseline (control) conditions and with the following added to the
mucosal chamber (n=8): 1) sonicate of a toxigenic cagA+ Hp isolate
from a DU patient (J258); 2) sonicate of a non-toxigenic cagA- Hp
isolate (Tx30a); 3) 2mM aspirin; 4) 20 mM aspirin; 5) N2 instead of
02/CO2, thus making the mucosa anoxic. Fluxes were compared
using non-parametric analysis. Light microscopy was performed to
assess mucosal damage.
Results Flux [mean(SEM)l Histological
Amoxycilin Metronidazole Damage
Control 2.4 (0.3) 20.3 (3.5) none
J258 (cagA+) 2.5 (0.6) 35.6 (3.1)** minimal
Tx3Oa (cagA-) 2.1 (0.3) 17.8 (1.5) minimal
Anoxia 4.7 (0.8)* 25.3 (4.2) severe
2 mM aspirin <0.3*** 21.2 (7.7) severe
20 mM aspirin <0.3*** 17.9 (1.6) severe
* P<0.02, ** P<0.01, *** P<0.001
Conclusions 1) AMO permeates gastric mucosa by a different
pathway than MET. 2) Toxigenic cagA+, but not non-toxigenic cagA-,
Hp increases MET permeation in vitro. 3) Increased MET permeation
is not secondary to epithelial cell junction damage (which is maximal
in anoxic and aspirin treated tissue).
AFG is in receipt of an Astra Research Fellowship
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FACTORS ASSOCIATED WITH HELICOBACTER PYLOR!
INFECTION AND DUODENAL ULCERS IN PATIENTS
ATTENDING ENDOSCOPY.
A.Oshowo. A.Botia, ELMurntaz, D.GilIam', J.Holton2, P.Boulos,
M.Hobsley. Depts. ofSurgery, Microbiology2 andEastman
Dental Institute', University College London Medical School,
London.
fHelicobacterpylori (H. pylori) is associated with peptic ulcer
diase. However,a s with H. pylon infection itself and
with duodenal ulcer (DU) disease itself need to be compard and
evaluated for their aetiological icance.
450 case-notes of unselected patients attending the Endoscopy
Clinic duing the period 1993/94, were retived and the folowing
vaiables wer recorded:- sex, age, smoking; diagnosis as
DU, oe non-ulcer dyspepsia(NUD), other nmroscopic
lesons; number of andoscopies; previous and present record of
diagosis and treatment ofH. pylori infection. The results,
analysed by loisc region anbis, were:
1. Assoced with DU: 2. Associated withH. pylori:
factor Pr factor P_
age 0.001 sex(male) 0.0001
smoking 0.0001 no.endosopies 0.0001
H. pylori 0.0138 oeso.(neg.) 0.0043
no.endoscopies 0.0122 NUD 0.0236
ROLE OF HEUCOBACTER PYLOR IN GASTRIC ADAPTATION TOREPEATED ASPRIN ADMINISTRATION IN MAN. J.W. KonIrf, A.Dembinski, W.Fuchs, J.Elbert, S.J. Konturek and W. Domschke.
Department of Medicine B, University of Monster Munster, Germany,Institute of Physiology, Jagiellonian University, Krakow, Poland, Takeda
Pharma, Aachen, Germany.
Background: The phenomenon of gastric adaptation after repeated
exposures to ASA is well documented in animals and in humans. Tne role
of Helicobacter pylon (H.pylor) as a possible patogenic factor of NSAID-induced gastropathy remains controversial. Aim: This study wasdesigned 1) to evoke the gastric adaptation in response to repeated
exposure to ASA in the same subjects before and atr eradication ofH.pbyon and 2) to examine the morphological and functional changes ofgastric mucosa during the 14 days treatment with ASA in subjects with
and without the presence of H.pylon infection. Material and Methods:
Eight healfthy volunteers (age 19-27) with H.pylri infection and no
Oastrointestinal symptoms were given ASA lg b.i.d. during 14 days.
ucosa mae was evaluated by endoscopy on the 3rd, 7th and 14thday usi modified Lanza score. uring each endosoopy mucosal bloodflow was measured using laser-Doppler flowmete. mucal biopsies
were obtained for estimation of DNA synthesis by measuring H-thyidineincorporation into DNA. Prior to each endoscopy the gastric microbeZing
was determined in three consecutive gastric washings. Three months
after successful eradicati%o of H.pylon (amoxicillin + clarithromycin +lansoprazole) confirmed by C-urea breath test and mucosal rapid urease(CLO) test the same subjects received again the 14 days treatment withASA at the same dosage and underwent the same examinations as priorto the antimicrobial therapy (lansoprazole+ amoxicillin+clarithromycin).
Results: In subjects with H.pylon infection ASA induced acute gastnc
mucosal damage mainly in gastric corpus; the endoscopic Lanza score
reached maximum at 3rd day and remained unchanged at 7th and 14thday of ASA treatment. After H.pylon eradication ASA-induced acutegastic mucosal damage also reached its maximum at 3rd day but theneclined to fall on day 14 to about 25% of initial peak thus confirming the
occurrence of adaptation. Mucosal blood flow was significantly higherbefore than after H.py/on eradication and in both cases it significantlyincreased on 3rd and 7th day. Before ASA administration DNA synthesis
was similar in subjects before and after eradication of H.pylon, howeverthe DNA synthesis rate showed significant increase on day 7 of ASA
administration only in H.pylon eradicated subjects. Gastric microbleeding
reached its maximum on the 3rd day of ASA treatment being significantlyhiQher in H.pylon-eradicated subjects than in those with H.pylon infection
This microbleeding decreased to almost normal values by end of the
study in H.pylon-eradicated subjects but remained significantly elevated in
H.pylon infected subjects. Conclusions: 1) Gastric adaptation to ASA isimpaired in H.pylon-positive subjects but eradication of H.pylori restores
the adapation and 2) DNA synthesis and possibly also mucosal celltumover in response to ASA are suppressed in H.pylon-infected patients
and this can be reversed by eradicaton of H.pylon.
MOTI S OF ULCE AND NON-ULCER ASSOCAIA D STRAIS OF
Hdirobadarlouw M Work, L Asion, RL Sidebotham*, RPH Loga* andQN Karin, Deprmts of Microbiolgy and Gatroenterology*, St. Majy's
Ho aMedical School, London,
Background Motility is a colonization faictor for Helicobacter pylon (lp),
presimbly becau it enables the bactenum to cross the viscid cuiws layer to
the nmcosal siae where it damages epithelial cels by attacmet and
cytotoxien relase. The density ofHp at the nucosal surface in the gastnc antnum
is sgnficat grar inpeip nts with duodnal uler (DU) than with non - ulcerdysepia (NUD). We have iveggat whedt this inrtant difrce in
col is due to an inhernt diffrence in motiy between ulcer and non-
uler aoated H4p trains
Methods Helicobacter pylon were isolated from endoscopic biopsies of
patitswihDU andNUD and onkured in presence of8% CO2 at 37°C in brain
heart infiision broth ppl Wed with calf snm and made selective with
antbiotics Bacteial nxiiy was quanatively mnared xi real tie wth a
Hobson BacTracker in broth (DU n = 14; NUD n = 13) at dififrat phases of
the grwth cyc, and also in medtyl celse (MC) ofmoleular weight 14 Kd(DUn = 6; NUD n = 6) rangig in viscosity from 5 - 50 centipoises (cp) to
Simulate the high viscoshY of the gaatic nwcus layer Data a reported as
criie veocity (CLV, pm/s), S & lie veloc (SLV, pm(s) and trackli (raio SLV/CLV). Staticsareby Mnn-Wbiney U-test.
Resuls (1). Modkies ofHp fiom DU and NUD paiets, when expressed as
CVL and track lineat, were not gi diffisit from each other when
measured in broth or in MC. (2). Helicobacter pykoi were, however(p < 0.01) more motile in brI when in log-phase t in lag or
tatoar phases of grwth [man CLV; lag phase 5.9 (DU) and 5.9 (NUD)
pm/s, log phase 28.7 and 28.4 pm(s, ataiony phase 6.3 and 6.4 pm/s]. (3).
Motilty ofHp in log-phase deceased i (p < 0.01 ) when the bacteria
were tiansfaed from broth (mean CLV 28.9 (DU) and 26.8 (NUD) pm/s), to
MC viscosiky 30 cp (mean CLV 5.7 and 5.8 pm(s), and ceased in MC viscosty
50 cp (mean CLV 4.7 and 4.9 pins - Brownian movemnt only). (4) Track
liy of Hp in log phase was aho greater (p < 0.01) in MC
viscosiy30 cp (0.91 (U) and 0.89 (NUD)J ta in broth (0.38 and 0.34).
Co en The greter densky ofHp at the antral nucosal suface in DU
pats when copared with NUD paiets is not due to an iherent difibrerce
in motilty ofthe ulce and non - ulc associated s: log phase 14 ehibit
slow - liearmotiy in highviscoskym inm Tespeciive ofsource.
DU 0.0156
Conclusions: Smokin remainsst ocied with DU.
eOphagitis is ne v a with H. pylon. It is intereting
however, that tie number ofendosAopy a patnt has undergone
posiivey infunce H. pylon status. The natu of this ink
between H. pylon infection and the number ofendcopies is
uncertain and requires futher inm gai, bu these facts suppon
a previously pubished study.
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PROLONGED ACID SUPPRESSION THERAPY AND
PROXIMAL MIGRATION OF HELICOBACTER PYLORI.
H Ihmaidat, CK MacKay, H Kasem, CR Carter, J Going*, JF
MacKenzie**, RC Stuart.
University Departments of Surgery, Gastroenterology" & Pathology*,
Glasgow Royal Infirmary, Glasgow
Intestinal metaplasia at the oesophago-gastric junction(OGJ), present
in 15-30/o of dyspeptic patients is a risk factor for adenocarcinoma.
Aim: to investigate whether Helicobacter pylori(Hp) or prolonged acid
suppression therapy is associated with intestinal metaplasia at the OGJ.
Method: At diagnostic endoscopy, biopsies were taken from gastric
antrum, body and OGJ in 190 patients. None had Barrett's oesophagus.
Hp status was assessed using Cresyl Violet stains. Intestinal metaplasia
was defined as the presence of Goblet cells seen on Haematoxylin &
Eosin and Periodic Acid Schiff Alcian Blue stains. Patients were
interviewed regarding duration of acid suppression therapy. Results: 62
patients had intestinal metaplasia at the OGJ, with Hp at the antrum in
65% and OGJ in 43.5%. This compared with 42.3% (p<0.01) and




Antrum +ve Antrum +ve Antrum -ve
& OGJ -ve & OGJ +ve & OGJ -ve
Total 3.5* 24* 12
(0-180) (0-216) (0-192)
Normals 4 20 12
(0-180) (0-2 16) (0-192)
Intestinal Metaplasia 2 24 15
(0-144) (0-204) (0-168)
Values: Median(range);*p<0.05 by Mann-Whitney U test.
Conclusion: Patients with intestinal metaplasia at the OGJ are
significantly more likely to be Helicobacter positive. There is evidence of
proximal migration ofHelicobacter in these patients. Prolonged acid
suppression therapy favours the migration ofHelicobacter pylori into the
proximal stomach. H. pylori eradication should be considered before
starting maintenance acid suppression therapy.
W25
W26
BACTERIAL CagA STATUS IS UNRELATED TO GASTRIC
FUNCTION INDEXES OR TO THE TYPE EITHER SEVERITY OF
SYMPTOMS IN PATIENTS WITH H.pylori-POSITIVE NON-ULCER
DYSPEPSIA (NUD).
F.Parente,V.lmbesi,G.Maconi,C.Cucino,O.Sangaletti,G.Bianchi Porro.
Gastrointestinal Unit, L.Sacco University Hospital, Milan, Italy
It has been widely shown that H.pylon (HP) infection induces
disturbances of gastric function in patients (pts) both with duodenal
ulcer and NUD. Little is known, however, about a possible
relationship between such disturbances and the bacterial strains.
Aim of this study was to assess whether gastric function parameters
and dyspeptic symptoms are related to CagA status.
Methods. 38 consecutive pts with HP-positive NUD were examined.
They had suffered from dyspepsia for > 6 months and none of them
had macroscopic lesions at upper GI endoscopy. HP positivity was
determined bN means of histology and urease rapid test on antralbiopsies and C-urea breath test. No pt had undergone previous anti-
HP therapy and any medication was discontinued at least 3 weeks
prior to the study. Dyspeptic symptoms were classified into 3 different
categories according to the predominant complaint, and scored for
severity from 0 to 3. In all subjects basal (BAO) and pentagastrin
stimulated acid output (MAO), fasting and meal-induced gastrin
concentrations, fasting pepsinogen I (PG I) levels and gastric
emptying of solids (by means of ultrasounds) were measured. CagA
status was determined indirectly by assaying serum CagA IgG
antibodies by commercial Westem-Blotting (Helico-Blot,Genelabs).
Results. 17 of 38 NUD pts were CagA seropositive (45%). Mean BAO
and MAO values of CagA seropositive pts (3.0±2.8 and 20.4±7.6
mmol/h,respectively) were comparable to those of seronegative pts
(3.8±2.5 and 23.5±7.3). No significant differences were found in
fasting (55.9±14.4 vs 57.2±11.6 pg/mI) and stimulated gastrin levels
[23370 (AUC) vs 21719] between the two groups. Similarly, gastric
emptying of solids as well as the type and severity of dyspeptic
symptoms did not significantly differ in the two groups of pts. In
contrast, fasting PG I levels were higher in seropositive than
seronegative pts (98.8±33 vs 79.4±32.6 ng/ml, p=0.07), concomitantly
with a higher degree of antral inflammation at histology.
Conclusions. Our findings indicate that gastric function disturbances
associated with HP infection and the type and severity of symptoms
in NUD pts are independent of bacterial CagA status.
DETECTION OFHELICOBACTER PYLORIFROM GI
SECRETIONS USING PCR.
A.O o J.HoIo, D.Gamn2, A.Bot, P.Boulos, MhHobslcy.
Depts. ofSurgery, Microiolokgy andEastman Dental Insh&W,
Univrsity Coee LxmdonMedical Sckhe London
- 0dOrakrand oral-fcal sad hae been
u_I~eo X the routc of -_ion ofHeicbacterpykiri(HP).
However, thesuce and route oft Onfsnre nal
AMmTo i e serei imn th uppa (I tract for
tra.mun,Iio potentian HP infectio
Mtd- Sixty patient rfened for rouine nd for
dysppic sympton were sudid 3 stric biopsie wer taken for
culture and he rapid urease tes Gt juice and d D 2)
aspirte wee collecd for culu and PCR.
Rai
HPpevaence (%I n = 60
C PCR UrcFc tea
Gastric biopsy 20(33%) 33(55%) 21(35%)
Gastricjuie 0 9(15%)
Duodenal ap. 0 5(8%) -
In sumiay, HP could not be cvuured from the secretou, but it
was culured fiom 33% of the gatric antral biopsies. In 8 and 15%
of patients, PCR forHPws positie m th duodenal and gatrc
scretions r vely, but only after c n to pduce
pellets. Thse patient wcre abo posidt by cuhture of the biopsies.
ConclusIon- Gast stinal secretion may harbour
Helicobacter pylori and play a sgnc role in the trns in,
especially in vomit and diaffhoeal diseas. However, it is not
known whether the PCR-detected o sms were dead or aive.
CULTURING H. PYLORI FROM GASTRIC ASPIRATES: THE
EFFECT OF ACID IN VVOAND1N VTRO.M Wliams', A Lawson2,22 1 1E Slater, R J Owen , R E Pounder, Royal Free Hospital School of
Medicine, London, 2Centrdl Public Healffi Laboatory, London.
Introduction: Atempted culue of H. pln (Hp) from gastric aspirate
yields poor resuls. Could finreased ntagiic pH release Hp from the
gastric mucosa into the himen, fri:itagHp culture frno gatric aspirates?
Methods: 6 seial moning gstric aqsates, 3 befbre and 3 during dosing
with omepok 40mg bid, were obtained fiom each of 11 healthy
vohmtwees. 10 were infected with Hp and 1 non-infected, as detmined by
serology and 13C urea brath tet Asites were taken after an oveight fst,
via a nasogastric tube insted 10 mm prior to sampling pHmetry was
pformed on eah aspirate. 5 ml of asprate was added to Helkobacter
trasport medium for cutue widin 2 hous Culue was blind as
to Hp and dosing stat. Aspiateswe incubated with Sputosol, centrifiged
and the rulting pellet resuspended in maximum recovery dihuent (RD).
Portions of resnpended aspirate were dihlted for 5 min eithe with 1:10
MRD or with 1:10 HCI-KCI buffer(pH 22) toreduce onamiair with
mper respiratoy hta flora (URTF). Aliquts fiom both were inoculated on
10% Columbia and Dents selective agar. Hp was ientified by morphology,
urease acfivity and detection ofthe ureA/B genes PCR.
Results: Maximum Reovery HCI-KCI Buffer
Dilu (n=60 n=56
POS (I/6) NEG (%/) POS (%) | NEG (%)
Before omeprazole 14 (47) 16 (53) 20 (77) 6 (23)
During omepra 3 (10) 27 (90) 20 (67) 10 (33)
HCI-KCI buffer gave sgnificantly higher yieds of Hp compared to MRD,
both before (p=0.02) and during (p<0.0001) omeaole dosing. Omeale
reduced the yield of Hp with MRD (p=-.002) but had no effect with HCl-
KCI (p=O.4). All Hp infected subjects yielded at least 1 positive aspirate fo-
HCI-KCl, whils 2 sbjects yiekled no positive aspirtes for IRD. Aspirates
firm the uninfected subject wer all negative by both methods.
Condcusion: 1. Isolation ofHp from the gastric aspirtes ofHp infected
subjects is inhibited by URTF overowing Hp colonies. 2. The addition of
acid in viro facilitat the isolation ofHp, by inhibitingURTF. 3. Decreasing
intagastric acidity in viw, using omeprazole, does not affect the isolation of
Hp using the HCI-KCI method Ti suggests that the apparent inhibition of
Hp culture by omeprazole is due to competition from URTF.
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A NEW MINIMALLY INVASIVE SURGICAL
TECHNIQUE FOR GASTRIC LEIOMYOMAS.
.CC.Hpwonrh, J.Muthusani, D.Menzies, R.W.Motson. Colchester
District General Hospital, Colchester, Essex UK.
A new surgical technique has been developed for dealing with
gastric leiomyomas. This is perfod under a general anaesthetic
and with the patient supine. The patient is gastroscoped to assess the
position of the leiomyoma. A 30 degree telescope is then inserted
through a 10mm umbilical port. The stomach is visualised and a
suture is passed through the anterior abdominal wall directly over the
anterior aspect of the stomach. This suture is then passed through
the anterior wall of the stomach and then back through the anterior
abdominal wall. A second suture is passed in the same way adjacent
to the first. Traction on these sutures therefore lifts up the anterior
wall of the stomach. A 10mm port is placed under direct vision in
the left upper quadrant. Using cutting diathermy a transverse
incision is made through the anterior wall of the stomach below the
sutures. Visualisalion by means of the gastroscope ensures that the
incision is placed allowing best access to the leiomyoma. The gastnc
leiomyoma can then be seen and grasped by Johannes laparoscopic
graspers. A second port (12mm) is positioned in the right upper
quadrant. Through this can be placed an endoscopic linear cutter.
Traction on the laparoscopic graspe pulls the lciomyoma through
the transverse incision in the stomach. The linear stapler can then be
placed across the stomach beneath the leiomyoma. Sequential
applications and firings of the linear staple removes the leiomyoma
and simultaneously closes the stomach. The anterior gastrotomy is
closed with a single layer of maxon.
Bianila Eight patients, median age 77 years (range 33-83 years)
who have presented with gastric leiomyomas have been treated. No
deaths or compication occured. One patient requird conversion to
an open procedure as the leiomyoma was very large. Following this
procedure patients are mobilising and allowed to drink and eat the
following day. The median length of stay in hospital was 5 days
(range 4-7 days). The patient requiring the open procedure remained
for 8 days. No peri or post operative blood transfusion was
required.
Conclusions This is a safe and effective technique. It allows
earlier mobilisation than conventional laparotomy.
LONG-TERM SURVIVAL, SYMrTOMS AND DRUG USE AFTER
ETIC ULCR HAEMORRIIUAGE
A Flvak, J Masson, L Bucnr, G McKnigt, P Branleyf, WC Smith,
NAG Mowat. GI Unit, Aberdeen Royal Infirmary', Dept ofPublic Health
AberdWn Uniwrsutgi Aberdeen UK
Aldmgh peptic ule ithe cXnmnomeatm onroes ofr per 01 bleding tdh are
no umelxctd publised dat on th long-tarm foow up.
Over a 2 year period out ofa woe co it po of 468,000, 414
p _a (421 a ) bled from peptc ulen Jd were a_ led to a singe
dedicated uni in Abadeu Of 414 patit 406(98.1%) were followed up
(nme 29.8 mod.) ad a doeiledqe ire ue d.
1I 30 day mortality wa 7.2% (m ae 79 yrs). A fiar 71 deaths
during folow up save an ovellmotali of 24.8% Thbeawn age at
wa 76 yeas Lifi t analyi co e d s nitced
revead n excess morlity ian e peptic u r group but only mt first year
of flow-p, ad by 5 yeas t overd moraity wa equa. Only one death
du to bbedi occed after 30 das. Cm ofAspirin ad NSAED in
cmbination (odds raio 2.4 (1.0-5.6)) but nt inddally, ad bbeed with
no prior abdominal pain (odds ratio 1.7 (0.9-3.3)) were asociatd with reduced
survival.
At filow-up 50.6% of painu had no dyspepsia. I e acid
suppression therapy was prscribed for 58.4% of patiets. Of thos
cdisea patiet on low dos aspirin (14.3%), acid s
terapy wa co-pecibed in 74.3%. Only 2.4% pa s were NSAIDs.
No.were n high dose aspirin nor aspirin plus NSD cobination. This
c ts with 21% taking acid suppr therpy ad 45% aling aspirin or
NSAID at the time of their ii p a.
Twety-re(9.4Y) pets reported upper GI bleig dunng follow-up but
only 6 (2.4%/*) required further hospital adminion.
In U. long-term U. mmyority of patients are ac. Rocurrent
bleeding is rare. After pepic ulcer ha orage bo early and le mortality
are pnncipally related to concurrnt da in an lderly population.
Canpared to contols there is an inial incased morlity rae which is not
sstained past the first year, and by 5 year surval is identical.
THE CHANGING PATTERN OF OESOPHAGO-GASTRIC CANCER.
JW ll OJ Craig, CS Bigg SA Run and SM Griffin
The OossphageGatric Cancer Unit, Newcatl General Hospitl, Newcastle upon
Tyn. NE4 CBE. UK.
The aim of this study wer to k objective evwidnc for clinicaly perceived
change in th natemical distribution and ge of prntation of cas of oesophgo-
astric maincy.
The recosf thU Nrthe Rein Ccr Retry over a ten yr period fron
1964 wer oxmine for oesophgeal and gastric ccr reistration. Data for age at
an prcis site ef tuer w oextracted. Incidce wa calkulated fron
published anl OPCS seal P*pution stattics. Chnp of quinquenium incidence
and e at prwnttionm an d by thU unpaired t -tet. Rets are given as
- (semI
10,172 cu t p cancr reistrations wer ientifid. The nan
anu in of p e caonr Oer tU 10 yr pwriod wa 34.4 cases
per 100,000 p_publtin an tU. ime oe ef densis wu 72 (rang 18-100);
hr changd signficntly ew the peie of thU study. The iniec of
_seplmgel cancr rm frm 9.8210.37) cases per 100,000 in the poerd 1984 to
IBS tO 11.24 (1.81)conper 100,000 in th pwrisd tO 191. (P-0.17). The
incidence of goat cancor i sightly frmn 25.3 (0.57) cases per 100,000 to 22.4
(2.99) cases per 100,000 (P- 0.10. Pyric a antra can fel markedly in
indce fren 2.1310.70) to 0.94(0.12) cases per 100,000 (P-0.02). Ths ratio of
gatric cardla to pyriclantrl Can re fra 1.06 to 2.03 (P-0.01) owe the
two five yr periods Patients with carl cancs were digoe at a consistently
youngr ap tha patints with distal gatric cancer (U.8 (0.53) vs 71.4 (0.48) Yars
P-0.002). Lewr third_spageal cacr - diagnd at a simar eg to cardia
patents (66.4 (0.45) yeas; P-0.4) ad similaly eorlier thn distal astric cancer
patints (P-0.007).
The pattern of s t cacer ha chaed in . pwried 1964 to 1993;
distal gstrccaer ha becm ls como. Patints in U. p e a
incre group with adnocinm ef thU c andccJunction
have a yeungr eg of prstation.
DENTAL PLAQUE AS A RESERVOIR FOR HELICOBACTER
PYLORI (HP): DOES IMMUNOCHEMISTRY ANSWER THE
QUESTION?
M.G..Marinone*, D.Facchinetti, R.Negrini§, E.Savoldi*, A.Turano§,
P.Sapelli*, A. Lanzini. Medicine 1, Dentistry* and Biochemistry and
Virology §. Spedali Civili and University. Brescia. Italy.
Presence of HP in dental plaque is controversial, a discrepancy
attributed to differences in methodology. Our aim was to validate and
apply for the first time an immunochemical technique to detect HP in
dental plaque.
80 consecutive patients (M:F=44:36, age range 16-87 years)
undergoing endoscopy were examined for oral hygiene and a sample
of dental plaque was removed before the procedure. Subjects on
antibiotics or using antiseptic mouth-washing were excluded. Oral
hygiene was classified using the Loe and Silness plaque and gingival
index. Dental plaque was obtained with a sterile Gracey curette, from
at least 5 dental elements, suspended in sterile saline, smeared on a
slide, dried, fixed in ethanol 900 and stored at 4°C until examination
All patients had six biopsies taken from antrus, body and fundus for
microscopic examination and a sample of blood for detection of HP
antibodies. Plaque smears were tested by indirect immunoperoxidase
technique based on a mixture of two monoclonal antibodies specific
for HP ( Negrini R. Gastroenterology 1989;96:414-20); its sensitivity
and specificity were both 100"h when tested on plaque samples
artificially enriched with HP.
51 patients (64%) were HP infected, as diagnosed by concordant
histology and serology. All of them had variable degree of active
chronic gastritis on microscopy and 15 had peptic ulcer. In none of
these infected patients was HP detected in dental plaque. Furthermore
the 400 dental plaque samples from the whole study population were
all HP negative. No relationship was found between oral hygiene
scores and presence ofHP in the stomach.
In conclusion, our results using a highly sensitive method for
detection of HP in dental plaque suggest that plaque is not a reservoir
for HP infection.
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SMALL INTESTINAL CRYPT HYPERPLASIA IN AFRICAN
TROPICAL ENTEROPATHY. AM Veitch', P Kelly', N Luo2, I
Segal3, SK Spies', MJG Farthing. 'Digestive Diseases Research
Centre, St Bartholomew's & The Royal London School of Medicine
& Dentistry, London, 2University Teaching Hospital, Lusaka,
Zambia & Gastroenterology divisions of the Universities of
3Witwatersrand and 4Pretoria, South Africa.
Introductio ad aims: We have previously found evidence of
tropical enteropathy in the healthy black population of Lusaka,
Zambia, but normal villous architecture in urban black South
Africans. In addition, we have demonstated increased mucosal T cell
activation in the Zambian population compared to South Africans. In
this study we have sought to determine wheth6r, like other T cell-
mediated enteropathies, tropical enteropathy is associated with crypt
hyperplasia.
Patients and methods: 12 black Zambian subjects, 22 black South
Africans and 21 white South Africans undergoing routine upper
gastointestinal endoscopy for dyspepsia (GU, DU, diarrhoea and
AIDS excluded) were studied. Formalin-fixed parffin-processed
biopsies were assessed by computerised image analysis to determine
villous height (VH) and crypt depth (CD). Duodenal biopsies, fixed
in Carnoy's solution and stored in 70%'/oethanol, were stained by the
Feulgen reaction. Crypt mitotic counts were determined by direct
counting of stained mitotic figures in microdissected crypts.
Results: Median VH was lower in Zambians [283 (262-389)gm]
than black South Africans [412 (235-456)un] or white South
Africans [377 (285-530)] p=0.03, but CD was not significantly
different between the groups. Median mitoses/crypt was greater in
Zambians [3.7 (1.9-7.9)] than black South Africans [2.4 (0.2-3.7)] or
white South Africans compared [2.1 (1-3.7)] p=0.003.
Conclusions: We have confirmed the presence of tropical
enteropathy in urban black Zambians, and its absence in urban black
and white South Africans. Our data suggest that tropical enteropathy
is associated with crypt hyperlasia, although this was not
accompanied by an increase in crypt depth.
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DETECTION OF INTRALUMINAL SEROTONIN (5-HT) IN
PATIENTS WITH HIV-RELATED DIARRHOEA. Kelly P.
Turvill JL, Farthing MJG. Digestive Diseases Research Centre, St
Bartholomew's & The Royal London School of Medicine &
Dentistry, London, UK.
Introduction: The pathogenesis of HIV-related diarrhoea remains
unknown and the role of 5-HT as an endogenous secretagogue or
prokinetic in this condition is unexplored. Enterochromaffin cells,
when activated by enterotoxins, are known to release 5-HT into the
intestinal lumen, where it can act as a secretagogue. We investigated
whether excess 5-HT is released into the small intestinal lumen in
patients with HIV-related diarrhoea.
Methods: Duodenal aspirates were obtained at upper
gastrointestinal endoscopy from an unselected group of 69 HIV
infected patients with persistent diarrhoea, and from 8 diarrhoea-free
control patients being investigated for dyspepsia. Aspirates were
collected into protease inhibitors, frozen to -80'C, and 5-HT
concentrations determined by HPLC with fluorimetric detection.
Results: 5-HT concentrations were close to the limits of detection
in all of the control aspirates (0-0.53nmol/1). 5-HT concentrations
were markedly elevated in a sub-group of the patients with HIV
related diarrhoea (range 0-224nmoV1I). Of the patients with HIV
related diarrhoea, 45 (61%) had 5-HT concentrations at control
levels, whereas 27 (39%/o) had markedly elevated concentrations
compared to controls (p=0.04 by Fisher's exact test). Aspirate pH
was not related to 5-HT concentration and some of the higher values
were seen in aspirates with pH>7.0. The group of patients with high
5-HT concentrations was not defined by enteric infection,
immunoglobulin or soluble tumour necrosis factor concentrations in
serum, immunoglobulin concentration in duodenal aspirate,
nutritional status or severity of enteropathy.
Conclusion: In a sub-population of patients with HIV-related
diarrhoea, intraduodenal concentrations of 5-HT were up to three
orders of magnitude higher than in controls. While the clinical
relevance of this observation is as yet unclear, similar concentrations
have been detected in jejujnal perfusates of human volunteers with
cholera toxin-induced secretion. These observations raise the
possibility that 5-HT may mediate some of the pathophysiological
disturbances which underlie this disorder, suggesting novel
approaches for therapeutic intervention.
INHIBITION OF CHOLERA TOXIN BUT NOT E.COLI
ENTEROTOXIN-INDUCED SECRETION BY SUBSTANCE P
(SP) ANTAGONIST. Turvill JL. Farthing MJG. DDRC, St
Bartholomew's& The Royal London School ofMedicine, UK.
Introduction. SP is known to evoke neurally mediated small
intestinal fluid secretion in several animal models. Furthermore, SP
antagonism inhibits the inflammatory enteritis caused by C. difficile
toxin A.
Aim. We investigated whether SP mediates the non-inflammatory
secretory state indued by cholera toxin (CT) and Escherichia coli
heat labile (LT) and heat stable enterotoxins (STa) in vivo.
MethodLCT and LT experiments: Anaesthetised male Wistar rats(180-220g) were pre-treated with the selective SP antagonist D pro2
D Trp79SP (PTT-SP) 3.0mg/kg ip. 20cm small intestinal segments
were isolated between cannulae into which 25gg CT or 25gg LT in
2ml saline was instilled and incubated. After 2h, in situ perfusion
was performed with plasma electrolyte solution (Na 140, K 4, Cl
104, HCO3 40 mmol/l) containing [I4C]-polyethylene glycol as a
non-absorbable marker. After an equilibration period, 3xlOmin
collections were made and net fluid and electrolyte movement
determined.
STa experiments: After pre-treatment with 3.0mg/kg PTT-SP, thejejunal segment was perfused with PES containing ["C]-PEG to
which 200jg/l STa (equivalent to 50000 mouse units) had been
added.
Results. CT-induced net water secretion (median -94.0pi/min/g dw[IQR -106.5 to -63.0]; n=ll1) was significantly reduced by pre-
treatment with PTT-SP (-10.4 [-42.5 to -4.1]; n=7, p<0.002). LT-
induced a similar degree of sezretion (-67.6 [-89.4 to -33.0]; n=16,
p=0.08 compared to CT control) which, by contrast, was notinhibited by PTT-SP (-50.7 [-67.6 to -35.3]; n=16, p=0.3). In the
same way, STa-induced secretion (-65.3 [-83.2 to -54.6], n=6) was
not effected by PTT-SP (-77.4 [-81.9 to -76.2]; n=5). Electrolytes
paralleled water.
Conclusion. The finding that the SP antagonist PTT SP significantly
inhibits CT but not LT or STa-induced secretion is consistent with
the observation that there are fumdamental differences in the way
these three enterotoxins activate a secretory reflex arc in the host.
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PARAOXETINE INHIBITS CHOLERA TOXIN INDUCED
SECRETION BY DEPLETING NEURONAL BUT NOT
ENTEROCHROMAFFIN (EC) CELL 5-HT. Turvill JL, Farthing
MJG. Digestive Disea Research Centre, St Bartholomew's & The
Royal London School of Medicine, UK.
Introduction. Depletion of the secretagogue and neurotransmnitter,5-HT, from the small intestine partially iihibits cholera toxin CT-induced secretion. Since a substantial proportion of this secretion is
neuronallymediated we postulated that a greater anti-secretory effect
may resut from the selective depletion of neuronal 5-HT from the
small intestine. We investigated whether the selective serotonin re-
uptake inhibitor, paroxetine, would cause neural but not EC celldepletion and whether this would result in the inhibition of CT-induced secretion in vivo.
Methods. Two groups of male Wistar rats (180-220g) were gavaged
for three days with paroxetine 3mg/kg in 1 ml water or water alone,
and then anaesthetised. In the first group, the mucosa was gently
scraped from the deeper small intestinal layers and 5-HT levels weredetermined by HPLC with fluorimetric detection. In the second
group, 25pg CT in 2ml saline was incubated in 20cm small intestinal
segments, isolated between cannulae. After 2h, in situ perfusion wasirformed with plasma electrolyte solution (Na 140, K 4, Cl 104,iC03 40mmoI/l) containing [ 4C]-PEG as a non-absorbable marker,
to determine and net water and electrolyte movements. Whole brain
was then removed for detemination of 5-HT levels as described
above.
Results. Mucosal 5-HT levels (med 81.0pmol/mg dw [IQR 65.3 to851; n-9) were unaffected by pre-treatment with paroxetine (87.5[74.3 to 112]; n=6, p=0.4 MW). By contrast, brain 5-HT levels(9.4pmol/mg [8.7 to 10.11; n=8) were significantly reduced byparoxetine 0.9 [0.8 to 1.0]; n=7, p<0.001). In keepimg with these
findings, C -induced net water secretion (-101 .2 ±l/min/g dw [-146.5
to -74.9]; n=14) was inhibited by pre-treatment with poxetine (-
33.2 [-49.5 to -18.6]; n=6, p<0.005). Electrolytes paralleled water.Summary and conclusion. Paroxetine depletes neuronal 5-HT, asdemonstrated by a reduction in brain 5-HT, but not EC cell 5-HTlevels within the small intesn mucosa. We postulate that the
associated inhibition of CT-induced secretion results either from (i)
the depletion of 5-HT within the myenteric plexus or (ii) thedesensitisation of submucosal nerves, which are unable to re-uptake
the 5-HT released from activated EC cells.
Gut 1997; 40 (suppl 1)
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ISCHAEIA-RE PERFUSION INJURY FOLLOWING
SYNGENE5IC SMALL DOWEL TRANSPLANTATION INDUCES
APOPTOSIS
KASaL S Shurey, CJ Gren (introduced by AB Price)
Depatment ofSc Resel, Northwick Park Institute for Medical
Reserh, Northwick Pak Hospital, Harow, Middlesex, HAl 3UJ, UK.
Two componets cause graft injury following small bowel
plantation; the damage induced by cold ischaemic storage and
exacebation ofthis following reerfusion. Te combined manifestation,
termed ic iafusion injury, has been described morphologically
as causing vilous destucion and crypt loss. Many of these cellular
changes have been attibuted to necrosis.
In a morphological study on syngmeic small bowel tnplantation in
Lewis rat, grfts werc stored in saline (n=6) or University ofWisconsin
(UW) solution (n=6) for 24 hours and trnplanted with portal venous
drainage. Samples of the graft obtained before harvest, after cold
ischaemic storage and after I hour ofreperfusion were processed for light
(LM) and electron microscopy (EM) using conventional protocols.
Grft storage resultd in loss of villous integrity (saline worse than
UW), but adequate crypt prscvation. Apoptosis ofsome denuded villous
epithelial cells was noted; there was no increase in crypt cell apoptosis
compared to normal.
After one hour of pon, there was extensive villous destruction.
Variable crypt loss was observed, with saline stored grafts showing more
damae than UW stored ones. 'Te preserved crypts showed karyorrhectic
debris and chromatin magnton on LM suggestive of apoptosis, which
was confirmed on EM. Some crypt cells exhibited condensation with
nuclear and cytoplasmic features of "dark cells". A minor increase in
acute inflammatory cells was noted in the lamina propria. Only an
occasional crypt cell showed ultrastructural features ofnecrosis.
This study has identified apoptosis as a prominent mode of cell death
following ischaemia-reperfsion injury in transplanted small bowel. This
has possible implications on general intestinal ischaemic injury and on the
development of specific therapeutic interventions.
ATYPICAL PRESENTATION OF COELIAC DISEASE: A
RETROSPECTIVE REVIEW OF ONE INSTITUTION'S
EXPERIENCE
RMSMitSchel, TJ Robinson. Dept. ofMedicine, Craigavon Area
Hospital, Northem Ireland
It is known that only a minority ofpaties with coehac disease
presen casically with diarhoea, steatorrhoea and features of
malabsorption; features at presentation are more likely to be red cell
abnormalties such as per macrocytosis or inreased red cell
distribution width, weit loss or conctirrt e diseases. In
our population the prevalence of coeliac diease is high apd often
presents atypically.
Clinical and laboratory data were collected from 127 consecutive
patients diagosed histologically with gluten sensitive enteropathy
with special reference to the ages at which the patients first
developed significant manifestations of the disease, when the disease
was diagnosed and the cause ofthe delay.
70 (50 female) of the 127 patients hada s c delayindiagnosis. Mean age at diagnosis ofthose diagnosed at initial
presentation was 43.6 years (males 45.1, females 42.9); mean age in
those whose diagnosis was delayed was ignifibhighe at 48.5
years (males 48.9, females 48.4, p<0.03); in this group the mean
delay was 107.3 months (range 6-480). In 44 patients (33 female)
red cell abnormalities only were present; 15 patients had an isolated
persistent macrocytosis which resolved on gluten-free diet. 17
patients (9 female) had gastrointestnl symptoms ofmalabsorptionbut presented late. 2 patients presented with a concurrent associated
disease and 5/50 female patients only had symptoms during
pregnancy.
In conclusion, the majority of our patients did not present
classically, therefore a high index of suspicion is required to diagnose
these patients, especially in patients with refractory red cell
abnormalities in populations where the condition has a high
prevalence.
INTESTINAL PERMEABILITY AND ABSORPTIVE CAPACITY
IN PATENTS RECEIVING PARENTERAL NUTRITION. WS
Wassif, R Crane, H Thadani, L Thompson, C Wicks, WJ
Marshall, I Bjamason. Department of Clinical Biochemistry,
King's College School of Medicine & Dentistry, London
Background: It has been suggested that there is a dual
supply for enterocyte nutrition, namely luminal during absorption
and blood bome durng fasting. In rats parenteral nutrition leads
to aiterations in motility and villus atrophy, but the effect of
fasting and parenteral nutrition in man is largely unknown. Aim:
To assess small intestinal permneability and absorptive capacity
in patients requiring parenteral nutrition following prolonged
fasting and responses to re-feeding. Mto: Weekly
assessments of intestinal permeability (lactulose/L-rhamnose)
and absorptive capacity (3-0-m-D-glucose, D-xylose, L-
rhamnose) were made in 9 patients requiring parenteral
nutritional support (for 15 median, range 8-29 days). Results:
Six of seven patients having been nil by mouth for at least a
week had signfianty (p<0.01) increased intestinal permeability(differential urinary excretion of lactuiose/L-rhamnose
0.18±0.13) as compared with heafthy controls (0.03±0.02) and
the two who had some oral intake (0.03±0.01). Furthermore
absorptive capacity was significantly (p<0.05) impaired in the
fasting patients (3-0-m-D-glucose 26.5±19.5%, D-xylose14.2±12.2%/o, L-rhamnose 3.7±2.8%) as compared with controls(44.6±7.7%, 30.7±7.3% and 10.5±2.5%, respectively). There
was a further deterioration in intestinal perenabUity and
absorptive capacity in patients on total parenteral nutrition
without oral intake, but not in those concomitantly receiving oral
supplementation (500-800 kcal/24 hours). Within a week of re-
establishing oral intake intestinal permeability retumed towards
the reference range (0.066±0.02) and absorptive capacity was
restored (3-0-m-D-glucose 48.1±21.3%, D-xylose 26.9±11.5%,
L-rhamnose 8.5±3.9%). Conclusions: Blood bome nutritionduring total fasting is insufficient to maintain gastrointestinalintegrity in man which may have implications for microbial
translocation and endotoxaemia. As small amounts of food
prevent this deterioration every effort should be made to
maintain some enteral intake in these patients.
Presentation and Incidence ofCola Disease nSouth Glamog.Hawkes ND,Swift G.L, Davies A ,Rhodes J,Smith P.M,Jenkins H.(Departments ofChild Health & Gastroenterology, University Hospital ofWales, & Department of Gastroenterology, Llandough Hospital, Cardiff )
Ainm 1) To assess the number ofnew cases of Coeliac Disease (CD) and
Dermatitis Herpetiformis (DH) and the symptoms at presentation in both
adults and children between 1" January 1991 and 31" December 1995 for
the resident population of South Glamorgan. 2) To compare incidence rates
with comparative data for the period 1981-1990.
Method& All children (aged <14 years ) and adults with CD or DH
diagnosed during the study period were identified from hospital activity
analysis data, pathology and dietetic records, letters circulated to local
General Practitioners and through the local Coeliac Society. All had
histologically proven disease and fufilled the fully revised ESPGAN criteria.
The Registrar General's mid year estimates for the population of South
Glamorgan were then used to calculate incidences.
ReuaL A total of 59 new cases ofCD were identified (9 children,50
adults) and 5 cases of DH(all adults). In the children (4 boys,5 girls) the
mean age at diagnosis was 7.6 years (range 1. 7- 14.9). 77% presented with
abdominal symptoms (with anaemia 57%), none with anaemia alone. Two
children presented with failure to thrive and two cases were identified
through family screening. In the adults with CD there was a significant
difrence in the sex ratio (13 males,37 females) [p<0.05J with a mean age
at diagnosis of 50.0 years (range 26.0-88.2, no difference between males
and females). 80%/o presented with abdominal symptoms (with anaemia
48%), 20/o with anaemia alone. Of the DH cases 3 were male, 2 female
with a mean age at diagnosis of 53.2 years (23.9-74.8). There were two
child sibling pairs and two adult patients had a parent with CD.
Tanimnualnid ence per10. oovulation ..*D<0.00viPatient Group 19118 196190 19119
CD-Childe 2.08 2.53 2. 15
CD-Adults 1.32* 2.215 3.08*_
IDH 0.43-0.43 0.3
C_kimsiaL In South Glamorgan the incidence ofCD in children and DH
in adults has remained constant over the past 15 years however there has
been a significant increase in the number of adults diagnosed with CD, the
diagnosis being more common in adult women.
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COELIAC DISEASE IS ASSOCIATED WITH NON-
SMOKING AND CESSATION OF SMOKING.
D.TQdi, H.H. Tsai.
Gastroenterology Department, Castle Hill Hospital, Castle Road,
Cottingham, E. Yorkshire. U.K. HU16 5JQ.
The association between ulceraive colitis and non-smoking is
well known. Coeliac disease is an allergic mucosal disease
which also have an inflammatory component and is associated
with inflammatory bowel disease. We investigated patients with
coeliac disease to see if they share the same epidemiological
characteristic.
Methods: A total of 330 patients with a definitive diagnosis of
coeliac disease were prospectively interviewed by a sandardised
questionnaire. 114 controls were recruited from accident and
emergency department and were matched for age and sex.
Results: 37 out of 330 (11.2%) patients with coeliac disease
were smokers compared to 48 out of 114 (42%) control patients.
This is a significant finding (P< 0.0001; OR:0.174 95% CI
0.105-0.288). There were 90 (27.3%) ex-smokers amongst the
coeliac group compared to 3 (2.6%) in the control group. This is
also a highly significant finding (P<0.0001; OR:13.88 95% CI
4.30-44.80). 16 of the patients who were ex-smokers stopped
smoking after diagnosis of coeliac disease. Exclusion of these
patients from the analysis, patients with coeliac disease were
still more likely to be ex-smokers compared to controls
(P<0.0001; OR 10.70,95% CI 3.30-34.65).
Conclusion: Coeliac disease, like ulcerative colitis is
associated with non-smoking, although the relative risk is lower
than that quoted for ulcerative colitis. The strikingly large
number of ex-smokers amongst coeliac patients is not due to
increased medical contact. These findings are unexplained and
deserve further study.
INSULIN INDEPENDENCE FOLLOWING COMBINED TOTAL
PANCREATECTOMY AND ISLET AUTOTRANSPLANTATION
SAWhitc. PRV Johnson, S Swifit, NP Kopiker*, JE Daviest, ACB
Wicks*, AC Burden*, SS Ubh, NIM London, AR D ison
Dqe tmbs ofSurgey and Medicine Leicester Gal Hospital and
Depamnt of Surgery University ofLicestert.
Total pa is a radical procedure for chronic p tis
but rae r the patint ins de . Over a 3 year period 14
patients (11 F: 3 M) have u rone total pan aectony combined
with islet auto n in an attenyt to prevent dabetes.
Foilowing p is were immedately isolated using
colagen ditension combined with a semni-automated panreas
digestion. nI 10 patients islets were also purified on a continuous
density gradient. The ie were then tansported back to the
operating theatre for atr on.
In 12 patients the islets were l directly into the liver via the
portal vein (median volume 9 m1s) in addition 2 of these paients also
received islets into the speen and 2 patients reeived a splenic
autotransplant alone. Post-opertive islet autograft insulin secretion
was assessed by serum C-peptide levels.
One patient died of a stroke 4 weeks post-operaively. Of the
remaining 13 C-peptide levels are available on 12 and are all within the
normal range (median 1.29 ng/ml). Four patients developed insulin
independence post-operatively but only two patients are currently
insulin independent (over I year foilow-up).
In conclusion insulin independence can be achieved following total
pancreatectomy when combined with islet autotransplantation but
cannot be predicted by post-opertive basal serum C-peptide levels that
are within the normal range.
AUDIT OF THE MANAGEMENT OF ACUTE PANCREATITIS IN
WESSEX. S.K.C.Toh, S.Phillips, D.Slade, C.D.Johnson. University
Surgical Unit, Southampton General Hospital, Southampton S016 6YD.
In the course of conducting a multicentre trial of a new treatment for
acute pancreatitis (AP), prospective data on the management of patients
admitted with AP was collected from 8 hospitals in Wessex between
Nov.1994-Nov.1995. Recent evidence-based national guidelines for the
management of AP have been proposed by the British Society of
Gastroenterology. Aim:To compare the results of our audit with the
proposed audit goals. Methods: All patients were seen within 24 hrs of
admission and APACHE-II scored. Follow-up data was subsequently
obtained through review of the notes after discharge. Results: 186
patients were admitted with AP: 80 women, 106 men. Age 15-98yr
(median 54), aetiology-gallstone(GS)33%, alcohol 20%, other 15%,
idiopathic 32%. There were 60 severe cases(32%). The following table
summarises the audit findings com with audit s:
Findin gs (no.) Audit Goals
Mortality 9.1/%(17) <10%
(28% severe AP) (<30%severeAP)
Diagnosis < 48brs 9&.4V.(183) 100%
Severity Stratifiatiom < 48hr* 19% (35) 100%
Percentage of Idiopathic Cases 32% (60) 20-25%
DefinitiveRx GS in mild AP<4 weeks 33% (15/45) 100%
Severe AP in HDU or ITU 67% (40/60) 100%
Radiological Facilities available 100% 100%
(USS, CT, Angiography)
Dynamic CT in severe AP between 33% (20/60) 100%
Day 3 - 10
Urgent ERCP in severe GS AP 41% (7/17) 100%
* Using Glasgow, APACHE-Il or C-Reactive Proteia criterbia
Conclusions:This prospective audit has identified shortcomings in the
management of AP. The principal deficiencies were the poor use of
objective severity stratification on admission, delayed treatment of
gallstones in mild GS AP, and difficulties in providing a 24-hour service
for urgent ERCP and bile duct decompression in severe GS AP.
IS PANCREATIC SURGERY SAFE IN A SMALL DISTRICT
GENERAL HOSPITAL ?
C-EMilln, C.J.Mitchell, J.MacFie.
The Combined Gastroenterology Service, Scarborough Hospital,
Woodlands Drive, Scarborough, Yorkshire YO12 6QL.
It has been suggested that pancreatic surgery should only be
perfomekd in larger, specialist units. We reviewed our District
General Hospital (DGH) experience over 6 years of 50 consecutive
patients (32 males) aged 31-84 yrs(mean 62) undergoing pancreatic
surgery. The indications for surgery were pancreatic cancer 25(50%/), acute pancreatitis and its complications 16 (32%), chronic
pancreatitis 6 (12%) and others 3 (6%). The procedures performed
included; Whipples 12 (24%), Triple bypass 12 (24%), sub-total
pancreatectomy I l(including 3 with cyst drainage) (22%), pylorus
preserving pancreatico-duodenectomy 5 (10%/), total pancreatectomy
3 (6%), palliative choledocho-jejunostomy 4 (8%) and necrosectomy
3 (6%).
Thirty-day mortality was 60/. Complications included 8 patients
with respiratory (2) or cardiac failure (!), pleural effusions (3),
arterial bleeding (1) or a bile leak (I); two required re-opaation.
Median length of hospital stay was 15 days (range 8-77). Median
survival for the 27 patients with malignant disease was 8 months
(range I to 23 months). The 23 patients with benign disease have
been followed for a median of 3 years; 3 have died, one from
recurrent acute pancreatitis and two others from unrelated causes. Of
the 20 surviving,4 have developed pancreatic insufficiency and a
further 2 have recurrent pain.
We conclude that successful pancreatic surgery can be performTed
safely in a DGH setting. Patient selection and expertise are more
important than numbers.
All
Gut 1997; 40 (suppl 1)
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DIFFERENCES IN PERCEPTION OF QUALITY OF LIFE ISSUES THE PAROTID GLAJ
BETWEEN PANCREATIC CANCER PATIENTS AND HEALTH FACTORS RESPONSIBI
PROFESSIONALS. AJK Piowicz, A Dzk
DFt CDJohnson, SGeorge, SPayne, Batoee' an DoalIkPancreas and Bfliasy Research Group, Southa ton Gneral Hoqsital Baiolemew's and Royal
BACKGROUND: The pDespite advances in medial and sugical inteiventions the outlook for ogical terisi
the pancreatic cacer pata -r s glomny. Recenty, attention has
focsed on the quality oflif(QOL) of ach patots.eiYt te resarch also be vulneable to factc
has been undertaknead no disease ecifc QOLq r enairse chronic pancreatitis (ACP
During developmet ofa pancreatic cancer module to supplt the this potential association bl
European r for Research and Treatment ofCancer or antibodies against sali
(EORTC) core cncerqu e the QLQ-C30, we have noted differing conclusions. The
de cesiL pec betw ea pro_ils and patiens.
Method.: We used uideisepl by the EORTC QOL hytss directly by de
group. An extenve itatureview wplmed to idefy relevant abnorlities in patients w
issues 40 pancratic cancer patis and 18 healh profosJonals have sensitive in detecting pa
been asked to iden the moat in_tat and rdevat QOL ise Of intraductal stones and glan
these, 21 patents nd 6 heath swe inteviewed to gin METHODS: The paotid
htintowhy such isae were inyortant in pancreic fce. the basis of abnormal E
Interviews were semi- eructured ad were analsed using a grounded idiopathic; n=7, gallstones;
theoy apprcL
ResWl: The iteraue review was lagey unproductive. The content scanned using a linear se
ofdata gathered firomproials d patiets were similar. A list of scanner. All machine psi
42 relevant and speific isse was generted suitable for inchlion in a glandular depth. A search
pancreatic cancer module. Thes inclded specific symptoms such as minor ductal ectasia and ca
pruritus, jamdice, ige and abdominl pain as wel as addiionl RESULTS: Stensen's du
QOL issus related to f£u of fisture, body imge and support. However, measuring 0.5 - 1 mm in
the context in whih these ises were identified dffered between the diameter between cont
two groups. Healthpre ls took a nisic approach and ulter didenotperceived a direct relaionhp betwe severity ofsyuptoms and overall ultrasonography did no
QOL, whereas patient'spcon reldted to the need to introduce or calcification in either th
alter existing coping srtegies The ccess or otherwin of these pancreatitis.
coping strategiesiucd QOL prptiOi. CONCLUSIONS: Accord
Conclusion: Many QOL instruments are desiged from the viewpoint morphology in patients w
ofthe health professionaL Tlhis work denstes the importnce of a that of controls and patiqualitative patient centred approach to initial development. Patient's developmentrols andperceptions should be inchluded in all stages ofQOL innsm t development of ACP and
development. A 27 item module has now been constructed, refined and pancreas, rather than on
approved by the EORTC for multi-lngual pretesting and field-testing. may share with the parotid
Liver W48-W72
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NDS ARE NOT VULNERABLE TO
LE FORt CRONIC PANCREATITIS
c-Jumasz, EA Stoner and CA Ainley. St
London School of Medicine and Dentistry.
*rotid glands share many functional and
tics with the pancreas, suggesting they may
ors responsible for alcoholic and idiopathic
Iand ICP). Previous studies have investigated
y measuring changes in salivary composition
livary gland antigens in CP and reached
e aim of the present study was to test this
ftermining the prevalence of parotid gland
vith CP by ultrasonography. This technique is
rotid duct ectasia and the presence of
adular calcifications.
glands of 23 patients with CP diagnosed on
ERPs (suspected aetiologies: alcohol; n=9,
;; n=7) together with 15 teatotal controls were
ctor 7.5 MHz probe on a ATL HDI 3000
uameters were set for optimal scanning at
h was made for major (Stensen's duct) and
alcification.
1ct was visualised in all control subjects,
diameter. There was no difference in duct
rols and patients with CP. Similarly,
t detect any duct ectasia or glandular
e controls or any of the patients with
ding to the parameters assessed, parotid gland
vith ACP and IPC is unchanged compared to
ents with gall stone CP. This suggests that
ICP depends on factors particular to the
any antigenic or metabolic characteristic it
J.
LEXIPAFANT, A PLATELET ACTIVATION FACTOR(PAF)
ANTAGONIST, REDUCES MORTALITY IN A
RANDOMISED PLACEBO-CONTROLLED STUDY IN
PATIENTS WITH SEVERE ACUTE PANCREATITIS.
S.K.C.Toh For the British Acute Pancreatitis Study Group
(18 Centres). University Surgical Unit, Southanpton General
Hospital, Southampton.
The complications and early deaths associated with acute
pancreatitis appear to involve inappropriate immune system
activation. PAF is a central mediator of this response. Our aim
was to investigate the effect of lexipafant, a potent PAF antagonist,
in a randomised, double-blind, placebo-controlled study, in patients
predicted to develop complications.
Patients with acute pancreatitis and APACHE II score>6 were
randomised within 72hrs of onset of symptoms to receive an
infusion of lexipafant (100mg/day for 7 days) (n=139) or identical
placebo (n=151). Seven patients who died were excluded (wrong
diagnosis,n=3; unrelated cause of death,n=3; protocol violation
(cancer of pancreas),n=l). Overall and attributable mortalities were
not significantly less after lexipafant (n=18, 12%) and (n=14, 9°/o)
than after placebo (n=24, 17%) and (n-21, 15%); (0.l<p<0.2).
However, 11 (10%) of 107 patients treated within 48hrs of onset
died, significantly less than 20 (20%) of 98 given placebo within
48hrs (p=0.04). Attributable mortality in these patients was
significantly less with active treatment (8 of 104, 8%) than placebo
(17 of 95. 18%); (p=0.03). Median change in organ failure score on
day 3 was significantly different in the two groups (lexipafant -I (-1
to 0), placebo 0 (-I to 0); p=0.04) and there were fewer local
complications in the lexipafant group (30/148, 20%/ vs 41/138,
30%; p=0.065).
Lexipafant appears to reduce complications and death in patients
predicted to have severe pancreatitis. This effect is most marked in
patients treated within 48 hrs of onset of symptoms, consistent with
the supposed mode of action of the drug.
ONDANSETRON IN THE TREATMENT OF THE IPRURPIUS
OF CHOLESTASIS: ARANDOMLSED CONTROLLEDTRIAL
J.W.OQetlua C. HaIgh, Rog WiM u ofLivwr Stue,
King's Coee Host, Loo ad *axoWdcome, Uxidge
Conventioal dig be_atixt oftepuitus ofcleatasis mey be
u e Serotoni reetr on dernu senoy nave-eis my
play a role in heperetio of p us, nd case repotshwe aseed
benefit fiom the 5-HT3 recepto a , ondstro Aim To define
the effiac of ti the pnkus of cla ies 19
patins(16 fale median age 59 y) we d (17 PBC, one
rejection post oAth i Jiver t anta,one hepats C). Al had
pnuits ristat to treus with kw., urodiol (each five
patients), asduiatanxes (4), tanxif (2), oAad rifampicin
Anpmuriic _mecations wer ed3 das beor su ety.
Metods P of itch wa rcdW (hory by day) umeg a visal
analogue score(VAS),ad satdhig actiiy(SA) (idpn oflini
v t) memured bymas ofa piezo-eletric crysa atahed to the
naL Both wer recrdedfw 24 hours pro- mdpost-ae.t ad the
VAS was co_aued for one wek Pa we r s d
bhd, to receve uerondar or plicebo. A single intvenous boles
of Smg irn /piacbo was fobw by ol o trnn 8mg /
plcebo twice dajy for five days Minu-ngfol rif was defid as
reduto to <50% ofbaseoe pmitus on day 1. R_eL Tat nmi nd
plaebo gwoupswermd-ched forag sex, dagoi sevety oflive
dimse p- ui p m md baseie pn bitu burdaLad
SA Paitus dshoed dimalvuiatio, with eveiog exace- Numdus
burden (the area under the uve ofVAS v tim) was reduced on the first
treat day compaeto baweh in both a _ d pbcebo
groups (p <0.05) but her weeno sigifica dimmlences at any tme
poit betwee the grops in pnutus burde, SA or in the time to
meanlSiglr S ry. da has no advanaeover placebo
in he tretu ofthepmus ofc asis.
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JAUNDICE ASSOCIATED WIT AUGMENTIN: THE TIP OF
THE ICEBERG? *JI.W. 0o *K. Oien, R1 C. Brown, P.
Bramley, K. M. Codhran, R.W. Crofton, W.S. Hislop, R. Park, **RN.M.
MacSween, *P. R. Mils. Dqts. bf *Gastrogterology an *Pathology,
Western Iafinary, Glasgow and West of Sccdlid Hospitals
Aug in (anoxycifli md davulnc acid) isanwg the most
commonly prescibd tics worklwide. Choketais
with Augmntin in the absence of other known cause was first
recognised i 1988. Aims. To estimate the sce, paent profile
and outcome of Aumn atioated cholestasis in the West of
Scotland (pop. 2.5m) from 1992-1996. Case fihding methods. Diect
postal quioni of 23 g aterooginstsr the West of Scotand,
search of coded dihrg dia o i the Glagow area, mad search
of patholgy records (KO.) Result 19 cases of jamdice wer
identified (ten male, men age 57.8y, range 44-91y). Full clinical
details were available in ISpatiats. In no pati was a casative link
with the drug p ted time of referraL Dwt dlatation was
excluded by ultasound and hepatitis serology was negative in all
patients. Median interval between start of drug therapy and
development of jaundice was 14.5d (rnge 6-46d). Median peak
bilirbin was 226pmo=1 (range 129-598pmo1l4). One death occurred,
from unrelated caues, in a 91yo patent who had mild, resoving
jaundice. Cholestasis resolved after median 93d (range 35-186d) in all
but one patient, in whom a mild utsansainitis has persisted for 4 years.
Duration of jaundice correlated with the length of interval between
drug exposure and onset of jaundice (r=0.76), but not to age, sex,
dose or duration of trement. The impiped frequency in the West of
Scotland in 1996 was one case of cholestasis per 22,000 Augim tin
prescriptions. Liver biopsy, performed in eight patients, showed portal
tract chronic inflammation, cholestasis, eosinophilia and vaying
degrees of cholangiopathy in al cases. Granulomatous inflammation
was present in one. Conclusions. Jaundice associated with Augmentin
is increasingly recognised, may be severe and prolonged, and is
frequently delayed after drug exposure which may hinder diagnosis.
Complete recovery is usual.
LIVER FUNCTION TESTS AND LIVER DAMAGE IN
HAEMOCHROMATOSI& D K George D H C Crawford and L W
Powell (introduced by R I Rus.c1I). The Liver Unit, Queensland
Institute of Medical Research, Brisbane, 4029, Australia.
Haemochromatosis (Hr') is an inherited disorder of iron metabolism
which can cause hepatic cirrhosis. The prevalence in most Caucasian
populations studied is approximately 1 in 300 though the disorder
remains under diagnosed. One reason for such under diagnosis may be
that liver function tests (LFT) are often normal. The significance of
abnormal LFT in HC has not previously been studied.
50 HC patients were analysed with respect to abnormalities ol
transaminases at diagnosis, age, sex, transferrin saturation, serum
ferritin, hepatic iron concentration (HIC), Scheuer grade of fibrosis
and the presence of other histological hepatic features.
56% had normal LEJT at diagnosis compared to 44% with abnorma
LFT. lTere were no significant differences between thb two groups in
terms of age, transferrin satraton or HIC. The group with abnormal
LFT however had significantly higher senrm ferritin levels (1812±986
vs 669±407, p<O.000l) and a greater male prepondernce (p<0.05).
29% of patients with normal LFI had no histological abnormalities
other than increased iron stores. 35% of rmtients with nornal LFT had
hepatic fibrosis without histological inflammation, steatosis or oter
histological abnormalities. All patients with abnormal LFI had
histological abnormalities other than increased hepatic iron stores.
Patients with abnormal LFT were more likely to have fibrosis than
those with normal LFT (82% vs 54%, p<0.05) and to have a more
severe grade of fibrosis (1.9±1.4 vs 0.8±0.8, p<0.001).
Liver dan;. t' can develop in HC due to increaced iron stores alone
and in the presence of nornal LFI. However, HC patients with
abnormal LFT are more likely to have fibrosis and at a more advanced
stage. Therefore, although abnormal LFT indicate the presence of
hepatic complications in haemochromatosis, normal LFT do nol
preclude the presence of hepatic damage. Recently the HC gene has
been cloned and a genetic diagnostic test may soon be available.
However, in general liver biopsy is still indicated in haemochromatosis
for diagnosis and assessment of hepatic complications.
FINDINGS ON LIVER BIOPSY FOR ABNORMAL LIVER
FUNCTION TESTS IN THE POST HEPATITIS C TESTING ERA.
G Vautier, P James and S Ryder. Departments of
Gastroenterology and Pathology, Queen's Medical Centre,
Nottingham, NG7 2UH.
Background. Abnormal liver function tests are relatively
common but their significance In the presence of negative
serological tests is uncertain.
Methods. We have prospectively studied 210 consecutive
patients aged 18 to 78 undergoing investigation for abnormal
liver function tests, defined as persistent elevation of ALT or GGT
over 6 months, in whom serology for hepatitis B and C,
autoantibodies, serum ferritin, alpha-1-antitrypsin, copper studies
(where appropriate), and ultrasound scanning were
normaVnegative. Alcohol histories were taken from patients and
corroborating relatives and if consumption >4g per day patients
were excluded.
Results. 8 patients refused liver biopsy. 9/202 (4.5%) were
cirrhotic on biopsy and a further 19 (9.4%) had increased fibrosis.
Final diagnoses were Non-Alcoholic steatohepatitis 68 [34%],
fatty liver without inflammation 74 (37%], alcohol related liver
disease 6 [3%], autoimmune hepatitis (steroid responsive) 4 [2%],
drug induced 31 [15%], primary biliary cirrhosis 1 [0.5%],
haemochromatosis 2 [1%], amyloidosis 1 [0.5%] and normal liver
15 [7.5%]. Complications of liver biopsy (non U/S guided,
menghini needle) were 4 patients with post biopsy pain and one
with a bile leak requiring 6 days hospitalisation. No patients
suffered haemorrhage.
Conclusions. Liver biopsy for abnormal liver function tests
produces a diagnosis of potentially progressive liver disease in
55%. 13% of patients had significant fibrosis or cirrhosis at the
time of biopsy. Clinical management was altered in 43 patients
(21 %) and only one significant complication of liver biopsy was
seen. Patients with persistent abnormalities of their liver function
tests should be offered liver biopsy.
THE EFFECT OF HORMONE REPLACEMENT THERAPY ON
SERUM AND URINARY MARKERS OF BONE TURNOVER IN
PRIMARY BILIARY CIRRHOSIS. SP Pereira', J O'Donohue', C
Moniz2, C Mackintosh2, H Abraha2, M Buxton-Thomas3, Roger Williams'.
'Institute of Liver Studies, and Depts. of 2Clinical Biochemistry and
3Nuclear Medicine, King's College Hospital, Londor SE5 9RS.
Evidence from retrospective studies suggests that hormone replacement
therapy (HRT) is well-tolerated and may be helpful in retarding the rate of
bone loss in primary biliary cirrhosis (PBC). However, there have been no
prospective studies in PBC of the effect ofHRT on bone mineral density or
serum and urinary markers of bone turnover. Methods: 42 post-
menopausal women with PBC (median age 57 yr, range 52-63 yr) were
treated with calcium+vitamin D, either alone (n=22) or together with
topical HRT (n=20; Estracombi, Ciba). Bone densitometry (Lunar) of the
femoral neck and L2-L4 vertebrae was performed at baseline, and serum
and urinary markers of bone turnover measured at three-monthly intervals.
We report here our baseline and three-month findings. Results: The two
groups were well-matched for age, year of menopause (49 yr, 43-51 yr),
histological stage, serum bilirubin level (median 15 pM, range 4-65 PM)
and bone densitometry scores. In the 42 patients, spinal or femoral
osteopaenia (T score -1 to -2.5) was present in 16 (38%/9), while 7 othrs
(l7/o) had established osteoporosis (T < -2.5). Baseline serum osteocalcin
and adjusted calcium concentrations were 7.0 og/i (4.2-14.9 jgO) and 2.4
mM (2.2-2.6 mM), respectively, which did not change significantly at three
months in either group. In the controls, urinary calcium and creatinine
levels, and urinary deoxypyridinoline:creatinine ratios, were sim;ilar at
baseline and three months. In contrast, urinary calcium concentrations fell
significantly in the HRT group, from 2.5 mM to 1.2 mM (p<0.05). Overall,
HRT was well-tolerated, with no increase in cholestasis and only one
withdrawal due to minor side-effects. Conclusions: The initial results of
this prospective study confirm that osteoporosis is common in post-
menopausal women with PBC, and that topical HRT is well-tolerated.
Compared with calcium+vitamin D alone, supplemental HRT is associated
with decreased urinary calcium excretion - a sensitive marker of bone
tumover.
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IgG, gM, IgA BHAT SHOCK PROTEIN ANTIBODIES
IN IMAY BIIARY ROSE-
EmCr OF UDCA ThERAPY
AVjrm T Davis, MA Asante HA Ahmed, IP Jazawi,
JD Maxwerl, TC Northfidd
Diviion ofMedicine, St Geore's Hop aMdiaiSckov4 London
Primary biliay cirrho.s (PBC) is an at e disese wh reuts
in destuction of intahepaic bie ductudes Epiopes dshrd by en
infectous gagt end the host have been proposed as a poible flak
betwen inton and autoinunuity. Heat shock prots (HSP) are
produced by prokryotic end eakyotic cds in reonse to sres
Expression ofHSP on bile duct epithelium has been demonstrated, end
Y T cels (capable of anirmmerese HSP) ound in
the liver may play a role i th ofbile ducts Urdeoxydolic
acid (UDCA), the treawAt of choice in PBC, has y
dects We tht es to HSP are ivolved in the
patdesof YC, dt UDCA tatment modifies ths response.
Ais:To A the pre ce ofHSPatBs in PBC md to assess
the efct ofUDCA treatMseAlMda:IgG, 1gM d IgSA odis
to the 65kD HSP were asse d in 41 PMC patents (F:M 39:3, median
age 65 yes rnge 33-82), usg an in houe EUSA. 33 were tudied
afer a median of 2 mnths of UDCA (10-lSm/gday). 45 normal
controls (F:M 35:10, ndIan ag 55 rang 30-65) wer alo studied.
Resuls:Te log optica denky - log men of normal (SEM) of the
contos adPC ar shown biow.
Normals All PBC Early PBC Lait PBC
n=45 n=41 n=27 n=14
G -0.006±0.011 0.044+0.012* 0.050+0.016* 0.032+0.018
gM -.00S+0.O10 0.065+0.015* 0.035+0.014* 0.124+0.029*9
JgA -Ol+0.00 0.055+0.006* 0.053+0.007* 0.057+0.010*
*p<0.02 compared with normal controls tp<0.03 vs earlyPBC
UDCA treat did not akter HSP antibody levels in any stage ofPBC
for a csses of Ig. Conclusion:Antiodies to HSP are elevated in PBC.
Short term UDCA theapy does not affect this response. The presence of
antibodes to HSP may suggest a role for this protein in the pathogenesis
of PBC. Further 8st to define thei role in the pathogeness and as
possible markers of disease actvity with longer treatment with UDCA
are needed.
BCL-2 AND WAF PROTEIN EXPRESSION IN
CHRONIC LIVER DISEASE
P. Papskyriakou-, M. Tsardi--, P. Kanavaros' and
E.Kouroumalis*.
Des of Gsstroentrology ad P thlogy*
Univesty Hospit Heraldion,. Crete, Greece.
Apopti is a possible mec im of cell d_eh in
liver . Is role hs not been ade ly
studied. Apoptosi is conroled by several ges
prtn productB eer inhibit or accelerete
We threfre stdid the protein expresion of one
iWN gen (bcd-2) and one promot gen
Uvr biops from 10 patIernt with pnmery bisry
cirrhosis (PBC), 10 wIh chrnic hepst C and 10
with chronic hepatiis B. wer studied by
knuoyohmsr usin mndsiatbodies
sgsinst bcl-2 and wet proteins.
Bcl-2 wa e in bil ducu ceis of all
patients studied, but in PBC it was idr
ovwerxes or not expred in most
inthekpstc bil ducbtl.
Thee we profoud Ihlrtion of portl tract by
bcl-2 poitive pcys in PC and to a lesr
extent in chroni hepatii. Mor many positive
intralobular lymphocyts wer idenified. By
contrat waf protein expresson w Identi11ed in
nuclei of hepatocytes now ware of piec meal
necrosis orny in chronic hepatitis either B or C. In
PBC no posifive nuclei were noted.
CgWusionl: 1) Apoptosis controling protins ae
expressed in lver disease. 2)Ciones of apoptobs
resisant infiltrating lympoytes exprIesng bcl-2
are predominant in chronic iver dis.
3) Apoptosis promofing proteins we expreed in
hepatocyte nuclei in viral hepatitis but not in PBC.
URSODEOXYCHOLIC ACID THERAPY FOR PRIMARY BILIARY
CIRRhOSIS: 10 YEARS' POPULATION-BASE3D EXPERIENCE.
BATESON, M.C. 6 GEDLING, P.
GENERAL HOSPITAL, BISHOP AUCKLAND, UK.
From 1981 all symptomatic cases of primary biliary
cirrhosis (PBC) in a health district of 153,000 residents
have been identified by the local gastroenterologist and
liver biopsy performed in all but one. After April 1987
all cases seen were offered treatment with ursodeoxy-
cholic acid (UDCA) 750 mg daily. The 37 treated with
UDCA were followed up at 1,2,4,6,9, a 12 months and
then 6 monthly. Results were compared with historical
local controls and published data in other series.
There was a uniform early improvement in abnormal
"liver function" tests, maximal at 4 months. There was
an early improvement in histology in 3 out of 8
rebiopsied at 4 months. Twenty-eight patients reported
improvement or cure in symptoms, 7 had no change, and
in 2 patients there was a prompt exacerbation which led
to immediate cessation of treatment.
Overall survival was significantly improved, though it
was still less than the general population and the effect
was only seen after 2 years' treatment. Histological
stage I disease, lower age and lower initial bilirubin,
and to a lesser extent serum IgG and haemoglobin levels
predicted better survival. In stage I disease median
follow- up was 4 years. Survival was normal in the 14
allocated to UDCA, and 1 case followed for 7 years lost
all clinical evidence of disease and may have been cured.
In stage II to IV disease median follow-up was 2½ years:
in the 23 allocated to UDCA there was a sustained trend
to improved survival (37% v. 28% at 7 years, Kaplan-
Meier analysis). Most deaths related to liver disease
and by chance none of the patients has proceeded to liver
transplant, so these are true absolute life tables.
CONCLUSION - UDCA is effective and easy to use,
avofids theined for more toxic drugs in PBC, and should
be offered to all cases not imminently expecting
transplant. There may be a case for treating
pre-symptomatic disease.
NITRIC OXIDE RELEASE IN THE SPLANCHNIC CIRCULATION
OF CIRRHOTIC RATS
AI Sarela & RT Mathie (Introduced by RCN Williamson). Department
of Surgery, Royal Postgraduate Medical School, Hammersmith
Hospital, London W12 ONN.
Enhanced splanchnic vascular nitric oxide (NO) activity has been
implicated in the pathogenesis of portal hypertension associated with
cirrhosis of the liver. However, the portal venous concentration of total
nitrite and nitrate (nitric oxide metabolites, NOx), which is established
as a reliable indicator ofNO production, has not been previously
studied.
Experimental micro-nodular cirrhosis was induced in adult male
Wistar rats by the administration of phenobarbitone and carbon
tetrachloride (n=7). Age- and weight-matched rats (n=5) and
phenobarbitone treated rats (n=5) served as controls. We assayed portal
venous concentrations ofNOx and total biochemical activity of nitric
oxide synthase (NOS) in the liver and mesentery ofboth groups.
Cirrhotic rats had significantly higher mean portal pressure than
controls (1 1.00 (S.E.M. 1.22) vs. 4.80 (0.96) mmHg; P=O.002[ Portal
venous concentrations ofNOx were significantly lower in cirrhosis than
in controls (75.33 (16.54) vs. 128.34 (15.66) ismol.r'; P'=0.02) There
was a significant negative correlation between portal pressure and portal
venous NOx concentrations Ir=-0.57; P-0.041. Total NOS activity in
the mesentery was higher in cirrhosis than controls 16.17 (1.19) vs. 3.30
(0.68) pmol.g'.min-'; P=0.04). In contrast, hepatic total NOS activity
was similar in both groups (1 1.79 (2.14) vs. 10.06 (1.42) pmol.g'.min1';
P=0.60).
These results imply that total NO release in the portal venous
drainage territory of cirrhotic rats is decreased, although mesenteric
NOS activity is enhanced. We speculate that NO release in the
splanchnic viscera may be downregulated in response to the overactivity
of another putative vasodilator which is NO-independent. The inverse
relationship between portal pressure and portal venous NOx
concentration would support this hypothesis.
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EFECT OF TEPSS ON RENAL BLOOD FLOW IN
CIRRHOTIC PATIENTS.
AJIii_ek DNRedad*, IADBoucer, PCHayes.
Depts. Medicine and Radiology*, Royal Infirmary ofEdburgh, UK.
It has been suggested that an acute increase in portal presu can
cause an im iae reduction in renal blood flow (RBF) via an
hepato-renal reflex. In addition, trnsugular in c
portosystemic stent-shunt (TIPSS) can improve renal function by
mechanisms that remain unclear. We used TEPSS placement as a
model to investigate the effect of an acute reduction in portal
pressure on RBF and other haemodynic paramers.
Methods: 10 cirrhotic patients (8 alcohol related; 6 male; mean
age 59.5(4.6) yrs; mean CPS 8.3(1.1)) were studied dwing elective
TIPSS procedure (8 for variceal haemofrhage, 2 for refractory
ascites). Unilateral RBF (thermodilution method) was measured prior
to and at 5, 15, 30, 45 and 60 minutes after shunt placement. Right
heart catheterization was undertaken prior to and 30 minutes
following shunt placement to measure cardiac output (CO), systemic
vascular resistance (SVR) and mean pulmonary artery preure
(PAP). Heart rate (HR), mean arterial pressure (MAP) and right
atrial pressure (RAP) were also measured at these times.
Results: See table. No change was observed in RBF at any time
point after TIPSS. Porto-atrial pressure gradient fell by a mean of
16.7(1.6)mmHg (p<0.001). RAP rose from 2.0(1.2) to
v.4(1.2) (p<0.001), t no ch was seen in HR or MAP.
RBF CO SVR PAP
(ml/min) (1/min) (DS/cm) mmH
pre-TIPSS 252.1(66.8) 5.8(1.0) 1313.5(111.8) 13.1(2.1)
+ 30 mins 277.2(69.0) 7.5(1.1) 932.8(111.6) 25.2(2.0)
p value NS p<0.005 p<0.005 <0.001
Condusion: There is no acute increase in RBF in response to the
acute drop in portal pressure caused by TIPSS. Any improvement in
renal function following TIPSS does not appear to involve an
immediate increase in RBF.
A NEW AUTOANTIILEN IN AUTOIMMUNE LIVER
DISEASE: ARGININOSUCCINATE LYASE
Pelli N', Cangado E', Mieli-Vergani G2, Vergani D'. Institute of
Hepatology', University College London Medical School, London;
Depts of Child Health, King's College Hospital2, London
Autoantibodies have a central role in the diagnosis and classification
of autoimmune liver diseases (AIID). LC1 antibody (LCI-ab), a
second marker of a severe form of autoimmune hepatitis (AIH), is often
associated with LKM-1 and is detected by immunofluorescence (IFL),
double dimension immunodiffusion (DDI) and Western blotting (Wb).
Ultracentrifugation and immunofluorescence studies show the LC1
antigen to be present in the cytosol of periportal hepatocytes, its
molecularnature remaining unknown. To investigate the target of LC1-
ab, we have used two LCl-ab +ve sera (one ANA and one LKM-l+ve)
to screen a panel of 18 periportal enzymes by DDI. These enzymes,
with a median degree of homology with the human counterpart of 78%,
included: lactic dehydrogenase, arginase, argiinosuccinate lyase
(ASL), beta-glucuronidase, malic enzyme, pyruvate kinase, fructose-
1,6-diphosphatase, alcohol dehydrogenase, 6-phosphogluconic
dehydrogenase, malic dehydrogenase, hexokinase, cytochrome
oxidase, aspartateamino transferase, alanineamino transferase,
adenosine-5-triphosphatase, gamma-glutamyl-transpeptidase,
glutathione peroxidase and alkaline phosphatase. Both sera recognised
ASL, a cytosolic enzyme involved in the urea cycle and gave a line of
complete identity between themselves. ASL and LC1 antibodies were
tested in 120 patients, age range 1-77 years (median 20), 74 with AIID
(25 AIH type I, 32 AIH type II, 17 PBC), 15 chronic HBV infection,
13 aI anti-trypsin deficiency, 18 extraepatic autoimmune disorders (16
connective tissue disease, I autoimmune thyroiditis, I autoimmune
haemolytic anaemia) and 24 healthy controls, age range 5-20 years
(median 15). Thirteen were positive for ASL: 2 AIH type I (8%), 7
AIH type 11 (22%) and 4 PBC (23%). All other patients and healthy
controls were negative. There was no correlation between ASL and
LCI positivity.
All Wi"nOf I I21-ahb. l ASl
-ab+ve I I CIandAST -ahbve74 1 15(20%) 1 13 (17%) 1 4 (5%)
Under high resolution DDI conditions (0.8% Agarose and 3% PEG),
using the two LCI-ab reference sera and testing simultaneously each
serum against ASL and LC 1 substrates, two lines were formed against
LC I, one of which was of partial identity and the other of non identity
with ASL. In conclusion a new autoantigen -ASL- is present in AILD.
The molecularnature of LC I remains still to be defined.
A PROSPECTIVE STUDY OF SPEEDBAND VERSUS STEIGMANN-
GOFF IN ENDOSCOPIC LIGATION OF OESOPHAGEAL VARICES.
T. Wong. S. Pereira, A. McNair, P. Harrison. Institute of Liver Studies,
King's College Hospital, London SE5 9RS.
Endoscopic ligation is the treatment of choice for oesophageal variceal
obliteration; however the use of an overtube leads to significant morbidity
and mortality. Recent advances in endoscopic technology have led to
development of multiple banding devices that do not require the application
of an overtube. In the present study we prospectively examined the safety
and efficacy of one such device: Speedband against the conventional
Stiegmann-Goff (Bard) ligator.
Patients and Methods. We prospectively studied 99 variceal banding
sessions in 45 patients. Speedband ligation was performed in 60 sessions,
and Bard in 39 sessions. Parameters examined included sedation dosage,
patient discomfort (mild, moderate, or severe), upper oesophageal damage,
immediate band slippage, total time of banding session, total time required
for band application (first to last band), and average time of application per
band. Variceal ligation sessions were randomly assigned to one of the 4
endoscopists experienced in both methods of band application, and the
Olympus Q200 endoscope was used for all procedures.
Results. Patients were well matched at time of endoscopy with respect to
number of varices (mean 3.3 vs 3.4), grade of varices (1.8 vs 1.7), age (49
yrs vs 50.4 yrs), number of bands applied (4.0 vs 3.4), and Child's-Pugh
score (64% vs 68% Child's-Pugh A), Speedband vs Bard respectively. The
use of Speedband was associated with a significant reduction in midazolam
(7.3 mg vs 9.2 mg, p=0.03), and pethidine (10.4 mg vs 24.3 mg p=0.01)
requirements. Patients undergoing Speedband application experienced less
discomfort (90% vs 66% mild discomfort, p<0.001), and less upper
oesophageal damage (76% no damage vs 55%, p<0.01). One patient
undergoing Bard ligation died due to an oesophageal rupture from the
overtube, and in a further 2 cases ligation was abandoned due to
oesophageal haemorrhage; no such complications occurred in the
Speedband group. The total time of the endoscopic session was reduced in
the Speedband group (7 min 58 secs vs 1 Imin 33 sec, p<0.001), as was the
time required for band application (2 min 52 secs vs 5 min 9 secs,
p<O.00 I), and average time taken per band application (46 secs vs 1 min 32
secs, p<0. 01). There were no differences between the groups with respect
to immediate band slippage (18% vs 33%, p=0.09).
Conclusions Speedband ligation is safer, quicker, and associated with less
patient discomfort and morbidity when compared with Bard ligation. On
the basis of this data, a multiple banding device is the method of choice for
endoscopic variceal ligation.
Detection of anti conformational CYP2D6 antibodies in patients with
autoimmune liver disease and HCV infection using a novel radioligand
assay
Ma YV, GAken P, Bianchi F4, Mieli-Vergani G2, Vergani DV. Institute
of HepatoloyI University College London Medical School, London;
Depts of Child Health, Molecular Medicine3, King's College
Hospital, London, UK and Semeiotica Medica4, University of
Bologna, Italy
LKM-1 antibody is thedi c marker ofautoimmune hepatitis(AE) type 2 and is also found in a proportion of padents with
hepatits C virus (HCV) infection. Cytochrome P4502D6 (CYP2D6)
is a major target antigen of LKM-1 in AIH, since the majority of
LKM-l positive AIH sera recognise the prokaryoticall expressed
cytochrome. In contrast, only a nmnority ofLKM-1/anti-HCV positive
sera do so. In order to investigate the target of LKM-1 in HCV
infection, we have established a highly sensitive and specific
radioligand assay using eukariotically expressed CYP2D6 as target. A
1.2 kb human CYP2D6 cDNA was isolated from a human liver cDNA
library and subcloned into an in vitro transcription vector pSP64
Poly(A). Recombinant CYP2D6 protein was then produced using an
in vitro transcription/translation and metabolically labelled with IS
methionine. This served as target in the immunoprecipitation assay.
Antibodies that bound radiolabelled CYP2D6 were
immunoprecipitated USing protien A-Sepharose beads and their levels
assessed as cpm in a liquid scintillation analyzr. A total of 53 LKM-l
positive sera from 22 children with AIH (median age 10, range 1 to
20 yrs) and 31 adults with HCV infection (mian age 49 range 16
to 71 yrs) were tested. One hundred and twent five - negative
sera iTom 101 age matched children with liver disease (9 XCV
infection, 23 HBV infection, 19 AIH tye 1, 18 autoimmune
sclerosing cholangitis, 19 al-antitrypsin deficiency and 13 Wilson's
disease) and 24 adults with systemic lupus erythematosus and sera
from 37 healthy children and 20 adults were also tested. Amongst
LKM-1 positive sera, reactivity to 3IS labelled CYP2D6 was observed
in all sera from AIH and in 26 (84%) from HCV infection. The cpm
in both conditions were significantly higher than in normal controls(P< 0.0001), and were correlated with the immunofluorescence titres
of LKM-1 in AIH (r=0. 84!, P<0.001) but not in HCV infection(r=0.26). No reactvity to S labelled CYP2D6 was observed in
patients negadve for LKM-1 and in normal controls. In conclusion: a)
CYP2D6 is a major target antigen in both AIH and HCV infection but
the antibody. affinty is different; b) the novel radioligand assay is
highly sensitive anr specific.
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THE IMPACT OF CHRONIC HEPATITIS C INFECTION ON MV
DISEASE AND lPROGRESSION IN INTRAVENOUS DRUG
ABUSERS. OHLHvuyn. CS Blair', PJ Flegg2, RP Brett2, SM Burns3,
PC Haye'. Depa e of Medicine' and Ifectious Diseases, Unive y
ofEdinburgh and Regional Virus Labrory, City Hospital, Edidbu .
It is unckarwhr co-infection widh hepatitis C virus (HCV) can
influence HV rated nbidity or ortaty, eihr by acoelerating HIV-
related disea p n, or by cotributing to end stae lie disease.
The aim of this study was to emi the effect of HCV infio on the
sverity andp ofHIV disee in a cohort ofEdinrgh IVDAs
Metho: In 240 (47%) out of508 patiet in the Edinburgh IVDA cohort,
HIV seroconvesio dae (midpoint betwe last native and first positive
test) and anti-HCV rolo wer available. Cmparison of the ni-HCV
positive and anti-HCV negaive groups was performed by Chi-square
analysis;p from dat ofHV was led by
Kaplan-Meier survival analysis. Paramer a_essd indluded clinical end
points (time of devopunt of siknficat synpo attributb to HIV
(CDC ste IV), time of development of AIDS (CDC 1993 criteria), and
time of death) and i- nolca'l end points (time ofCD4+ count droppingbelow 200/mm3, i00/mm3 and 50/mm3 respectivey).
Resuls: 202 out of 240 patiet (4%/) had posiive anti-HCV serology.
There was no significant dif in te fquency of clinical and
imunological endpoints between the anti-HCV positive and negative
groups. Progrsion analysis from HIV seroonvrsion to HlV relaed
clinical endpoints indicated that anti-HCV serolgy was not a signifcant
factor influencing the rate of HIV progession (rlative risks (RR) for anti-
HCV positive group: seroconversion to CDC IV: 1.01; serocoversion to
AIDS: 1.05; s Conversion to death: 0.90). Likewise HCV serostatus did
not significantly affect progression to immunological end points (RR for
anti-HCV positive group: seroconversion to CD4+<200: 1.04;
seroconversion to CD4+<100: 1.13; seroconversion to CD4+<50: 0.97).
Condusions: This study demonstrates that HCV coinfction does not
influence the rate of progression to either clinical or immunological end
points in our population of HIV-infected drug users. Further data are
required to assess the effect ofHIV on the progression of HCV-related liver
disease.
LOWER PREVALENCE OF MARKIERS OF AUTOIMMUNITY
IN CHRONIC HEPATITIS C IN NORTH-EAST OF ENGLAND.
L.Zapial, M Bassendine.
Dept.of Medicine, University ofNewcasde upon Tyne, UK.
Background: It has been suggested that there is an interaction bet%veen
HCV and autoimmunity, in some case series of chronic hepatitis C high
overall prevalence of serum antitissue antibodies (41-66%) and
rheumatoid factor (70-76%) have been reported. Aim: to estimate the
prevalence of markers of autoimmunity in pts affected by chronic
hepatitis C living in the North-East of England. Patients and methods:
101 antiHCV+ve pts by second-generation ELISA or RIBA (59 male, 42
female, mean age 43+10, range 24-88) with chronic hepatitis C
diagnosed on the basis of persistently elevated ALT, HCV RNA
positivity (Roche Amplicore) and liver histology were tested for: anti-
smooth muscle antibodies (SMA), anti liver/kidney microsomal
antibodies (LKM), antinuclear antibodies (ANA), anti-mitochondrial
antibodies (AMA), anti-thyroid mic l antibodies and rheumatoid
factor (RF). All pts were caucasian and bom in the UK. Results: all pts
were AMA and LKM negative
male _ANA SMA thyroid
male 0/59 2/59* 1/59
female 1/42* 2/42* 2/42
tot/% 1/101 (1%) 4/101 (4%) 3/101 (3%)
RF<40 40<RF<640 RF>640
male 14/59 6/59 1/59
female 8/42 4/42 7/42 #
tot/V. - 22/101 (21.4%) 10/101 (10.2%) 8/101 (7.1%)
*titre<40, #p<0.01 (female vs male)
In SMA+vs and ANA+ve pts the overall biochemical profile did not
show features of autoimmune chronic hepatitis. 2/4 SMA+ve and the
ANA+ve pt had liver biopsies which confirmed HCV etiology.
Conclusions: 1) The prevalence of antitissue antibodies among our pts is
very much lower than overseas case series. 2) Although the prevalence of
RF was lower than elsewhere it was detectable in 37.7% of pts in
keeping vith the hypothesis that HCV can cause a benign proliferation of
B cells.
INTERFERON (IFN) SPARING EFFECT OF ADJUVANT TAURO-
URSODEOXYCHOLIC ACID (T-UDCA) FOR TREATMENT OF
CHRONIC HEPATITIS C. RESULTS ON LIVER HISTOLOGY.
MG Pigozzi, R Sorbara, A Reggiami, M De Tavonatti, L Bettini, GP Lorini,
C Lazzari, A Cominotti*, M Favret*, S Sosta, A Lanzini.
Co-ordinating Centres: Medicine I and Pathology II*, Spedali Civili. Brescia.
Iy.
Long-term IFN adminisetation combined with a dose tapering srategy has
been reported to be the most effective treatment for chronic hepatitis C
(Hepatology 1995; 22: 700-6). Based on a dose tapering strategy, we have
previously reported an IFN sparing effect of adjuvant t-UDCA administration
(Hepatology 1996; 24; 403A) as judged on serum transaminases, but the
effect on liver histology was not assessed.
The aim pfthe present study was to assess the effect on liver histology of a
strtegy combiing t-UDCA adjuvant therapy with 6 months full dose IFN
followed by further 6 months IFN dose tapering.
121 patients wit chronic hepatitis C have been randomised to receive
either lymphoblastoid IFN alone (3 MU/m2/t.i.w. (regimen A) or IFN + t-
UDCA (10 mg/kg/day) (regimen B) for 6 months, followed by further 6
months IFN dose tapeing for reponders (ALT < 1.5 upper limit of normal).
Control liver biopsies were carried out 6 months after stopping IFN, while t-
UDCA was ma ned for regimen B. Disease grading and staging was
asse by eshak score system ( J Hepatol 1995; 22: 696-9).
68 patients have been preently followed up for 18 months, and the
proportion of responders was similar for regimens A and B (19/32 and 21/36
respectively, NS). 43 patients have had repeat biopsy at 18 months.
Histological grding decreased from 7.5 + 0.8 pretrtment to 5 + 0.9 during
regimen A (n = 22, p<0.03) ad fim 7.3 + 0.8 to 4.9+ 0.8durengrgimen
B (n = 21, p<0.03). Staging remained ucued bceore and during tatment
at 2.2 + 0.4 vs 2.0 ± 0.4 respectively for both rgimens. As a result of dose
aperin, 6 monh cumuabtive IFN dose was higher in patients treated with
lFN alone (583 ± 21 MU) th in those tated with IFN + t-UDCA (505 ± 8
MU, p<0.002).
Our results indicate that adjuvant t-UDCA has an EN spaing efct, with
improvement of liver histology similar to th achieved with higer IFN
doses. We conclude that it may be worth furither testn the EFN sparing
ef%dct of t-UDCA by extending the dose tapering strategy to the whole
treatment period.
PLASMA TLM-1 LEVELS INCREASE WITH SEVERITY OF
LIVER DISEASE IN CHRONIC HEPATITIS C.
Walsh K.M.,Timmn P.M1.,Campbeli S,MacSween R.N.M9 .,
Mtorr A.J.
Dertmnt of Gastroenterology and Human Nutrition,
Gasgow Royal In ry;Biochmistry Dept,Stobhill
Hospital1 and Pathology Dept,Western Infirmary', Glsgow
U.K.
BACKGROUND A non-invasive and easily repeatable test
of liver disease activity in chronic hepatitis C would be
valuable, especially in patients with bleeding disorders in
whom liver biopsy has increased risks. As chronic liver
disease progresses, there is an imbalance between
synthesis and breakdown of extraceliular matrix (ECM).
Tissue inhibitor of metalloproteinaise-l(TIMP-l) is one of
a group of enzymes which inhibits metalloproteinases
and are involved in the breakdown of ECM. We have
measured TIMP-i activity in patients with chronic
hepatitis C and compared this with liver histology.
METHODS: Plasma TIMP-1 levels were measured using a
specfiic sandwich enzyme immunoassay kit (Amersham UK)
in 10 patients with mild chronic hepatitis, 9 patients with
severe chronic hepatitis or cirrhosis and 14 contrbls with
normal liver function tests. Liver biopsies on the
patients with hepatitis C were scored for a histological
activity index by an independent observer, blind to
clinical details or TIMP-1 results.
RESULTS: Plasma TIMP-l levels in patients with severe
liver disease (846.5 ng/ml + 351.2) and with mild liver
disease (533.1 ng/mi + 313.6), were elevated compared to
controls (187.1 ng/ml + 62.2), p<0.05. TIMP-1 levels in
patients with severe liver disease were significantly
higher than in those with mild liver diase, p<0.05.
(mean + S.D.)
CONCLDSION: Plasma TIMP-1 levels increase with severity
of liver disease in chronic hepatitis C. The data suggest
that plasma TIMP-1 measurements maybe used as a
non-invasive indicator of disease activity in chronic
hepatitis C.
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OUTCOME OF ORTHOTOPIC LIVER TRANSPLANTATION IN
HAEMOPHILIA
iHGordoi, PK Mistry', CA Saj2 and CA Lee3 (introduced by JS
Dooley). Liver Transplatato and HepatobNary Medcie Dept.1,
P Caend populktio StastiCS Dept.2 and Hnopbln
Cen Royal Free Hospial School ofMedine, Rowland Hll
Street, Londs NW3 2PF.
Introducwti Many eo i have developed cirrhosis or hepato-
celhlar carcinoma (HCC) due to chronic hpatitis B and/or C virus
infection (HBV/HCV) tnsmittd from clotting factor con ; the
outcome of toe who have required or p livcr transplantation
(OLT), is assesed.
Methods Transplant centres of patients identified by medical databa
search were conacted and survival data assessed by Kaplan-Meier
analysis.
Result Twenty-five male h pilc, mean age 39 yeas (range 5-
63 years) underwent OLT in 15 centres between 1982 and 1996.
Indications for tlantation were HCV cirrhosis (68%/o), HBV cirrhosis
(16%), HCC (12%) and biliary atresia (4%). Six patients (24%) were HIV
positive pre-OLT; one had suffered an AIDS-defining illness. Post-OLT,
the mean time to nonnal clotting factor levels was 18 hours (range 0-48
hours) and exogenous clotting factors were sped at a mean of49 hours
(range 0-480 hours). Four patients had bleeding complications despite
nonnal clotting values. The 1 and 3 year survival of 6 HIV positive
recipients (67% and 23%) was significantly less (p=0.0003 each time-
point) than that of 19 HIV negative recipients (90%!. and 83%); 2 of the 5
HIV positive deaths were due to HIV-unrelated causes. Coagulopathy
was cured in all 23 patients who survived more than 10 days post-OLT.
Six of 16 patients (37%) with HCV cirrhosis pre-OLT developed biopsy-
proven HCV at a mean of 9 months post-OLT. Three of the 4 HBV
positive patients also developed disease recurrence.
Conclusions OLT cures the coagulopathy of haemophilia. HCV
cirrhosis is the commonest indication for OLT but outcome may be
complicated by the effects of HIV co-infection or by graft-recurrence of
HCV.
ABERRANT EXPRESSION OF P53 AND KI-67 DURING ACUTE
AND CHRONIC REJECTION FOLLOWING ORTHOTOPIC
LIVER TRANSPLANTATION
MM Dollinger"2 iN Plevrs', A Graham2, SEM Howie2, PC Hayes',
DJ Harrison2. (1) Department of Medicine, The Royal Infirmary,
Edinburgh EH3 9YW, (2) Department of Pathology, University
Medical School, Edinburgh, EHS 9AG, Scotand, UK.
Apoptosis and proiferation are important in reglating immune
responses such as allograft rejection. Unlike apoptosis, proliferation
and its role have not been ivesigad in hepaic graft rqection
thusfr. Ki-67 is a common marker of cell growth, while p53 is able
to inhibit cell growth and induce apoptosis as a response to DNA
damage. Aim: To sudy the of p53 and Ki-67 in the liver
tissue during acute and chronic rejection (AR/CR). Medtods:
Paraffi-embedded liver biopsies of 10 patients with AR before/after
treatment with i.v. steroids and of 13 patients with CR were studied
by immocytochanistry, using mononuclear antibodies agant p53
and Ki-67. Results were assessed semi-quantitatively and compared to
normal controls. Results: p53 was expred in hepatocytes, bie
ducts (BD) and cells of the ilmmtory infilrate during AR and CR,
while no reactivity was detectable in normal controls. Treatment with
steroids did not affect the expression. Staining for Ki-67 showed an
increased expression in inflammatory cells and hepatocytes during
both types of rejection compared to controls, while bile ducts reacted
sporadically only during chronic rejection. Steroid treatment reduced
the number of Ki-67 positive cells of the inflammatory infiltrate.
Conclusion: The expression of Ki-67 indicates, that during acute and
chronic rejection proliferation is upregulated in both, infiltrating
inflammatory cells and parenchymal cells. Additional
immunosuppressive therapy suppresses the proliferation of the
inflammatory cells. p53 seems to be implicated in the immune
response, either as a response to the increased proliferation rate or to
accumulation ofgenome damage.
SERUM GLUTATHIONE-S-TRANSFERASE a (GST) IN
ACUTE LIVER ALLOGRAFT REJECTION
A. Nagral. P. Butler. C.A.Sabin.* B.R. Davidson. K. Rolles.
A.K. Burroughs. Liver Transplantation, Primary care and
Population Sciences,* Royal Free Hospital, London NW3 2QG,
UK
Introduction/Aim: GST has been suggested as a sensitive
marker of cellular rejection. This study was performed to
determine the utility of GST as a marker of acute rejection.
Methods: Daily measurements of serum transaminases and
GST (enzyme immunometric assay, Biotrin) were prospectively
recorded in 23 consecutive liver transplant recipients for the
first 20 days post transplantation. 56 liver biopsies performed
following clinical/biochemical deterioration in liver function; 38
showed acute rejection.
Results: GST peaked on the 2nd day (median 125 pg/l, range
75-321 pg/I) after transplant and preceded the ALT peak by one
day. GST levels then steadily declined, reaching baseline by
day 6 and plateauing till day 8. Even after the initial peak, GST
correlated well with the ALT in the majority of patients median
correlation coefficient of 0.6 (IQ range 0.45-0.77); and with the
bilirubin, median corelation coefficient 0.47 (IQ range 0.14 to
0.6). There was no significant difference in the GST levels
between rejection and other causes of hepatic dysfunction on
each of 3 days preceding, and the biopsy day. ALT levels had
a high sensitivity for rejection (97.4%) but a low specificity
(16.7%) GST did not improve these values. In 16 patients
treated for moderate/severe rejection, the improvement in the
histological score of rejection was not associated with a
consistent change in GST.
Conclusion: GST does not offer any advantage compared to
ALT in diagnosing rejection or determining response to
treatment of rejection.
GRAFT DYSFUNCTION ASSOCIATED WITHAUTOIMMUNITY
IN PAEDIATRIC LIVER TRANSPLANATION.
N Kerkarl, N Hadzic', ET Davies2, B Portmann3, M Rela4, ND
Heaton4, D Vergani5, and G Mieli-Vergani'. Depts of Child Health',
Institute of Liver Studies3, Transplant Surgery4 & Immunolog,
King's College Hospital, Institute of Hepatology5, University
College, London, UK.
Over a five-year period of observation seven children (3% of220
liver transplant recipients) developed an unexplained but characteristic
form of graft dysfunction. Five were male and the median age at
presentation was 10.3 years (range 2-19.4). The median period after
surgery was 24 months (range 6-45). The indication for
transplantation were extrahepatic biliary atresia (4), Alagille's
syndrome (1), drug induced fulminant liver failure (1) and alpha-1-
antitrypsin deficiency (1). Four were on triple immunosuppression
with cyclosporin A, azathioprine and prednisolone, while three were
on tacrolimus. Infectious and surgical complications were excluded.
Liver biopsy showed the histological changes of chronic active
hepatitis including portal and periportal hepatitis with lymphocytes
and plasma cells, bridging collapse, perivenular cell necrosis without
changes typical of acute or chronic rejection. All patients had
increased levels of immunoglobulin G (median 23.7 g/L (range 17.2-
34.4)] and elevated titres of autoantibodies. All but one responded to
prednisolone 2 mg/kg/day and increase or addition of azathioprine
(1.5-2 mg/kg/day) within a median period of 22.5 days and remained
in remission on a reduced dose of prednisolone (0.05-0.1 mg/kg/day)
and the same dose of azathioprine during follow up (median 250
days).
Our data show that manifestations diagnostic of autoimmune
hepatitis, and responsive to the classical treatment for this condition,
can appear in liver transplant patients while on immunosuppression.
Whether autoimmune manifestations precede, and may be the cause
of, graft dysfunction remains to be established in a prospective study.
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ALULIARY LIVER TRANSPLANTATION FOR METABOLIC
DISEASES
Baker A, Rela M, Gibbs P,Muiesan P, Vilca-Melendez, HK Bali C, Mieli-
Veai G, Heaton ND
Department of Child Heal and Liver Transplat Sugical Service, Kings
College Hospital, London SE5
Liver transplatation has beo used successfuly to replace the deive
or missing eymefproten or reospor site in liver-based metaboic disorders.
The majority of ths disordes produce cirrhosis and total liver replacwmet
is required. TMhee are, however, some non-cirhotic disorders, such as
Crigler-Najar Syndrome Type 1 (CNSI) whoe although liver replacement
has been succesfd, auiary liver transplantation (ALT) offers the prospect
of correcting the maabolic defect, whilst rtaining sufficient native liver to
support life if the graft fails an also retains the potetial for Wee therapy in
the future.
5 chidren with CNS1 and I child with propioic acidmnia (PA)
underwent ALT, median ap 8 years (range 1-13); median weigt 25k (rane
10-49). Median senrn bilirubin at ALT for CNSI was 270 unol/1 (rawe
222-418) despite 16 hours of ph py daily. The chdild with PA had
recurret hypeammonenic coma on a protein-restricted diet with ammonia
levels of 80 umol/1.
Orthotopic left lateral segment ALT was performed in 4 cases and right
orthotopic ALT in 1 patient with CNS1 and in the child with PA. Patiens
with CNSI had median serun bilirubin levels on day 5 post-ransplant of 50
umol/l(range 32-92) and 30 umol(range 20-45) at a median follow-up of 16
months (range 6-39). The child with PA is on a nonnal diet with normal
serum ammonia levels at 6 months.
Complications included severe acute rejection in 3 patients requiring
conversion to FK506 and the late development lymphoproliferative disease
(LPD) in one due to EBV ifection. He was retansplanted sucoessfully after
the first ALT but died 4 months later from extensive LPD. We have shown
that it is possible to correct the metabolic errors abnormalities in CNSI and
PA with ALT. Other non-irrhotic inbom errors of metabolism are also
suitable for ALT, but the volume of liver tissue required for a successful
ou_comenta.depaido, ihe disa.
LONG-TERM SURVIVAL AND ALCOHOL RELAPSE AFTER
LIVER TRANSPLANTATION FOR ALCOHOLIC LIVER
DISEASE. S.P. Pereira', P. Muiesan2, L. Howard3, M. Rea2, N. Heaton2,
Roger Wiliam's. 'Institute of Liver Studies, 2Liver Transplant Surgical
Service and 3Departmnent of Psychological Medicine, King's College
Hospital, London SES 9RS.
Short-term survival rates after ordhtopic liver trnplantation (OLT) for
end-stage alcoholic liver disease (ALD) are reported to be similar to dtose
for other chronic liver diseases. However, the frequency of alcohol relapse,
and its effects on long-term graft and patient survival, remain unclear.
Aims: To review the outcone of transplantation for ALD in a single centre
over the past 10 years, with particular emphasis on survival and recidivism
after OLT. Methods: From Jan 1987 t6 Sept 1996, 111 patients (98M,
13F; mean age 51 yr, range 33-69 yr) underwent OLT for Child's B or C
alcoholic cirrhosis, after an alcohol abstinence of> 6 months. In 89 patients
(80%!.), alcohol was the only aetiological factor, while 20 (18%/0) also had
chronic B or C hepatitis and 17 (15%) had developed hepatoma as a
complication of ALD. Post-transplant, alcohol relapse was assessed by
outpatient and case note review, and by a Severity of Alcohol Dependence
Questionnaire sent to transplant survivors. Result: 19 deaths (all males)
occurred in the first 3 months -- due to sepsis or cardiac complicatons in
14 (74%). A further 12 patients (IOM, 2F) died 0.9-7.5 yr (median 1.6 yr)
post-transplant, most frequently due to hepatoma recurrence (n=3) or other
malignancies (n=4). The actuarial survival rate for the 111 patients was
79o/o at one year, and 64% at 5 years -- compared with figures of76% and
69% in 700 patients transplanted for other chronic liver diseae. Of the 92
patients who survived at least 3 months post-transplant, 18 (201/) reported
at least one episode of drinking > 3 units daily, while a similar number
admitted to 'social' drinking, after a median period of abstinenco of 9
months. Five patients developed recurrent alcoholic cirrhosis/graft failure
within 5 years -- two of whom died at 10-24 months. Codusnui : Long-
term survival after OLT for ALD is similar to that fbr other liver tanusplant
recipients. In our experience, alcohol relapse occurs in a large minority of
patients, though at lower levels of alcohol intake than previously. In those
with problermatic drinking post-transplant, graft damage occurs rapidly.
CLINICAL OUTCOME AND rILow CYTOMETRIC (FACS)
IGG CROSSMATCH IN LIVER TRANSPLANTATION.
M McCarthy, PT Donaldson, M van Dam*, and Roger Williams.
Institute of Liver Studies, King's College Hospital, London SE5 9RS,
and *Dept of Tissue Typing, St Mary's Hospital, London W2.
Introduction: The role of preformed donor-specific IgG allo-
antibodies. in kidney and heart grafts is well established. However,
although a number of recent studies have suggested that these
antibodies may increase the risk of both rejection and early graft failure
in liver transplants,12 this remains controversial.3 The differences
between studies may simply reflect variations in the sensitivity of
methods used to detect these antibodies. In the present study we have
sought correlation between preformed IgG antibodies and clinical
outcome using two different crossmatch techniques. Methods:
Between May 1995 and June 1996, 82 adult liver allograft recipients
(34 females, 48 males) were examined for the presence of pre-formed
donor-specific IgG allo-antibodies using flow cytometry (82 cases) and
a standard microcytotoxicity assay (65 cases). Results: A flow
cytometric crossmatch was detected in 18/82 (22%/), however only 9/15
flow cytometric antibody positive patients were antibody positive by
cytotoxicity assay. Patients with FACS positive crossmatches were
more likely to develop two or more episodes of acute cellular rejection
(4/18 cf 4/64, p = 0.044, RR = 4.29), and more likely to develop
hepatic artery thrombosis (3/18 cf 1/64, p = 0.009, RR = 12.6). At
follow-up survival was 80%!. in those who were FACS negative and
67/o in those with FACS positive IgG antibodies. However, despite a
clear trend the survival analysis did not reach statistical significance (p =
0.31). Conclusions: These results confirm the greater degree of
sensitivity of flow cytometry for the detection of IgG positive
crossmatches and suggest that flow cytometry may help predict those at
risk of developing severe graft rejection or hepatic artery thrombosis.
'Takaya et al. Transplantation 1992; 53: 400.
2van Hoek et al. Semin Liver Disease 1992; 12: 41.
3Donaldson et al. Transplantation 1995; 60: 1016.
EFFECT OF ABRUPT ALCOHOL WITDRAWAL ON LIVER
TRANSAMINASES AND MARKERS OF LIVER FIBROSIS
S Campbl(l)(4), PM Timmst2), P Maxwell(2), E Docherty(3),MZ Rah-
mand3) MEJ Lean4), BJ Danesh (1)
Departments of Gastroenterologyti), BiochemistrY(), Psychiatry(3),
Stobhill Hospital, Glasgow. Department ofHuman Nutrition(4), Glas-
gow Royal Infirmary.
Introduction: It has been suggested that liver function tests
(LFT's) may worsen in alcoholics following abrupt withdrawal from
alcohol but evidence for this is limited. We assessed LFT's and two
markers of hepatic fibrosis; pro-collagen m peptide (PUTP) and tissue
inhibitor of metalloproteinase 1 (TI) in patients admitted to an al-
cohol rehabilitation unit.
Method:. We recruited 24 patients with a history ofalcohol abuse,
bujt no evidence of liver disease of another cause. Seven consecutive
daily blood samples were obtained. Measurements of nutritonal status
and withdrawal severity were made. Our arbitrary criteria for worsen-
ing ofLFT's were: a 50% rise from baseline value with the elevated
value above the laboratory normal reference range
Resuls: 7 out ofthe 24 subjects (29.2/o) showed worsening of
their LFT's (95% confidence interval 11.0%-47.4%). These patients all
showed a rise in both AST and ALT of imilar proportion, but not of
gamma GT, bilirubin, kaline phosphatase, cr n knase or CRP.
There was no significant difference between the group who showed
worsening and the others who teided to show improving trans-
minases with respect to baselint linical, nutritional or laboratory
findings, or short-tenn outcome.
PIIP levels increased in both gro:.Ds from day I to day 7 (P=0.05).
TEMPI levels tended to rise in the group with worsen trans-
aminases, but tended to fall in the other group. (P=O.09)
Condusion: This study confirms the clinical imprson that wors-
ening ofAST and ALT is common in alcohol withd l. Alcohol
withdrawal is associated with a rise in PElP, and a rise in TEMPI in
those with worsening transaminase. We conclude that acute alcohol
withdrawal may be associated with an increase in hepatic fibrosis.
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WHY DO PATIENTS WITE WEIGHT LOSS HAVE A WORSE
OUTCOME WHEN UNDERGOING CHEMOTHERAPY FOR
GASTROITESTINAL MALIGNANCIES?
H.J.N. Andrevev, A.R Norman, J. Oates, D. Cunningham.
(HJNA is funded by the BDF) the Gastrointestnal Unit, Royal Marsdmen
Hospital & the CRC Centre of Cancer Therapeutics, Institute of Cancer
Research, Sutton, Surrey.
Aims: To examine whether weight loss at presentation for
chemotherapy for gastrointestinal carcinomas influences outcome and
whether nutritional intervention could be worthwhile.
Methods: Data were gathered prospectively. The outcomes were
compared of patients with or without weight loss treated for locally
advanced or metastatic tumours of the oesophagus, stomach, pancreas,
colon or rectum.
Results: Of 1,555 consecutive patients included, weight loss was
reported more commonly by men (51%) than women (44%) at
presentation (p=0.01). Patients with weight loss received less
chemotherapy but developed more frequent and more severe dose
limiting toxicity - plantar-palmar syndrome (p<0.0001) and stomatitis
(p<O.OOl) - than patients without weight loss. Consequently, patients
with weight loss on average received I month less treatment (p<0.0001).
Weight loss correlated with shorter failure free (p<0.0001, Hazard
Ratio=1.25) and overall survival (p<0.0001, Hazard Ratio=1.63),
decreased response (p=0.006), quality of life (p<0.0001) and
performance status (p<0.0001). Patients who stopped losing weight had
better overall survival (p=0.0004). Weight loss at presentation was an
independent prognostic variable (Hazard Ratio =1.43).
Conclusions: The poorer outcome from treatment in patients with
weight loss appears to occur because they develop more toxicity, have
more breaks from treatment and receive significantly less chemotherapy
rather than any specifically reduced tumour responsiveness to
treatment. Randomised nutritional support intervention studies are
urgently required in these groups of patients.
Ramiambed Da.ble-bM.d l .ofpolmerk vwsm ahmal dlii Uvetalemt of
acdve Crali's bm&
S Vermn. S Brown M HGiffr
Dep_D efGdst-e-tq . MIta Hull I_Isb NBS Tn4t. alft RIt_. Hill
Entoral nagrtim s nowaccepted as a primmy theapy for actrve Cruis's disssa Opera
ceyaisashbvsuidw&A poymei diis (PD) awe a dctive as elemal
prq iim (ED) This lr i
therapeicay atda muk rsi polymei dii wit - mamao-acid bsed
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0 4 0 4
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CRP 18+4 5+1 75+27 5+1
Hb 12.2+.38 12.8+.4 11.1+.9 12.5+.4
Albumin 40+L3 42.7+9 41.8+1.9 45.S+.35
ESR 36+10 20+7 53+16 40+11
* (mean + SEM)
The fail in bowel activity on Tc-99m HMPAO imstes wa not diffet in the two
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Differences in protein content ofetel feeds are not relevant to their thrpeutic
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SERUM LEPTIN IN INFLAMATORY BOWEL DISEASE (IBD):
IMPLICATIONS FOR THE PATHOGENESIS OF ANOREXIA AND
WEIGHT LOSS. MBBaBlElr,REM.Ha lsRBess r,EMA I,M1GFmthg
Di[hstw Diseas ReseRh CoIe St B siodm's & The Royal Lndon School of
Meicine& Dtisry, LmLdonUK
INTRODUCTION: IBD is frequently associated with loss of appetite and
body weight. Healthy individuals, however, adjust their appetite and
maintain their body weight within a narrow range. It is proposed that this
control is due in part to leptin, a newly described hormone, which is
secreted by fat cells and acts in the CNS to suppress appetite. In animals,
administration of IL-1, and TNF-a, which are both implicated in
inflammatory cachexia, increase circulating leptin levels and induce
anorexia and weight loss. The aim of this study was to explore the
hypothesis that patients with IBD in relapse fail to increase their appetite
in response to weight loss due to inappropriately raised serum leptin
concentrations. METHODS: Serum leptin concentrations were measured
by radioimmunoassay in 35 (17 men) control subjects and 72 patients (34
men; 52 Crohn's, 20 UC) with IBD. Body mass index and % body fat was
recorded. Loss of appetite was assessed on a 4 point scale from "not at all"
(score 0) to "very much" (3). Disease activity was assessed clinically and
by measurement of the ESR and C-reactive protein. RESULTS: Serum
leptin concentrations in the controls was 8.0 (3.1-14.1ng/ml, median[initerquartile range]) and 4.8 (2.6-10.Ing/ml) in the IBD patients. Serum
leptin concentrations were highly correlated with % body fat (figure) in
the control group (r = 0.84, P = 0.03) and IBD patients (r = 0.82, P 0.006);
the difference in leptin concentrations between the two groups was
accounted for by lower body fat in the IBD patients.
E 60 The relationship between %
0 A of body fat and serum leptin40 concentrations in 35 control
LiI20 0I1 subjects (A) and 72 patientsiQ 20 with IBD (o). The
0O °0_ regression lines (not shown)for the 2 groups of patients
00 20 40 were almost superimposed.
Body fat (%)
12 patients (6 men) had moderate/severe anorexia (grade 2/3) associated
with a disease relapse (ESR>30mm/h, CRP>40). Serum leptin of these
patients (4.3[3.2-8.lng/ml]) was no different when compared to healthy
and quiescent disease controls (5.3[3.5-10.6ng/ml]) matched for sex and
% body fat (mean 24.2%, range 4.8-43.9). CONCLUSION: Serum leptin is
appropriately suppressed in patients with anorexia and IBD. In contrast to
the animal work, this study does not support a role for leptin in cachexia
associated with IBD.
RAPID COLONIC FERMENTATION IS ASSOCIATED WITH
SYMPTOMf IN EBS AND CORRECTED BY EXCLUSION DIET.
*T.S King, M. Elia, *J.Q. Hunter. *Department of Gastroenterology,
Addenbrooke's Hospital, 'Dunn Clinical Nutrition Centre, Cambridge.
Introduction: Use of an exclusion diet reduces symptoms in 50%
of IBS patients. Food intolerance is unlikely to be immunologically
mediated but may be related to colonic fernentation. Methods: 5
female IBS patients and 4 female controls followed two fixed diets
(12.5g NSP, 128g starch, 3.6g resistant starch/day; 8MJ/d. adjusted to
estimated TEE; protein:carbohydrate:fat 15:45:10): a standard western
diet (STD) followed by an exclusion diet (EXN), in which common
sources of food intolerance were prohibited. Subjects followed each
diet for 14 days, with a 2 week wash-out period. Food diades were
filled daily and all meals were provided from a metabolic kitchen for the
last 7 days of each diet. A symptom score was calculated daily. On the
last day of each diet total excretion of hydrogen (H2) and methane
(CH4 were measured for 24 hours in a purpose-built and validated
1.4m whole-body calorimeter. Breath H2 and CHR concentratons
following 20Q lactulose were also measured on each diet. Results:
mean mean mean mean max
symptom total H. total CH4 total rate total rate
score ml/24hrs ml/241rs mlhmi mi/mn
stP sty Stp S tp
patients std 8.3 361 152 0.4 2.5
exn 5.9 90 84 0.1 0.4
controls std 1.3 147 266 0.3 0.7
exn 1.5 86 480 0.4 1.2
Rapid gas excretion in the calorimeter was associated with onset of
symptoms. Breath concentations of H2 and CH4 after lactulose altered
in parallel with changes in 24-hour gas excretion in 4/5 patients and 3/4
controls. Conclusions: 1) Symptoms are associated with rapid
excretion of H2 and CH4, and improvement of symptoms by diet
coincides with reduced excretion. 2) The effect of diet on
methanogenesis is variable. 3) The reduction in H2 excretion with
exclusion diet is consistent with the expected low colonic avalability of
easily digestible rice starch. However changes in gas excretion during
lactulose breath tests demonsae that qualitaive changes in colonic
fermentation also occur. These factors may explain the efficacy of
exclusion diets in LBS.
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A RANDOMISED DOUBLE BLIND PROSPECTIVE STUDY OF
LONG CHAIN TRIGLYCERIDE (LCT), MCT/LCT AND MEDIUM
CHAIN TRIGLYCERIDE (MCT) DURING PARENTERAL
NUTRION
A Dennison* J Jameson*, K Maden", N Bird** and R Law"
*Deatment of Surgery, Lecese Gerl Hospital and ** Univety
Department of Surgery, Royal Hla re Hospital, Sheffield UK.
The best non-nitrogen calorie source duriW parenteral urition
remains controversial. This sdy was performed to establish whether
the use of a 20%/o MCT emudsion would demonstrate significant
advantages over conventional LCT.
Foilowing a voluntoer udy stabs the sety of a 20%/o
MCT emulsion (B.BraunM lingen) ethil committ approval was
obtained for a prosp e udy. Fifty seven patients were randomised
to receive conventional 20%/. LCT, 10/. MCT/10^/. LCT or 20%/o MCT
as 50%/o of their non-niro calones during routine TPN. Paets
were studied for 10 days after which all patients reverted to our
standard TPN regimen.
Results were analyse by analysis of covaiance of the final day
measurement with respect to the iniial value for each variable, prior to
breaking the randomisation code. There were no adverse clinical
reactions in any of the groups. Cardiovascular and respiratory
parameters and routine haematological, biochemical and acid base
measurement were unchanged. Differences were demonsrated in
bilirubin levels where LCT (72.3 ± 31 mmolA mean ± sem) was
significantly higher than MCT (19.6 ± 6.1) or MCT/LCT (23.4 ± 12.5),
(p = 0.025). Levels of free glycerol were also reduced in the LCT
group (1.28 ± 0.1 mmol/l) compared with MCT (2.48 ± 0.23 and
MCT/LCT (2.67 ± 0.27) p<0.001). There was also a trend towards a
higher white blood cell count in the LCT group.
This study demonstrates that 20% MCT emulsions are safe for
routine clinical use and also suggests that MCT or MCT containing
emulsions have advantages metabolically and on liver function.
GASTROESOPHAGEAL REFLUX IN PATIENTS FED BY PERCUTANEOUS
ENDOSCOPIC GASTROSTOMY (PEG) - SCINTIGRAPHIC DETECTION.
KK Balan, S Vinjamuri, J Bennett* and M Critchley, Depart-
ments of Nuclear Medicine and Gastroenterology*, Royal
Liverpool University Hospital, Liverpool L7 8XP U.K.
Percutaneous endoscopic gastrostomy (PEG) is the method
of choice for long-term enteral nutrition in patients unable
to swallow due to a variety of medical conditions. PEG
eliminates the need for surgical gastrostomy and nasogastric
tubes, is easily performed with few demands on health serv-
ice resources. Aspiration pneumonia may complicate PEG
insertion but there are few studies on gastroesophaqeal
reflux (GOR) in PEG patients.
Methods: 22 patients (14 M, 8F, aqe 43-83 yrs, median 69)
with PEG underwent radionuclide GOR studies. 13 patients
had neurological and 9 had mechanical dysphagia. They
received 100 ml of oranoe juice containing 25 MBa of Tc99m-
tin colloid followed by 301ml of normal saline throuoh the
PEG tube. Patients lay supine under the gamma camera linked
to a digital computer system. 4 min. and 4 h images over
stomach, oesophagus and lungs were examined for GOR and
lung aspiration.
Results: 10 patients, 8 of whom with neurological dys-
phagia and 2 of whom with mechanical dysphagia, had severe
GOR. 2 other patients with neurological dysphagia had mild
GOR. One patient with severe GOR also had lung aspiration
at 4 hrs. 10 patients had normal studies.
Conclusions: 1) Radionuclide imaging is useful in asse-
ssing GOR in PEG patients 2) GOR appears to be a major
p-oblem in patients with PEG and 3) PEG patients with
neurological dysphagia appear to be at greater risk for GOR
than those with mechanical dysphagia.
OPTMSING CATHETER SURVIVAL IN PERIPHERAL
PARENTERAL NUTRION: A RANDOMISED CONTROL TRIAL
B.M.Dobbins, P.Deady, G.V.Miller, M.J.Tighe, I.G.Martin and
M.J.McMahon. University Department of Surgery, The General
Infirmary at Leeds, Great George Street, Leeds, LSI 3EX
Peripheral vein thrombophlebitis (PVT) is a major obstacle to
successful and prolonged administration of peripheral intravenous
nutrition (IVN). This study assesses the impact of glyceryl trinitrate
(GTN), heparin & hydrocortisone and a combination of both therapies on
the incidence and time to onset of PVT during the administration of
standard (1200 osm/kg) peripheral IVN via a fine bore polyurethane
catheter. One hundred and eleven patients were randomised to receive
standard peripheral nutrition with either a 5mg GTN patch directly over
the catheter tip (Group 1, n= 42), heparin 1500 iu & hydrocortisone
15mg added to the infusate (Group 2, n=40) or a combination of all three
interventions (Group 3, n=-29). Limbs were examined daily and catheters
removed if any signs of PVT became evident (pain, swelling, erythema,
tenderness, increase in , or a palpable venous cord). The
three groups were matched for age, gender, indications for IVN and total
duration of nutritional support.
The use of a GTN patch alone (group 1) was associated with a shorter
time to onset and higher incidence of PVT than either of the other
groups (median catheter suvival 6days (group 1) vs 10 days (groups
2&3); p<0.03*). There was no additional benifit of GTN in addition to
heparin & hydrocortisone alone (p=ns* Group 3 vs Group 2). In
addition, choice of vein significantly influenced cateter survival, since
significantly lower incidence of PVT and longer duration to develop
PVT was observed when the basilic vein was used (compared to the
cephalic vein) in all 3 study groups (median catheter survival 10 days
(basilic vein) vs 6 days (cephalic vein); p<0.01*).
In conclusion, a GTN patch alone, and the addition of a GTN patch to
heparin & hydrocortisone in the infisate, offer no benefit in terms of
peripheral catheter survival. We would recommend peripheral feeding
using heparin & hydrocortisone in the infiusate using the basilic vein
whenever possible to optimise catheter survival and reduce morbidity.
(*Chi squared and Log Rank statistics)
SALL BOIWL JUICE DIACCARID ACTIVITY IN THE
PE -TERM INFANT
Cade A, Walters M, Puntis J W L
Department of Paediatrics & Child Health,
Clarendon Wing, Leeds General Infirmary, LS2 9NS.
Conflict exists regarding the efficiency of
lactose hydrolysis in the premature newborn.
Lactase activity in the foetus appears low, but
preterm infants fed lactose containing formula
usually grow without losing carbohydrate in the
stool. Experimental data both supporting and
refuting efficient lactose hydrolysis is
generally derived using indirect assessments. A
more direct approach is to measure disaccharidase
activity in duodenal fluid or mucosa. One study
of 8 infants from 26 - 29 weeks gestation
suggested that during the first 3 weeks of life,
lactase activity increased and from the outset
was comparable with older children. We have
obtained duodenal aspirates from preterm infants
over the first 2 months of life. 40 infants were
studied; median (range) gestational age 29 weeks(24 - 40) and birthweight 1260 g (600 - 2550).
31 were appropriately grown and 9 were small for
gestational age. Disaccharidases were measured
by a 2 step colourimetric assay using a standard
Boehringer Mannheim kit. 34/56 (61%) of lactase,
44/56 (79%) of maltase and 23/56 (42%) of sucrase
activities fell below the lower published
reference range for older children. There was no
apparent increase in enzyme activities or fall in
sucrase:lactase ratio with increasing postnatal
age. Despite this, none of the children showed
clinical evidence of carbohydrate malabsorption.
We conclude that disaccharidase activities are
frequently low in the preterm enterally fed
newborn compared with older children, however,
the absence of clinical evidence of lactose
malabsorption suggests that undigested lactose is
assimiliated in the colon. There is probably no
reason for preterm formula milks to contain less
lactose than breast milk as many do at present.
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Inteinal trasit and release characteristic of 2ancreatin
enzyme microsaheres.
'S Ghoul, lCj Taylor, 2p Hillel. 'Dept of Paeditrics, 2Dept of
Medical Physics, Universiy of Sheffield, UK
Mismatch in gut tranit betwee food and panxratin may be relevtto
recu rqorts of colaic stricturs in cystic fibrosis (CF) patiats. We
investigated the gat mcenptyg and smal1 bowel tnit of food and
pandrtin in 10 pacreatic inufficiat CF patats agpd 9 to 38 yars
(of whom four in grop I had ood and six in group 2 had subqtirnl
nutritin satus). Twin M s g combmied with breah
hydrogo sampipng was used to track the cancurrat movamt of
indium lablled panestin nmicsphores and an tandard todunoin
labeled sm solid tes meal. Smal bowe btnt tne for food was
established w- a yrinsuc " h e el
Patitl Median Median snall Median 50% gastric
group Wt SD gut trauit tying time:
soore time FOOD ENZYME
I (n=-4) :+0.4 2.8hr gg8&in 99min
2 (n=6) -2.6 4.Ohr 133mnu 36min
Small bowel transit for food was delayed (>6 hours) in 3 subjects. The
difference in gastric 1/2 amptying time bdween enzymes and food was
sigiificantly greater (range 47-195 min) in patients with suboptimal
nutritional status (p=0.03, df=1, Fishers exact probability test). Enzyme
"hot spots" in 2 subjects were visualised in the colon by 2 hours. This
discrepancy in transit of pancreatic enyme microspheres and food
boluses could account for continuing malabsorption in some CF patients
and identify a mechanism whereby intact microspheres reach the colon.
HIGH PREVALENCE OF UNDETECTED INFLAMMATORY
BOWELDISEASE (IBD); DATAFROMTHENOTIINGHAM
FAECAL OCCULT BLOOD (FOB) SCREENING TRIAL
G(FJHowfh, M.H.E. Robinson, D. Jenkins*, J.D. H e
R.F.A. Logan,. Depatr ts of Surgery, Public Heath &
Epidemiology and Pathology, Univesity Hospital, University of
Nottngham, NG7 2UH.
The severity of symptms frm IBD can vary from devastating
to none and a prvious stdy from the Notngham FOB seening
trial suested that the prevalence of asyom tic IBD might be
substantial (GUT 1989;30:481483). The screnig trial has now
been completd. Th aim of this study is to rassess the pvaence
of IBD detected in the trial.
FOB tests were pefmed by 44,838 of the 75,253 subjects
aged 49-74 offered Paents knw to have IBD were
exchled from FOB sceenig. Asj FOB positive on one or
more occasios (n= 1778) were m gatd by cokoocopy or
flexible sigmoidoscoy and brium . 94 were found to have
IBD at endoscopy and cn ed by biology. 57 subjects had
previously u ed IBD (55 ulerative colitis (UC), 2 Crohn's
disease (CD)). The rai 37 (31 UC, 6 CD) had had a
previous diagnosis of IBD b this had not been recgnised when
they were iited to be screened. The prevalence of previoy
undeeted IBD in ose offered screening was 73/10' (95%cl 54-
92/105) for UC and 2.7/105 (95%cl 0.3-10/10') for CD. Based on
those accepting screening the prevaknce of unded UC was
123/10' (95%cl 90-155/105) and for CD 4.5/105 (95%cl 0.5-
16/10'). The prevalence of undeectd UC was higher in the over
60s and also was almost two-fold higher m men ta wome (164
v.87/105). Proctosigmoid UC aounted for 54% (31/57) of cases
and pan colitis for 20% (11/57). 82% (47/57) had some symptoms
but had not consulted or had not been referred for investigation;
62% reported rectal bleeding and 60% had mild diarto.
The prevalence of undetec UC is much greater than
previously reported. Prevalence is higher in men, increases with
age, and low-grade symptoms are common. Increased detection of
prevalent UC needs to be allowed for in studies of comparing UC
incidence.
B VITAMIN DEFICIENCIES MAY BE COMMON IN THE
ACUTE INPATIENT POPULATION.
CP Jamieson, OA Obeid, J Powell-Tuck,
Rank Department of Human Nutrition, Royal London Hospital,
Whitechapel, London El1 BB.
1 10 patients were selected at random from those admitted
via the Accident and Emergency department over 3 days.
Erythrocyte transketolase (ETK), glutathione reductase (EGR)
and aspartate aminotransferase (EAA) enzyme assays were
used to determine thiamin, riboflavin and pyridoxine
deficiencies respectively. A deficiency state was diagnosed
when the percentage activation with added coenzyme was
greater than the conventionally accepted limits of 23%, 20%
or 86% for ETK, EGR, and EAA assays respectively.
77% of patients were under the care of the directorate of
General Medicine, 15% General Surgery and 8%
Orthopaedics. 56% of the study group were men, 73%
Caucasian,. 20% Asian and 7% Afro-Carribean. A total of 66
patients (60%) had at least one biocheMical B vitamin
deficiency. Of the 17 patients who had a body mass index
(BMI) below the desired range of 20-25 kg/mf 15 had one or
more deficiencies. The majority of deficient patients, however,
had BMI values within the desired range. The median age of
the deficient patient group was lower at 59y compared with
69y in the non-deficient group (p=0.002, Mann Whitney
U test). Overall the prevalences of specific deficiencies were
9%, 41%, 35% and 22% for thiamin, riboflavin, pyridoxine and
multiple deficiency states respectively. Four patients were
admitted with alcohol related disease; of these two were
thiamin deficient and one had combined riboflavin and
pyridoxine deficiencies.
B vitamin deficiencies seem common in the acute inpatient
population and are not limited to those patients with
protein-energy undernutrition.
MORTALITY IN INFLAMMATORY BOWEL DISEASE:
THE CASE FOR A NATIONAL CONFIDENTIAL ENQUIRY.
FH Gordon SM Montgomery, MI Hmilton and RE Pounder.
Infammatory Bowel Disease Study Group, Royal Free Hospital
School of Medicdne, Rowland Hill Street, London NW3 2PF, UK.
Introduction Mortality due to iflammatry bowel disease (IBD) has
decreased steadily since 1950, but population-based cohort studies
suggest that IBD patients continue to have a higher mortality rate than
expected, partly due to a higher incidence of gastro-intestinal
malignancies. Records held by the Office for National Statistics since
1993 permit detailed analysis of mortality in IBD patients, including
calculation of the number continuing to die from complications of the
disease itself or from colorectal malignancies.
Methods Patients who died in England and Wales between January 1"
1993 and 31I December 1995 inclusive and whose death certificates
included the codes 555 (Crohn's disease/CD) or 556 (ulcerative
colitis/UC) were identified from Office for National Statistics records.
Results IBD was listed as a cause of death in 2581 patients, of which
1146 (44%) had CD and (1435) 56% had UC. CD was the underlying
cause of death in 462 (40.3%) of patients with CD on their certificate,
whereas the figure for UC was 509 (35.0%). The mean age at death for
those with CD was 68.2 and 72.3 years (male and female respectively)
and 70.7 and 76.0 years (male and female) for those with UC. Of those
patients who had CD or UC as their underlying cause of death, 54 (12%)
and 25 (5%) were less than 50 years-old, respectively. Colorectal
carcinoma accounted for the deaths of 9 (8%) and 23 (24%) of CD and
UC patients under 50 years-old, respectively.
Conclusions At least 300 IBD patients per annum in England and
Wales continue to die from their disease and its complications despite
improved treatment and endoscopic follow-up. Most deaths occur in
elderly patients, but a surprisingly high number of younger patents
continue to die either from their disease (CD patients) or from colorectal
carcinoma (UC patients). Further study, such as by national confidential
enquiry, may identify reasons for these deaths and lead to improved
survival ofIBD patients.
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INFLAMEATORY BOWEL DISEASE IN A
NATIONAL BIRTH COHORT
SM. Mantgomerv. D. Morris, N. Thompson, J. Subhani,
S. Ebrahim, RE. Pounder, and AJ. Wakefield.
Inflammatory Bowel Disea Study Group, Department of
Medicine, Royal Free Hospital School ofMedicine, London.
Aim: A birth cohort withpse ly collected data was
used to investigate the prevale of imatory bowel
diseas (IBD) at age 26 ye and the association of
childhood diseases with disis of IBD.
Metbods: The 1970 British Cohort Study (BCS70) is a
longitudinal study of everybody born in Grea Britain
between 5 - 11 April 1970. A survey of Crohn's disease and
ulcerative colitis was c t at the age of 25/26 years,
with 9,800 (85%/a) re ing. Diis of IBD, using
standardised crita, was confirmed by cohort members'
physicians and by histology. Reports of otitis media and
eczema were collected prospectively at the ages of 5 and 10
years.
Reslts: By age 26 years, 24 cases of Crohn's disease and
20 cases of ulcerative colitis had boen diagnosed,
representing prevalence rates of 2.45 and 2.04 per 1,000
respectively. The earliest diagnosis of IBD had been made at
age 12 years. Otitis media at 5 years was significantly
associated with ulcerative colitis (relative risk=4.00, 1.20 -
13.30), but not Crohn's disease (0.44, 0.06 - 3.31). Eczema
at 10 years was associated with ulcerative colitis (4.88, 1.85 -
12.86), but not Crohn's disease (0.81, 0.19 - 3.53).
Conclusions: A very high prevalence of IBD, particularly
Crohn's disease, was found amongst British 26-year olds.
Otitis media and eczema were significantly associated with
future ulcerative colitis, but not Crohn's disease.
TREATMENT OF REFRACTORY INFLAMMATORY BOWEL
DISEASE WITH GRANULOCYTE APHERESIS
HJ Rembacklen HE Newbould, MF Dixon, RS Bwy, M Hedrikwc, DM Chalmers,
ATR Axon. Centre for Digestive Disease, The General Infirmiry, Leed, UK
Uncontrolled studies have suggested that leucocyte apheresis may be a useful
in the trtment of inflammatory bowel diseae (IBD). We report the results
of a pilot study evaluating tie use of granulocyte aphereis in patients who had
failed to respond to sndard medical dterapy.
Eighteen patients with active ulcerative colitis (UC) and six with active
Crohn's disease (CD) were recruited. These patients had not responded to
prednisolone and, in most cases, azathioprme and 5-ASA compounds.
Granulocyte apheresis was performed weekly uswing a column (GI, Otsuka
Pharmacetc Co. Ltd). Response was sessed by symptom indices,
sigmoidoscopy, histological scoring and leucocyte sci ing.
In UC, 3 patients went into remission and the overall clinical symptom
score for all patients, fell from a median of 9 on entry to 3.5 after four weeks
(Wilcoxon P-value=0.012). There was a statistically significant improvement
in the mucosal appeare at sigmoidoscopy at entry compWred to after four
weeks treatment (mean change -0.53, Wilcoxon P-value=0.016). The
histological score also improved from a median of 5 to 4 (Wilcoxon P-
value=0.096).
One patient with CD withdrew due to dizziness, 1 achieved remission
and there was a reduction in the median CDAI score from 306 to 177.5 after
four weeks treatment (Wilcoxon P-value=0.09). The leucocyte scintigraphy
score also improved from a mean value of 2.5 at entry to 1.5 after four weeks
(Wilcoxon test, P-value=0.25). There were no significant change in median
haemoglobin, white cell or platelet counts during the study. There were no
changes in laboratory values that caused concern and the procedure was well
tolerated both by in- and out-patients.
This is the first study looking at granulocyte apheresis in patients with
steroid resistant IBD. Our data suggests that the treatment is both feasible and
safe and may have be effective in both UC and CD. However, larger,
controlled studies are required.
SOCLAL IMPLICATIONS OF CHILDHOOD CROHN'S
DISEASE;
GA Moody, JA Eaden& JF Mayberry
A validated questionnaire investigating quality of life was
mailed to the parents of all child members of Crohn's in
Childhood (CICRA) (age 5-17). 64 questionnaires were
retuned along with 35 from patlents in the adult age wnge(not analysed). The mean age of patients interviewed was14.1 + Z.8, (range 6-17), with equal numbers of males tofemales. The mean duration of illness was 4.9 i 3.3 years;
patients had 1.4 + 0.7 operations (range 0 - 6). Of the
children investigated over half had si' ficant absences from
school (60%), with a mean of 3 2 months off school in
the previous year. Many felt their teachers lkew nothing
about CD (53%) and that they were unsvmnathetic (50%).
Of the 24 who had taken examiations 80% thought they had
underachieved because of ill health.
Patients were asked whether they were able to perform




their friends 28 42% 5 8% 33 50%
Go out 37 56%) 3 4% 26 40%
Take part in sport 41 (63%) 3 (4% 22 23%
Go on holiday 25 38%) 0 41 62%)
Stay overnight at afriends house 25 (38%) 8 (13%) 33 (49%)
The commonest questions asked be the children were (i)
what is CD? (50%) (ii) why me? (i4%), (iii) will it affectmy schooling (52% and (iv) will t affect my chnces ofgetting a job (67%)
In conclusion children with CD have a sigmfatly impaired
quality of life they fear every day childhd activities and
their future. ¶lhey need sympathetic management and effort
should be concentrated on improving teir day to day









A RANDOMISED CONTROLLED TRIAL OF ESSENTIAL FATTY
ACIDS (EFA) IN ACUTE ULCERATIVE COLTIS(UC).
Stack WA, Cole AT, Makhdoom Z*, Murray FE, Cullen DE, Stewart
JCM¶, Everitt SE, Holmes G* and Hawkey CJ. Divisions of
Gastroenterology, University Hospital, Queen's Medical Centre,
Nottingham, and Derby Royal Infirmary*, Scotia Phannaceuticals
Guilfordi.
Background: Omega-3 EFA (fish oil) has recently been shown to be
beneficial in decreasing relapse rates in Crohn's disease (Beluzzi NEJM
1996; 334:1557). Omega-3 EFA appear to be of more limited benefit in
acute ulcerative colitis and possible synergy with omega-6(plant oil)
EFA has been suggested. We therefore carried out a randomised double
blind controlled trial of omega-3 and omega-6 EFA supplementation in
acute UC to detennine if they reduced steroid requirement and to
investigate if synergism existed between them.
Metods: Patients with acute relapse of colitis were randomised to
receive omega-3 EPA (eicosapentaenoic acid l.5g), omega-6 EFA
(gamma linolenic acid 2.1g), both or placebo daily for four months.
Prednisolone use was systematically reduced using a standard
withdrawal protocol. As the trial was exploratory, the main analysis was
of steroid use in patients treated per protocol by logistic regression
analysis.
Results: 66 (36F) patients were randomised to treatment and 53
completed the study. 6 patients withdrew due to severe exacerbations of
UC (2 placebo, 2 omega-3, and 1 each omega-6 and both groups), 4
withdrew because of side effects (I each group), and 3 defaulted from
follow up. Daily mean prednisolone (±SD) for all groups was
19.8±9.6. 11.4±9.1, 8.9±9.3 and 7.2±8.lmg/d for months 1 to 4
respectively (p<0.001; month 1 to 4 ).There was no significant
difference in mean daily prednisolone requirement in patients treated
with omega-3 and omega-6 EFA either alone or together compared with
placebo (Table).
Month I Month 2 Month 3 Month4
Omega-3(14) 16.4±6.6 11.1±9.9 9.8±10.0 7.6±9.8
Omega-6(13) 21.8±7.1 13.7±8.7 8.4±8.6 7.0±6.4
Both (13) 21.6±5.9 12.3±10.8 9.4±7.6 7.5±9.8
Placebo (13) 22.8±3.5 8.6±7.3 7.9±11.0 6.7±8.0
Similar findings were obtained when results were compared on an
intention to treat analysis.
Conclusion: In acute UC we could find no steroid sparing effect with
omega-3 or omega-6 EFA supplementation compared with placebo
whether given alone or in combination.
MACROSCOPIC AND HISTOLOGICAL INACTIVITY IN
ULCERATIVE COLITIS (UC) SURVEILLANCE: A GOOD
PROGNOSTIC SIGN?
E Chiotakakou-Faliakou, S Ganesh, K Wilkinson, A Forbes.
St Mark's Hospital, Watford Road, Harrow, HAl 3UJ.
Surveillance colonoscopy in UC is imperfect and expensive.
Better targeting of especially high and relatively low risk patients
would improve its cost-effectiveness. A clinical impression that
the risk of neoplasia is lower in those with persistently inactive
disease has been tested. Thirteen cases of confirmed dysplasia
or carcinoma (n=3) documernted between 1/1/93 and 31/12/95 in
a major surveillance program, which currenty includes more than
400 patients with macroscopically extensive colitis of >10 years
duration, were reviewed. For each case, 2 unresected UC
controls matched for age, sex, and disease duration were
selected from the database. Contemporary reoords of biennial
colonoscopic appearances and the degree of histological activity
were compared with those for the patients with neoplasia. At the
first occasion of dysplasia/malignancy the cases had had a mean
of 23.1 years extensive UC (controls 23.5y), and had unrgone
6.8 surveillance colonoscopies (4.9). 58% of colonoscopies in
the cases had been reported to show normal appearances or
quiescent disease, compared to 78% in the controls (x2: p<0.05).
48% of histological reports in patients with subsequent neoplasia
indicated inactive disease, compared to 58% in the controls (not
significant). Although persistent macroscopic and histological
quiescence of extensive UC may be associated with a lower risk
of progression to early dysplasia/malignancy, the magnitude of
this effect is unlikely to be sufficient to support a reduced
frequency of surveillance colonoscopy.
MUCOSAL AMINOSALICYLATE LEVELS CORRELATE WITH
CLINICAL ACTIVITY IN PATIENTS WITH ULCERATIVE COLMS.
F.Hussain. R. Ajan. M.Grukhnan. R. Bolton, S. Riley. Chesterfield,
Doncaster and Northme Genral Hospital, Shfficld UK.
Introduction Despite mainna mesazine ment some patiet with
ulceratvc colitis relapse frequently. Svstaeic drug kvels do not relate to
clinical activitv and correlate poorly with tissue lvels. We have drefore
studied the relationship between rectal tissue drug kvels and clinical
outcome. Metheod 20 patints (10 male, age 19-75 years) taking delayed-
relase mesalazi 2.4g/day wer recruited. Each underwent clinical
assessment and sigmidoscopy at 0. 3. and 6 months or at reapse. At eacb
timepoint 24 hour urine collecio and rectal biopsies wem taken for drug
analysis. 9 patits relapsed during the study (reported compliance was
good)
Resuls: mean (snm) Quiescent Quiescent Du
throughout but relapse
n=l I subsequently n=9
relapse n=9
Mucosal ac5ASA ng/mg 8.2(2.7) 6.2(1.2) 2.3(0.7)
Mucosal 5ASAng/mg 6.2(1.6) 3.6(1.6) 0.3(0.18)
Urine ac5ASA mg 483(40) 854(178) 557.5(46)
Urinc SASAmg 79.5(15) 152.7(43) 70.9(15)
Mucosal drug levels were significantly lower at relapse dtan during
quiescent disease (5ASA p=0.02. ac5ASA: p'0.008) Urinary drug levels
m.cre lower but this did not achieve statistical s . Mucosal 5ASA
drug lcvels were also reduced in patients who were quiescet at entry but
who subsequently relapsed (p= 0.02) wheras total urnary drug levels and
ac-5ASA were significantly increased (p=0.04).conpared to patents who
were quiescent throughout. Conclsen Mucosal lvels in
paticnts with ulcertive colitis fall appiabl at times of rdape. Paets
who subsequently relapse have lower rectal mucosal 5ASA lve and higher
urinary drug excretion. This nay reflect diffces I and
may predispose to relapse. Rectal mucosal drug analysis is a uw l tool in
the study of patients with ulcerative colitis.
( Research part funded by Smith Kline Beecham Phaacicals, U.K)
CROHN'S DISEASE PATIENTS IN CUNICAL REBSSION SHOW
EVIDENCE OF ONGOING UOSL INFLAMMATION.LIA ., S Ghosh,
H D mmond, A Feguson. GI Unit Depafmn ofMedcine, UnWity of
Edinburgh, Westen Genere Hospkel, Edinburgh, Scoand.
Background: Clinical renission in Crohn's Disease is generally defined as a
CDAI <150. Endoic and hisologic dsease aclvesm not correlate.
Inflammaory mrkers i tiole gut lavap flid (YWGLF) such as grandocyte
elastase (GE) and IL-1 3 hav been used as odclive measures of both small
bowel and coonic mucossl inilawmmo. UVe aimed to study whhr dinical
reTission is associaed with nomisaion ofGLF inilammatory markers.
Methods: In a prspecive study, CDAI was reoorded in well chaactderid
CD paents undergoing whde gutlWaa W polyetylene lyco elecirdyte
sduton (Khan-PrepO, Norgne), generdy as a bowel prer-n prior to
colonoscopy or buium enema. The Ir dear fluid passed per rectum was
colectd, pressed by addon of prta inhibtor and stred at -70°C. IL-
1 (normel < 4pmL) and IL-8 (nornWi concentatmn2pgmL)
concen1ralons ware measured by EUSA and GE concenton (norml
<39nkat/L) was measured by an enzyme-sbste racion as described
previously.
Resuts: 24 paients wth CD were in dinical ronission with CDAJ<150. 15/24
(62%) of these palents had raised VYLF IL-11 concentons, 16/24 (67%)
had raised IL-8 concentalons and 7/24 (30%) has raised GE concentatons.
Overall,
67% of paients in cinical renission had one or more anormal VYGLF
inflammatory parameters.
ConclsIon: A sigficant proportion of CD paients in dinical renission have
SLF features suggestve of ongoing mucosa infamion. We have
previousy showm that CD patnts with abnormal VGLF inflammaory
markers relapse more oflen than those vth normal VWLF paramtes.
Further research is needed to ascertin wheher medcal trpy to induce
mucossl renission Wil produce longer relapse fle periods
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FURTHER VERIFICATION OF THE REALLY USEFUL
SIMPLE COLMITS ACTIVIY INDEX.
RSialidsx. RCS Ayres, RE Pounder, RN Allan.
Inflammatory BowlDissaw Study Grow, Dqertment ofMedicine,
Royal Free Hospital School ofMedicine, London, DDqwpznnt of
Gastroetology, Queen Elibeth Univerity Hospital,E ,
Birminghm.
Backgeud & Aims: We have devised a clinical scoring system of
five simple questions to ases the activity ofulcerative colitis (UC)
which conrltes significantly with the Powell-Tuck score (1). We have
now evaluated the simple clinical score agait a complex score
devised from clinical and l y data (2) as well as biochemical and
haematoloical lresult reevant to UC (3).
MeEbis: 60 paients with UC underwent 110 ments. They
completed a qusioCsairec ng: bowel fiequncy (day & night);
presence ofblood in stool; urgency of defecion; geneal well being
and extrcolonic manifestatons. Labortory tests included:
haemoglobin; platelet count; haematocrit; eythoyte simentation
rate and serm albumin. Scores were calculated as published (1,2) and
compared using Pearson correlation.
Result: Simpk Index r value p value
Correlile wS; ______




Platelet count 0.323 0.0006
Haematocrit -0.325 0.0005
ESR 0.321 0.0015
For 8 patients assessed during an exacerbation of their disease the
simple score correlated well with the complex score and laboratory
parameters.
Condludon: This simple clinical colitis activity index is a robust tool
for assessing the activity ofulcerative colitis.
Ref. (I).RS Walmalny et al.GuLt1994:35; supl 5: S29. (2). M Seo et al Am J Gastro.
1992:87;8; 971. (3).W Cooke, P Prior. J Clin Gastorenterol 1984: 6; 17.
PERIPHERAL BLOOD PROINFLAMMATORY CYTOKINE
PROFILE IN ACTIVE INFLAMMATORY BOWEL DISEASE
(IBD) DIFFER BETWEEN SMOKERS AND NON-SMOKERS.
Bhatti MA, Hodgson HJF.
Royal Postgraduate Medical School, Hanmersmith Hospital, London.
Strong evidence exists that patients with Crohn's disease (CD) are more
likely to be smokers than control population whilst, on the other hand,
nicotine improves the condition of patients with active ulcerative colitis
(UC). However the mechanism(s) of the effects of nicotine remains
elusive. We have investigated whether there are differences in pro-
inflammatory cytokines IL-1I, IL-6, IL-8 between smokers and non-
smokers in ex-vivo LPS stimulated blood.
METHODS: 6ml blood were taken from each patient with both active
and inactive UC and CD (12 in each group; total n=48) and 12 healthy
volunteers (7 patients with UC, 11 with CD and 5 healthy volunteers
were smokers). Plasma was separated from 3ml of each blood sample
and other 3ml were incubated for 24 h with 20ng/ml LPS before
isolating cell free plasma. All cytokines were measured by sandwich
ELISA (lower detection limit l5pg/ml). Disease activity was measured
by Crohn's disease activity index in CD and Truelove and Witts criteria
in UC.
RESUTS: Among patient with IBD LPS stimulated IL-Ij and IL-8
levels among non-smokers were significantly higher than smokers
(p<O.05 & P<0.01 respectively). This effect was more pronounced for
IL-8 levels particularly among active UC and CD patients (Non-smokers
Smokers; UC(median) 1143: 684 pg/ml. p<0.001 & CD 954: 630
pg/ml: p<O.Ol). IL-6 levels were not significantly different between
smokers and non-smokers. IL-1p and IL-8 levels also correlated well
with disease activity (r=0.543 & r=0.64 respectively). In spite of lower
cytokine levels, number of monocytes, a primary source of pro-
inflammatory cytokines, was higher among smokers (p < 0.001).
CONCLUSIONS: 1. Non-smokers tend to have higher levels of pro-
inflammatory cytokines than smokers.
2. These results indicate one possible way (probably a cytostatic activity)
by which nicotine is effective among active UC patients.
MESENTERIC MARGINAL ULCERATION IN CROHN'S
DISEASE: CORRELATION WITHVASCULAR ANATOMY AND
CRITICALLY-PERFUSED SITES. A And=y, RE Pounder, AJ
Wakefield, AP Dhillon. Inflammatory Bowel Disease Study Group,
Depts of Histopathology/Medicine, Royal Free Hospital, London, UK.
Rackd=ouxdlAi In Crohn's disease (CD) of the ileum, ulcers lie
along the same side of the bowel as the mesenteric attachment (ie.
mesenteric margin), while the anti-mesenteric mucosa is often spared.
The mesenteric and anti-mesenteric borders of the human small intestine
are supplied respectively by vasa brevia (VB) and vasa recta (VR)
feeding vessels. CD affects the terminal ileum more often than the
jejunum. It has been proposed that mucosal infarction, as a consequence
of primary granulomatous vasculitis, contributes to CD. We tested the
hypothesis that CD ulcers along the ileal mese ic margin are
explained by the existence of VB end arteries within the human ileum
but not the jejunum. Metho(&. Post mortem specimens of normal
terminal ileum and jejunum were dissected from adult cadavers (n-8).
Mesenteric arcade arteries were cannulated and perfused with carbon
(India) ink with or without prior ligation of single isolated VR or VB.
Specimens were fixed and cleared by Spalteholtzes method. The blood
supply of the bowel wall and the submucosal plexus was examined by
dissection microscopy. Tissues were also examined hislgically.
ResukL The submucosal vascular plexus of the jejunum was more
extensive than that of the terminal ileum. The submucosal vascular
plexus derived from ileal VB were noted to be end-arteries with little
or no communication with the submucosal plexus formed from VR.
Ligation of both isolated ileal and jejunal VR prior to carbon ink
perfusion did not affect filling of the submucosal plexus. Prior ligation
of ileal, but not jejunal, VB revealed filling defects of the submucosal
plexus along the mesenteric margin. Cga1IaFOp. In the ileum, VB do
not communicate with the main submucosal plexus, (ie. they are end
arteries) suggesting that pathological occlusion of ileal VB would
preferentially render ischaemic, areas of the ileum along the mesenteric
margin. These findings support a vascular hypothesis for CD and may
explain the ileal and mesenteric distribution of CD ulcers.
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EXPRESSION OF INTEGRIN a407 ON CIRCULATING
LYMPHOCYTES IN INFLAMMATORY BOWEL DISEASE.
Arun Dhiman, Mike J. Weldon, Douglas J. Ringler, Jennifer A.
Tooze" & J.D. Maxweil Divisions of Gastroenterolog and
.Haematology, St. George's Hospital Medical School, London
SW17 ORE and.'LeukoSite Inc., Cambridge, MA 02142 USA
Backgrowd: The ceil adhesion molecule integrin a407 is involved in
the migration of B and T Iymphocytes to the gut. ati-a4 itegin
antibodies reduce colonic inflammation in the Cotton-top tamarin.
Aim: To detemine if there is any change in the expreso of integr
a407 on circulating Iymhocytes in inflammatory bowel disese patients.
Methods: Peripheral venous Iymhocytes from 7 normal controh, 16
Crohn's disease (CD) and 9 ulcerative colitis (UC) patieats (both active
and inactive disease) were studied using flow cytometry. The percentage
of Iymphocytes expressing intergin a4f7 was determied usig
monoclonal antibody Act- I and an indirect imnmofluorescence
technique. The relative number of a437 receptors per Iymhocyte was
compared by calbrating the mean fluorescence intensity (MFI) in
fluorescnce (MEF) units for each populatin ofa407+ lmwhocytes.
Results Mean percent a47 M of a4
I 3pu3ViW= =Ia5U5Duucs MiLU
Controbs 71.9 ± 5.3 2816 ± 419
CD Active 69.1 ± 3.5 3614 ± 313
Inactive 77.3 ± 3.8 2810 ± 524
UC Active 68.2 ± 5.8 2624 ±234
Inactive 82.0 ± 2.3 2799 ± 441
No significant difference in values (p>0.084) between any disease group
and control group, or between any two disease groups.
Conclusion: In inflammatory bowel disease, mucosal accumulation of
lymphocytes is not associated with a change in the proportion of
circulating lymphocytes expressing the gut homing integrin a4,B7, or in
the relative density of lymphocyte a407 receptors. However, anti-a417
therapy may be beneficial in treating inflammation by reducing the
proportion of lymphocytes recirculating through the gut.
ABSENCE OF E£COLI, LISTERLI AND KLEBSIELL
PNEUMONIAE ANTIGENS WITHIN INFLAMfMATORY
BOWEL DISEASE TISSUES.
RS Wamsley R Sim, A Anthony, RE Pounder, AJ Wakefield.
Inflammatory Bowel Disease Study Group, Dqetment of Medicine,
Royal Free Hospital School ofMedicine, London.
Background & Aims: Colonic bacteia may have a major role in the
pathology of inflammatory bowel disease (IBD). E.coli, Listeria and
Streptococcal antigens have been found in the inflamed bowel wall of
French families with IBD (Yui et al, Gastr terology 1995;108:1396)
and serum antibodies to a number of orgaisms including Klebsiella
pneumoniae and E. coli occur in IBD. We therefore undertook an
investigation for persistent microbial antigens within IBD affected
tissues.
Methods: Formahin-fixed and paraffin-processed sections from
resected bowel specimens of 53 patients (19 ulcerative colitis [UC],
one with AS; 23 Crohn's disease [CD]; 11 normal tissues from cancer
resections) were investigated. Control tissue consisted of normal
human small bowel injected submucosally with E.coli, Listeria
Monocytogenes NCTC 7973, Proteus mirabils and Klebsiella
pneumoniae serotypes K2,3,17,21,26,36 and 50, along with colonic
biopsies from a child with E.coli 0114 infection. Sections underwent
Gram-Twort and specific immunohistochemical staining with
antibodies for E. coli (DAKO B357), L. Monocytogenes (DIFCO 2302-
50) and K pneumoniae (Biogenesis 5580-5208 and Sanbio-Monosan
2006), using an immuno-peroxidase technique (DAKO Duet).
Results: E.coli; positive staining on luminal surface, including ulcers
in 41% ofUC, CD and normals. Listeria Monocytogenes; two cases
(both Crohn's disease) showed positive staining confined to mucus
layer. Klebsiella Pneumoniae; superficial staining in 14% (4 CD, 2 UC,
2 nonnal) ofpatients.
Conclusion; Microbial antigens ofE.coli, Listeria monocytogenes
and Klebsiellapneumoniae are found only on the epithelial surface and
not within the affected tissues in inflammatory bowel disease.
THE IMMUNE RESPONSE TO KLEBSIELLA PNEUMONIAE
IN INFLAMMATORY BOWEL DISEASE AND ANKYLOSING
SPONDYLITIS.
RS Walmslev, H Tiwana*, C Wilson*, MJ Hudson **,A Ebringer*,
RE Pounder, AJ Wakefield. Inflammatory Bowel Disease Study Group,
Royal Free Hospital School of Medicine, London.*Division of Life
Sciences, King's College, London. **Department of Microbial
Pathogenicity, Centre for Applied Microbiology and Research, Porton
Down. UK.
Background: Occult bowel inflammation is found in up to two
thirds of ankylosing spondylitis (AS) patients. IgA antibodies to
Klebsiella pneumoniae (Kleb.p) are implicated in the pathogenesis of
AS in HLA-B27 positive patients and have been found in inflammatory
bowel disease (IBD). It has been suggested that the important serotypes
ofKleb.p in AS are K26, 36 and 50. The serotypes involved in IBD are
unknown. Aims: To define the antibody subclass response and Kleb.p
serotypes involved in IBD and AS. Methods: Sera was studied from
HLA-B27 positive AS patients (40), Crohn's disease [CD] (46),
ulcerative colitis [UC] (38), coeliac distase (50) and normal blood
donors (40). Direct, Ig subclass-specific ELISAs were performed using
whole bacterial and capsular extacts of Kleb.p serotypes
K2,3,17,21,26,36 and 50. Mean ODs were compared using Student's t-
test, significance was taken as p<0.02. Results: Significantly raised
antibodies compared with normal controls were found in: AS; IgG to
capsular extracts of K2,3,21,36,50 and whole bacterial preps. of
K36,50; IgA to capsular K2,3,17,21,26,36,50 and whole bactena
K21,26,36,50. CD: IgG and IgA to capsular extracts of all serotypes;
IgG to whole bacteria K17; IgA to whole bacteria K17,21,26,36,50.
IgM to capsular and whole bacteria of all serotypes: UC; IgG to
capsular K17,36,50 and whole bacteria K3,50; IgA to capsular extracts
K2,3: Coeliac disease; no elevation.
Conclusion; A broad range ofKleb.p capsular serotypes are
involved in the immune response to Kleb.p in AS, CD and UC. The
similarity of immune response between IBD and AS is further evidence
of the common association of gut and joint inflammation.
SMOKING AND APPENDICECTOMY IN TWINS DISCORDANT
FOR INFIAMMATORY BOWEL DISEASE (IBD).
ISnhhaaL S Montgomery, S Ebrahim, R Pounder, A Wakefield
IBD Study Group, Royal Ftee Hospital, London, NW3 2QG, UK
These factors have been shown to either be protective (e.g. smoking &
appendicetomy in ulerative colitis (UC)), or a risk (e.g. smoking in Crohn's
disease (CD)), for the development of IBD. Potential confounders indude
mateial and culturl arcumstances in childhood. An unaffected co-twnn
provides an ideal control, miiizi random and "false" systematic differences
in these confounders. In addition a twin also controls for genetic susceptibility.
Finaly the timing of the exposures, in reationship to the disse onset, is
critical to their assessment as "true" risk factors. A twin case-control method
was used to study these factors. Medsod: A UK registry of 175 twins-pairs, at
least one of which had IBD, was valted for disease status and zygosity. Each
member was sent, sequentia, questionnaires asking about childhood events
and smoking (Q1) and other life events inculuing appendicetomy (Q2). Result:
Of the 110 same-sex discordant pairs in the regsstry both twins in 88 pairs
plied to Q1 (80o), and in 67Pai Q2 (79%".
Risk factors Case Control Odds Ratio
Smoking ever
Crohn's disease 24 17 2.5 p=0.18
ulcerative colitis 18 19 0.8 p=1.00
Smoking before Diagnosis
Crohn's disease 21 14 2.5 p=0.18
ulcerative colitis 17 18 0.6 p=0.72
Appendicectomy
ever 9 6 1.6 p=0.57
before diwnosis 3 6 0.5 p=0.48
Appendicitis 0 5 p=0.057
Tbough no exposure achieved significance, the trend in smoking was similar
to that previously reported for the UC and CD. There were no cases of
appendicitis among the twins with IBD, tis despite very similar environmental
exposures (assessed by sharing a bedroom, classes, hobbies and time together)
to their twins who developed appendicitis.
Conclusion.: Differences in exposures in twin studies are more noteworthy
because of the very close matching of case and controL Though no factor
achieved significance, the relationship of appendicitis to IBD seems worthy of
further study.
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INVESTIGATION OF PLATELET-ACTIVATING FACTOR-INDUCED LOW TISSUE ENDOTHELIN LEVELS IN INFLAMIdATORY
SECRETION IN HUMAN COLON. R.A. Borman, R. Jewell, K. Hillier, BOWEL DISEASE, DESPITE ENHANCED ET-2 GENE
Clinical Pharmacology Group, Biomedical Sciences, University of EXPRESSION S.A.McCartney, *T.D.Warner, *M Woods,
Southampton,Sou hwnptonS016 7PX, UK. ~~P.D.Fairclough, M.J.G.Farthing. Digestive Diseases Research Centre andSouthampton, Southamp on S016 UK. PD*The William Harvey Research Institute, St Bartholomew's and the Royal
London School of Medicine and Dentistry. London U.K.
Platelet-activating factor (PAF) has been implicated as a putative mediator
of the diarrhoea associated with inflammatory bowel disease (IBD), Endothelins (ETs) are implicated in the pathophysiology of inflammatory
endotoxic shock, and cholera. Increased levels of PAF have been found in bowel disease (IBD). ETs are produced by inflammatory, endothelial and
specimens of human colon taken from patients with IBD, and when culture epithelial cells in response to stimulation from cytokines (eg TNF-ax, IL- I
medium bathing such specimens is applied to rat colon, there is a significant and IL-2). ETs stimulate further cytokine and prostanoid production and
increase in fluid secretion across the mucosa. In addition, it has been shown cause local ischaemia and increased vascular permeability. We have
that exogenously-applied PAF enhances fluid secretion in rat colon. The aim assessed the tissue content of ETs by sandwich ELISA and expression of
of the present study was to determine whether PAF exerts pro-secretory mRNA for the preproendothelins 1, 2 and 3, ETA and E.TB endothelin
actions in human colon, and to investigate the mechanism of action. receptors in patients with active, treated and quiescent IBD. Biopsy or
Segments ofhuman sigmoid colon were obtained from specimens removed resection material was obtained from 55 patients: 21 with Crohn's disease,
at operafions for carcinoma. After removal of smooth muscle, sheets of 18 ulcerative colitis and controls. Samples were snap frozen and
~ .rr stored at -70°C. ETl/2 was measured in 45 samples and RT-PCR for
mucosa complete with submucosa were mounted in Ussing chambers for mrNA preproET-12 an 3easand reces and GAPDH
measurement of short-circuit current (I,.; an indicator of electrogenic fluid performed on 54 samples
secretion). Tissues were exposed to varying concentrations of PAF, and There was significantly less ET-l/2 in UC and Crohn's vs. controls: UC
responses modlfied by a selection of iinhbitors. 15.3+4 pg/mg vs. 25.4 + 2.8 (P < 0.03, Mann Whitney); CD 13.4 ±2.2 (P =
Serosal application of PAF(c0- to 10-M) induced a significant increase 0.0035). No significant differences were seen between subgroups on or off
in IS, across human sigmoid colonic mucosa, with a maximum response of therapy, quiescent or active. RT-PCR for preproET-2 showed that message
74.3±9.5gAcm' at 10- M and an EC50 of 18.2nM (n=6). Mucosal was present in 40% of control specimens, 81% of CD samples (P < 0.02 )
application of PAF (10-6M) had no effect on IS (n=6). Prior treatment of and 72% of UC samples ( P<0.06 ). PreproET-l was present in <15% of all
tissues with indomethacin (IpM, n=4) or WEB 2170 (a PAF receptor samples and preproET-3 was virtually absent in all. All patients with active
antagonist, 10M, n=4) significantly reduced the secretory response to PAF, CD were positive for preproET-2 (n= 17). ETA receptors were upregulated
signifying the response is mediated via a specific PAF receptor and in association with preproET-2, and mRNA was present in 43% of
dependent on a product ofcyclo-oxygenase enzymes. In addition, application controls, 79% with CD (P < 0.03 ) and 7 1% of UC samples( P < 0. 2
of the loop diuretic bumetanide (10-8 to 10-5M, an inhibitor of chloride ion mRNA for ETB receptors was less prevalent than that for ETA but in
secretion) caused a concentration-dependent inhibition of the secretory similar proportions.
response to PAF (n=3). Conclusions: Colonic mucosa from patients with IBD contains a reduced
In conclusion, application of PAF induces significant fluid secretion across quantity of ETs, contrary to previous evidence. This is in contrast to
human colonic mucosa. The response is dependent on a specific PAF increased mRNA for preproET-2 and ETA receptors. This disparity may
receptor and cyclo-oxygenase products. The n'se in Isc can be accounted for be due to enhanced gene expression matched by increased protease activity
by an increase in chloride ion secretion. in inflamed tissue degrading unbound ET. Interestingly it appears that ET-
This study was supported by MRC lOPA award G9507991. 2, not ET-1, is the physiologically significant isopeptide within the human
colon.
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STONE INHIBITORIPROMOTOR RATIO, A RISK FACTOR FOR
RENAL CALCIUM OXALATE CALCUU FORMATION IN
INFLAMMATORY BOWEL DISEASE - N. McConnell. S. Campbell, I.
Gillanders, H. Rolton and B.J. Danesh. Biochermistry and Gastoen-
terology Departments, Stobhill NHS Trust Glasgow, G21 3UW, U.K.
INTRODUCTION: Enteric hyperoxaluna has traditionally been seen
as the cause ofFe higher incidence of calcium oxalate renal stones in
inflammaory bowel disease and malabsorption syndromes compared
to the general population. This study was undertaken to examine un-
nary factrs contribuing to this increased risk.
METHODS: Forty patients with inflammatry bowel disease (IBD)
were studied along with 17 healthy contols. Two of 25 patients with
Crohn's disease had sones confirned (8%), a furhr 5 (20%) had a
histry of renal sbone symptoms. None of the 15 pabents wih ulra-
tve colis (UC) had eihr stones present or a history of renal stone
symptoms. Levels of oxalate and calcium (known stone promoters),
and citrate and magnesium nwn stone inhibitors) were measured in
24 hour wine xcions.
RESULTS: Hyperoxaluna was present in 36% of Crohn's pient
but none oft UC group. Renal calculior hisry of stDnesym
were no more common in hyperoxalurlc Crohn's patet than in those
wih normnal unnary oxalate output indicating urnary oxalat levels are
less important in stone development than previously suggested.
Crohn's patents had significanty lower unnary magnesium and citlrae
outputs compared to both the control and UC groups. In this study a
combined defiiency of unnary magnesium and citrate relative to uri
nary calcium, as expressed in a Citx Mg/Ca index (CMC), correlated
well with apparent risk of renal calculi. Risk of developing nephrolthi-
asis was higher in Crohn's disease conpared to UC and was highest
in Crohn's patints fowing gastrointestinal surgery.
CONCLUSION: In Crohn's dise a low stone inhibitor/promoter
raio seems to be a precondition of stone fomaon, whereas hyper-
oxaluna is not and unnary magnesium depletion may be the critcal
abomlt in the patnts. Avoiding magnesium deplebon and cor-
recting inhibitor status by citrate replacement may be a more success-
ful strabgy fr stone prevention in IBD, using the CMC index.
LOW BONE MINERAL DENSITY IS RELATED TO DISEASE
DURATION IN CROHN'S DISEASE AND TO GLUCOCORTICOID
TREATMENT AND MALE GENDER IN ULCERATIVE COLITIIS.
S. Ardizzone, S. Bollani, P. Bettica* P. Molteni, M.
Bevilacqi.a*, G. Bianchi Porro. Departments of Gastroenterologv
and *Endocrinology, University-Hospital "L. Sacco", Milan,
Italy.
Low bone mineral density has been shown in inflammatory bowel
disease (IBD), but it is not clear, whether, this bone
complication is the same in Crohn's disease (CD) and in
ulcerative colitis (UC). In this cross sectional study we
evaluated spine and femoral neck bone mineral density (BMDJ
(expressed as t score), calciotropic hormones .(PTH, 25 OH)D,
1,25(OH)2D) and biochemical markers of bone turnover
(ostecalcin, OC; total alkaline phosphatase, ALP; type I
collagen C-terminal telopeptide, ICTP) in 51 CD (30 women, 21
men) and 40 'JC (15 women, 25 men) patients. inirty heaithy
subjects weze selected as age-matched controls (C) TI-.e L,
IBD groups were similar for: age (CD=38.7 i 13.2 years,
UC=34.4 ± 12.5), disease duration (CD=83.5 i 67.7 months,
'JC=70.9±44.0) and cumulative prednisolone dose (CPD)
(CD=6.16±5.54 g, UC=6.87±5.84). Spine and femur t scores were
similar in the two groups (spine: CD=1.49±1.46; UC=1.67±1.13;
femur: CD=1.89±1.36; UC=1.60±1.03). Based upon the WHO
guidelines, only 8 4 of CD patients and 15 E of UC patients
had a normal BMD, 55 6 'CD) and 67 4 (UC) were osteopenic, and
37 % (CD) and 18 % (UC) were osteoporotic. The distribution
among the 3 different diagnostic groups was not significantly
different between CD and UC groups (p=0. 11) . PTH and 25 (OH) 2D
concentrations were not significantly different among IBD
patients and controls. However, 1,25(OH)D concentrations wer-
significanly lower in CD and UC patients compared to controls
(CD=28.7±8.6, CU=28.7±9.4, C = 34.6±11.4, p<0.05). Bone
turnover was increased in UC patients, but not in CD patients,
as shown by significantly increased concentrations in UC
patients of both OC (CD=7.77±5.06, UC=10.03±6.24, C=
6.58±2.87, p < 0.05 vs C) and ICTP (CD=5.74±3.94,
UC=10.2±8.47, C = 3.48±0.95, p<0.05 vs CD and C). In a
stepwise regression that included age, sex, disease duration
and CPD as independent variables, the femur t score was
significantly inversely related to disease duration (r2 =
0.125, F = 6.06) in CD patients. In UC patients, the spine t
score was inversely related to age (r2 0.107, F=5.49), and was
significantly related to sex, and was more negative in males
(r2 = 0. 3, F - 16.1); the femur t score was significantly
related to sex ( more negative in males) and inversely related
to the CPD (r2 - 0.283, F=7.3). In conclusion, our data show
that IBD ratients have a diffuse osteopenia whose degree is
not different in CD and UC; however, bone turnover is
significantly higher in UC. Finally, osteopenia is related to
disease duration in CD, while it is related to maleness and
glucorticoid treatment in UC.
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INDUCIBLE NOS (iNOS) IS EXPRESSED IN THE NORMAL
HUMAN COLON
P.J. Roberts, K. Morgan*, M. Shorthouse, J.O. Hunter, S.J. Middleton,
R. Miller. Department of Gastroenterology, Addenbrooke's Hospital,
Cambridge CB2 2QQ and *Department of Biochemistry, University of
Cambridge.
It is suggested that the expression of inducible Nitric Oxide Syndtase
(iNOS) is nm on-dependent in the human colon. Hitherto, the
expression of iNOS has only been demonstratd in the inflamed human
colon. We investigated iNOS exprssion in both acutely inflamed and
nonnal colonic tissue.
Materials and Melhods
Colectomy specimens from patients with active ulcerative colitis
(n=8) and histologically nonrnal dssue from patients undergoing
resection for colorectal carcinoma (n=8) were studied. TLssue was
immediately frozen in liquid nitrogen and post-fixed as required. RT-
PCR using specific iNOS primers giving a 423bp product and standard
westem blotting were performed on fiesh, frozen tissue to evaluate
expression of iNOS. Cellular localisation of iNOS protein was
established using ABC immunohistochemistry with a monospecific
iNOS antibody (Santa Cruz). Paraffin-embedded, diseased (n=6) and
normal (n=6) colonoscopic and sigmoidoscopic biopsies were
evaluated for iNOS localisation to exclude the possibility that iNOS
expression was secondary to surgical manipulation.
Results
iNOS mRNA and protein was expressed in all specimens.
Irrespective of the means by which tissue was obtained, labelling of
iNOS was seen not only in diseased but also in nonnal tissue in both
epithelial and inflammatory cells of the lamina propria. This staining
was neutralised when the antibody was pre-absorbed with iNOS
peptide illustrating specific iNOS localisation.
Conclusion
These results suggest that iNOS is expressed in the epithelium of
normal colon in addition to that of ulcerative colitis. It may have an, as
yet, undetermined physiological role.
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THE CONTRIBUTION OF DIErARY PROTEN FROM MEAT TO
FAECAL SULPHEDE EXCRETION.
E.AM. Mage and J.H. Cummings. Dunn Clinical Nutrition Centre, Hills
Road, Cambridge, UK.
Ain: To determine the effect of conuming diets dffedring in meat
content on concentration of faecal sulphide (mmol/g wet wdgh ).
Background: he dssimimlation of inorganic sulphur compounds
(SO4, S03 etc.) by sulphate-reducing bactria (SRB) and by the
fermentation of sulphu amino acids produces hydrogen sulphide (HS-)
within the colonic humen. HS- is a cell poison and Is toic to the colonic
epithellum by idibition of -oxidation of butyrate. In a study of the
effect of ditary sulphate on SRB actvity in uleratve colitds (UC)
patients, terat in dtary sulpht Itke affected sulphide
prduton in the colon (PItcher et aL, 1996). This study investigates the
contribution of sulphu aminD acid in tbe diet to geration of sulphide
in the colon.
Metods: Six healthy, male volunte were maintained in a metabolic
suite and fed a sequence of five randmised diets, varying in meat
content only (0g, 60g, 240g, 420g and 600g/day). lbe duaion of each
test period was ten days. On days 9 and 10 of each pedod, faecal and
urine samples were collected for the meurement of sulphde and
sulphate respectively. Faecal HS- concenons were measurd by the
adapted methylene blue method (Florin, 1991) and total uinary sulphate
was measured by ion exchange chromatography (Florin et al., 1991).
Results: Mean faecal sulphide concentrations for the diets containing
Og/day, 60g/day, 240g/day, 420g/day and 600g/day respecvely were as
follows: 0.216 mmol/g wet weight (+/- 0.13 ); 0.268 mmol/g wet weight
(+/- 0.17); 1.09 mmo/g wet weight (+/- 0.83); 0.72 mmol/g wet weight
(+/- 0.54) and 2.78 mmoVg wet weight (+/- 1.63). Mean total urinary
sulphates Increased from 21.5 mmol/day on the Og/day diet to 45.8
mmolday on the 600g/day diet (60g/day- 22.5 mmol/day; 240g/day-
26.5mmol/day; 420g/day- 41.8 mmol/day).
Conclusions: Faecal sulphide excretion Increased with increased meat
consumption, in a dose response manner except for the 420g/day period.
Intake of meat provides an important source of sulphur containing
amino acids and may have implications for HS- production in UC.
Further work is being carried out to investigate the effects of other
sulphur compounds on HS- production in the human colon.
Pitcher, M.C.L., Magee, E.A.M., Beaty, E.R. and Cummings, J.H.,
(1996), Gastroenterology, 110: A992.
Florin, T.H.J., (1991), Clin. Chim. Acta., 196: 127-134.
Florin, T.H.J., Neale, G., Gibson, G.R., Christl, S.U. and Cummings, J.H.,
(1991), Gut, 32: 766-773.
MECHANISMS FOR DETOXIFYING HYDROGEN SULPHIDE IN
THE GASTROINTESTINAL TRACT
S Singh, R Picton & MJS Langman. Dept. of Medicine, Queen
Elizabeth Hospital, Birmingham Bi 5 2TH.
Hydrogen sulphide (H2S) is synthesised mainly by sulphate
reducing bacteria in the large bowel. The mechanisms by which
this highly toxic gas is detoxicated thus preventing mucosal
injury are poorly understood. The microsomal enzyme thiol
methyltransferase (TMT) is able to detoxify H2S by methylation.
The mitochondrial enzyme rhodanese is also able to detoxify H2S
by conversion to thiocyanate. We have sought activity for TMT
and rhodanese in the human gastrointestinal tract. In addition, as
a control, we have determined activity of the cytosolic enzyme
thiol purine methyltransferase (TPMT). This enzyme methylates
sulphydryl groups on aromatic compounds e.g. 6-mercaptopurine,
but is not able to detoxify H2S.
Mucosa was obtained from surgery. TMT assay was performed
using mercaptoethanol as the methyl acceptor and co-factor,
tritium labelled S-adenosyl methionine. TPMT assay was
performed using 6-mercaptopurine as the methyl acceptor.
Rhodanese activity was determined by measuring thiocyanate
production from thiosulphate and cyanide
Oesop Stomach Small Right Left Rectum
hagus intest. Colon Colon
n 4 5 2 5 12 7
TMTx 103 4(1) 43(13) 91(12) 87011) 50(9) 51(6)
Rhodanese 16(6) 34(11) 68(32) 129(38) 11219) 111018)
TPMTx103 12(3) 26(9) 36(4) 33(6) 28(4) 30(3)
The Table shows mean(SEM) pmol/min/ug enzyme activity.
Activity of TMT and rhodanese was highest in the large bowel,
with lowest levels in oesophagus. in contrast TPMT activitv was
highest in the stomach. The distribution and activity of enzymes
detoxifying H2S may be important in ulcerative colitis or large
bowel cancer, where chronic mucosal injury by H2S may play a
pathogenic role.
GROWTH FAILURE IN INFLAMMATORY BOWEL DISEASE.
S.A.McCartney, E.M.Hallyburton, S.E.Patchett, M.J.G.Farthing Digestive
Diseases Research Centre. St BartholomeWs and the Royal London
School of Medicine and Dentistry. London U.K.
Growth failure is the most common extraintestinal complication of
Crohn's disease (CD) and ulcerative colitis (UC) in children and
adolescents. Here we present interim data (at age 18 yrs) from a
prospective study of growth in 67 children and adolescents with IBD (52
CD and 15 UC). The difference between observed and expected
midparental height (MPH) was related to diagnosis, duration of disease
and site of disease.
Results
Crohn's disease Colonic Large + Small bowel lleocaecal
disease only small bowel only
Height - MPH/cm -0.35 - 5.8 - 7.1 - 5.2
Mean (95% Cl) (-5.6/4.9) (-9.91-2.5) (-11.9/-2.5) (-10.1/-0.3)
Mean age at 12.2 9.8 13 11.5
diagnosis (Range) (7 -15) (4 -13) (1 1-17) (7 -16)
n 13 19 9 11
Ulcerative colitis Pancolitis Distal
Height - MPH/cm -4.5 -0.06
Mean (95% Cl) (-10.7/1.7) (-14.2/1 4.0)
Mean age at 10.8 10.2
-diagnosis (Range) (7 - 13) (2.5/-18)
n 12 3
71% of patients with early onset CD and 60% with UC fail to meet their
expected heights by 18 yrs, except for CD patients with disease restricted
to the colon. Patients with small bowel disease alone were most severely
affected, despite having a shorter duration of disease than those with
combined small bowel and colonic disease. There was a trend for disease
duration to relate positively to growth deficit (< 5 yrs of disease: mean
deficit -2.5cm vs. > 8 yrs of disease -6.8 cm).
Failure to achieve optimal linear growth in IBD is common and is related
to site of disease and probably age of onset.
A27
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LOSS OF BONE MASS IN INFLAMMATORY BOWEL DISEASE
(IBD) PATENTS ON LONG TERM STEROIDS, IS THERE A
SAFE LIMIT M.F.M. Santoe12, R.J. Erdtsieck', M.van Blankenstein2.
Dept. of Intenl Medicine HI' ad Gastrenterolo9, University
Hospital, Rotterdam, The Nethrands.
The aim of this study was to establish the effect of total life
time steroid dosage (TLSD) on bone mass in IBD patients on
ongoing or previous steroid treatment The TSLD was calculated
for each patient at their first bone mass masuement, performed
to monitor the effects of steroid tratment.
Bone mass was measured by means of dual energy x-ray
absorptiometry (DXA) in the lumbar spine and the femoral neck
and with single photon absorptiometry in the proximal and distal
forearm. The obtained data were compared with a normative
Dutch population and transformed into Z-scores (number of S.D.
from zero), corrected for age, sex and menopausal state.
128 patients were assessed, 118 of whom had received long
term steroids without prophylactic supplements. 92 had Crohn's
disease, 36 ulcerative colitis. The mean duration of steroid
therapy was 102 months (± 6 months SEM), and the mean daily
prednisone dose was 13 mg (± 0,7 mg). Bone mineral densities
(BMD), measured at the spine (L2-L4), the femoral neck, the
trochanteric region, the proximal and distal forearm were -.84, -
.75, -.83, -.31 and -.61 respectively. Except for the BMD in the
proximal forearm, all sites were significantly reduced (P<.01). A
significant negative correlation was observed between BMD at
the various sites, the TLSD and the duration of steroid treatment,
especially when exceeding 100 months. A decrease of BMD > 1
SD was only found in patients with a TLSD > 7.5 gram
prednisone. BMD was not influenced by the type of IBD, the
duration of the disease and the number or nature of resections.
Conclusions: I.Bone mass loss in IBD is related to TLSD and
the duration of steroid treatment. 2.The upper limit of a
relatively safe TLSP seems to be about 7.5 gram prednisone.
3.Above this limit patients should be monitored by regular BMD
measurements.
HYBRID CAPTURE FOLLOWED BY RT-PCR DOES NOT DETECT
MEASLES RNA N INTESTINAL TISSUE
C N., Bruce. I., Davis. M., Pounder. R., WakefieL A.
IBD Study Group, Dept of H iopathnlo, Royal Free Hospital, London
NW3 2QG.
Alm. The sum of this study wa to Use a sitn ad robust m od of
meases RNA deetio to sea for measls RNA in bow
diseas (IBD) and ilesti cool tiss. Recut iuioical aNd
vi and IBDD.
Metds. TWO mIelass,cl in (N) pa. RNA trncpts, derivd
from a nb vor d a modfied veio of thes, wre
used to sie tisue t. The first w used to ddermie
the d tecion lim seasitvity for the to he eeployed and the second,
modifiedtran c u as imernl podtiv co ol. This second,
moded trbancript yided a product aft reverse ac riptin folwed by
the rec (RT-PCR), which was the wild-
type, nm odi d form to is ion afe a ros
eletrophoeis. In to ofmuls vim in
IBD, freh frn roetion tissu fiom paties with Croe's diea
(nl0) uWlcet colitis (n-3) non-IBD orol patss (n-7) wee
hoenomid min 2ml of total RNA iolation reagt (Advancd
B Ltd.). Duple s wr d wh l0
of the i nl conol btaipt prior to RNA eatiol Hybrid cape,
usingmeaskles-secifi6c i support was
performed on extcted RNA. Sul of hybrid capte eust was used for
measles RT-PCR using rTth DNA polymeras and EZ buffer (Peidn
Elme). Products wee dectrophoresed and analysed by Souten
hybridisaion using an internal probe. Extcted RNA was also used for RT-
PCR of a ousekeping mRNA species (mRNA of the splisosome UIA
subunit) to assess RNA quality.
Results. Hybrid capture inreased the detecdon senitivity by 100-fold
over RT-PCR. As few as 104 tascripts in a tissue hogna could be
deteced using this method. All but one sample were UIA mRNA positive
and all samples were positive for the internal control transript afr RT-
PCR. None ofthe samples analysed were positive for meashs RNA.
Conclusion. No measles RNA could be detected in intostinal tissue, either
IBD or control, using the methods described in ftis expeimen
CYTOKINE EXPRESSION AND RELAPSE OF ULCERATIVE
COLmS: A PROSPECTIVE STUDY.
F. H u R.Ajan, M. Gruman R. Bolton, S.Riley. Dnaster,
Chesterfield and Northern General Hospital Sheffield, UK.
In patients wit ulcerative colitis the betweeo ine
expression and clinical activity remains unclear. We have therefire
undertak a prospwcive study of 12 patients with ulcertive colitis (8
females, aged 19-76 years). Clinical asme,ig do p and rectal
biopsie wee undertak at 0, 3, and 6 months or at reapse and biopsies
analyse for ctokin e s . IL-lp, IL-lrcor antgonist (IL-IRA),
IL-2, IL4, IL-6, HA, IL-10, IL-12, IL-13, IL-15, IFN-y and TNF-a
mRNA were analysed using RT-PCR followed by Soudhen bltting of the
PCR products. IL-lp and IL-IRA protein was measured by ELISA. 6
patents relapseddurg ihe course of the study. Rut:
aeRNA Quiscen Quieset but Prior During
throughout subsequently to rlape rapse
n=18 relapsen=12 n=6
IL-8 7/14 7/7 5/5 5/5
IL-2 2/14 1/7 5/5 1/5
IL-6 5/14 3/ 4/5 5/5
IL-15 4/14 1/7 3/5 3/5
IFN-y 5/14 3/7 2/5 4/5
IL-lO 4/14 2/7 4/5 3/5
ELISA mean (sm) pg/mg
IL-IP 2.9(1.6) 3(0.7) 31(20) 7(l)
IL-IRA 1160(160) 1100(200) 740(160) 1280(400)
RA/lp ratio 460(90) 586(176) 80(24) 214(60)
(IL-4,12,13,TNF-a mRNA were infr t expred). C h : All
patients in relas expremed HA8 ald IL-6 and most e IFN-y.
Patiat Who subsequsutly relased we mor hkely to cxpess HA at tmes
of s ce (p<0.05). IL-2 o wa icrad por to but not
duin r s pisodi p<O.O) s * a poile roe i niating but
no peppet. EL-lp rein w reased durn relpe(p<0.05) comared to quat disa. IL-1 RA did not icres dur
reap hsimb a between IL-lp and IL-IRA may be inportat inthe
disof relapse.
LIMITED EXPOSURE OF LEFT COLON TO DAILY
DOSED ORAL FORMULATION IN ACTIVE DISTAL
ULCERATIVE COLITIS: EXPLANATION OF POOR
RESPONSE TO TREATMENT?
JM Hebden, *AC Perkins, *M Frier, tCG Wilson, RC Spiller.Dept of Medicine & *Dept of Medical Physics, University
Hospital, Nottingham. tDept of Pharmaceutical Sciences,Strathclyde University, Strathclyde.
Patients with active left-sided ulcerative colitis (UC) oftenfail to respond to topically active oral agents such as SASA's.
We have previously shown by daily dosing of a radiolabelled
resin that the distal colon behaves like a conduit in healthy
volunteers, containing less material compared to the proximal
colon (33±7 v 66±7%, Gut 1995; 37: A47). Our aim was to
examine the relative distribution in distal UC. Methods: On 4
consecutive mornings 10 patients (age 33-67; 6M:4F) with
active UC extending to the splenic flexure ingested a Eudragit-
coated gelatin capsule containing Inl l1 labelled amberlite resin.
Patients were scanned on the 4th morning immediately prior todosing with X counts, and at 4, 8 & 12h later. The distribution of
label in ascending (AC), transverse (TC), descending (DC) and
rectosigmoid colon (RS) was expressed as % of total colonic
activity. Transit time (TT) through each region was calculated as
regional counts + X counts x 24h. Similarly, % daily dose (DD)in each region was regional counts + X counts. Results:(mean±SEM). Averaging the 4 scans, percentage activity wasdistributed as follows: AC 54±4, TC 37±3, DC 7±2 & RS 3±1%.
The mean % in the distal colon (DC+RS) was significantly less
than in healthy controls [n=101 (9±3% v 33±7%, p<0.002).
Distal colonic TT was shorter in colitics (3.9±2.1 v 19.3±3.5h),
and resulted in a smaller %DD resident within this area(0.16±0.09 v 0.81±0.15 x DD, p<0.002). Conclusions:
Following daily dosing of an enteric coated formulation, only
1/10th of the total activity within the colon lay in the distal
segment (DC+RS) in patients with distal colitis. Limited
exposure of the inflammed distal colon to topically active oral
agents may explain the poor response to treatment.
A28
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SAPHENO-PERITONEAL SHUNTING FOR DIURETIC
RESISTANT ASCITES. S Ryder, J Doran and R Chamley,
Departments of Medicine and Surgery, Queen's Medical Centre,
Notingham, NH-17 2UH.
Background. Treatment of diuretic resistant ascites is usually
by repeated large volume paracentesis, altOugh this is effective,
it does involve repeated hospitalisations and has a significant risk
of complications. We have used a surgical anastamis of the
saphenous vein to the peritoneal cavity to provide intemal
drainage.
Patfents and Method. Surgery was undertaken in 8 patients, 6
under GA and 2 under LA Saphenous vein patency was
assessed by doppler ultrasound. A groin incision was made, the
saphenous vein isolated and a reversed segment anastamosed
to the reflection of the peritoneal cavity below the inguinal
ligament. All 8 patients had diuretic resistant ascites and had
been treated with at least 4 paracenteses prior to surgery. 5 had
alcoholic liver disease, I hepatitis B, I hepatitis C and I Budd-
Chiari syndrome. Median follow-up was 15 months.
Results. Successful shunt formation was achieved in 7/8
patients (88%). Frequency of paracentesis was markedly
reduced following surgery (mean 1.7 per month to 0.1 per month,
p=0.001). Diuretic dose was reduced in 7 out of 8 patients and
discontinued in 5 patients. Surgery failed in one patient due to
infection of the wound site. Two further patients developed
wound infections which required antibiotic therapy. No
thrombotic or other septic complications occurred. Median
hospital stay after shunt formation was 6 days (range 2 to 18).
One patient later underwent liver transplantation, three further
patients died at 7,12 and 14 months following shunt creation.
Conclusion. Sapheno-peritoneal shunting is an effective
means of treating diuretic resistant ascites. It does not involve
insertion of foreign material into the vasculature and may
represent an alternative to repeated paracentesis without the
risks of thrombosis and infection seen with Le Veen shunts.
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HIGH DOSE URSODEOXYCHOLIC ACID (UDCA) IN PRIMARY
SCLEROSING CHOLANGITIS (PSC): RESULTS AFTER TWO YEARS OF
A RANDOMISED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
SA Mitchell, D Bansi, N Hunt*, J Christie, K Fleming* and R Chapman.
Department of Gastroenterology and Nuffield Department of
Pathology, Oxford Radcliffe Hospital, Oxford, UK.
Aim: Previous trials of UDCA therapy in PSC have shown
improvements in liver biochemistry but varying changes in liver
histology. We report the results after 2 years of a double-blind placebo
controlled trial of high dose (20mg/kg/day) UDCA in PSC.
Methods: 24 patients (17 male, mean age 54, range 24-81) were
randomised to UDCA (n-12) or placebo (n-12). All patients had a
pre-trial liver biopsy and cholangiography. 20 patients had repeat liver
biopsy and cholangiography at 2 years. 2 patients were withdrawn
from the study, the first after 6 months from the UDCA group due to a
dominant stricture which required stenting and the second after 15
months from the placebo group due to recurrent variceal haemorrhage.
One patient from the placebo group died from an unrelated cause. Pre-
and post- trial liver biopsies were staged and graded using a modified
histological activity index (HAI) by two histopathologists.
Results: The two groups did not differ significantly on entry. No
improvement in symptoms was recorded. Despite the high dose of
UDCA used there were no reported side effects. Significant
improvement (p<0.05) was observed in the serum levels of ALP (mean
455 vs 779 iu/I) and yGT (mean 157 vs 377 iu/I) in the UDCA group at
2 years compared with entry levels but changes in the bilirubin and
AST were not significant. In the placebo group no significant changes
were noted. Liver histology revealed an unchanged or improved HAI
score in 9/10 of the UDCA group but a worse score in 5/9 of the
placebo group. Disease stage remained unchanged or decreased in
8/10 of the UDCA group but progressed in 5/9 of the placebo group.
Conclusion: High dose UDCA treatment of patients with PSC is well
tolerated and associated with a significant improvement in both ALP
and yGT after 2 years. In contrast to our previous trial (Hepatology
1992; 16:92A.) using lower doses of UDCA, the majority of the group
treated with high dose UDCA had unchanged or improved
inflammation (HAI) scores on liver histology and 4/10 showed
regression of the disease stage.
MATERNAL AND PERINATAL OUTCOME IN SkEVERE
PREGNANCY-RELATED LIVER DISEASE. SP Pereira- J
O'Donohue, J Wendon, Roger Williams. Institute of Liver Studies, King's
College Hospital, London SE5 9RS.
Acute fatty liver of pregnancy (AFLP) and the syndrome of haemolysis,
elevated liver enzymes and low platelets (HELLP), are rare but major
complications of the third trimester of pregnancy, with published maternal
and perinatal mortality rates of approximately 20%/. Aims: To review the
outcome of a large group of patients with severe liver dysfunction in late
pregnancy, treated according to a standard protocol for acute liver failure.
Methods: Over a 10 year period, 46 women (median age 30 yr, range 17-
41 yr) with a provisional diagnosis of severe AFLP or HELLP syndrome
(median gestational age 35 wk, range 24-40 wk), were transferred to our
Liver Failure Unit. Results: At admission, 32 patients (73%) were
preeclamptic, and 21 (46%) were encephalopathic and/or ventilated. The
median INR was 1.6 (range 0.9-3.4) and platelet count 107 (19-409x109A).
40 patients (87%) had a raised serum creatinine (median 210 ILM, range
63-758 FM). The median serum bilirubin concentration was 113 ILM (17-
646 lM), rising to a peak value within 48 h of 153 pM (19-646 pM). 32
patients (70%) had clinical features and laboratory values consistent with
AFLP, while seven (15%) had HELLP syndrome. In seven other patients,
causes of severe liver dysfunction unrelated to AFLP or HELLP syndrome,
were found. Infectious complications occurred in 19 of the 39 patients
(49%) with AFLP or HELLP syndrome - 17 of whom were in the AFLP
group. Major bleeding complications occurred in 12 women (10 with
AFLP). Nine required laparotomies for clot evacuation, while one with
preeclamptic liver rupture underwent liver transplantation. None of the
eight patients who delivered vaginally had bleeding complications. Four of
the 32 patients with AFLP (12.5%) had a fatal outcome, with a
corresponding perinatal mortality rate of 91/6. There were no maternal or
perinatal deaths associated with HELLP syndrome. Conclusions: In
contrast to many previous studies, the results of this large series suggest a
relatively favourable matemal and perinatal outcome in severe AFLP and
HELLP syndrome.
PRODUCTION OF ANGIOGENIC AND
CHEMOATTRACTANT CHEMOKINES DURING
MONOCYTE:HEPATOMA CELL ADHESION.
KJ Simnpson, NW Lukacs, H Evanofi RM Strieter & SL Kunkel
(introduced by PC Hayes). Dept of Pathology and Division of
Pulmonary and Critical Care Medicine, University of Michigan,
Ann Arbor, , USA 48105.
The aim of this study was to determine if interlukin 8 (1L8), a
potent angiogenic chemokine, and macrophage inflammaory
protein la (MEPla), a powerfil chenmotract for monocytes,
are produced during monocyte adhesion with hepatoma celis.
METHODS. Human hepatoma cell lines (HepG2 and SK Hep)
were co-cultured with PBMC for 24 hours and chanokine
concentration measured by ELISA. Monocytes and hepatocytes
were separated in transwell culture plates (Costar) to determine if
adhesion was a prerequisite for chemokine production.
RESULTS. Monocytes alone produced little IL8 (1.46+0.42
ng/mI, mean + SEM, n=8) and MEPla (0.01+0.01 ng/ml, n=8).
Hepatoma cells also produced little or no 1L8 (HepG2 0.79+0.04,
SK Hep 13.23+3.5, n=8) and MEPla (HepG2 0, SK Hep
0.03+0.01, n=8). Both LS and MEPla concentrations
significantly increased when monocytes were co-cultured with
HepG2 (IL8 19.58+2.5, MIPla 3.64+0.16, n=8) or SK Hep cells
(IL8 362.0+80.8, MIPla 3.48+0.58, n=8). Separating PBMC
from the hepatoma cells, using transwell plates, resulted in
significantly reduced concentrations of IL8 (HepG2 5.66+0.43,
SK Hep 47.9+7.7, n=8) and MIPla (HepG2 0.40+0.03, SK Hep
0.30+0.06, n=8).
CONCLUSIONS. Production of EL8 and MEIP occurs during
monocyte adhesion with hepatoma cells in an adhesion dependant
manner. This may enhance the recruitment of other inflnatory
cells to the site of a hepatoma, but may also enhance the growth
and metastatic potential ofthe tumor by promoting angiogenesis.
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PROLIFERATING HEPATOCYTE CELL LINES CONDITION BENEFICIAL IN VITRO EFFECTS OF TUCARESOL ON
THEIR EXTRACELLULAR ENVIRONMENT WHILST THE IMMUNE RESPONSE TO HEPATMS C VIRUS
DEVELOPING THREE DIMENSIONAL CONFIGURATION IN A M.LC.mn , S.Chokshi, N.Tzampouras, F.Torre, Roger Williams
HOLLOW FIBRE CARTRIDGE. and N.V.Naoumov. *hImute of Liver Studies, King's College
D Floyd', P McCloskey', C Selden', E Roberts2 and H Hodgson'. Hospital, London and Institute of Hepatology, University College
'Dept. of Medicine, RPMS, London. 2Gastro Dept, Toronto, Canada. London Medical School, London.
Introduction: Bioartificial liver support devices must both nourish A strong T helper lymphocyte (T.) response to hepatits C virus is
and detoxify the blood of liver-failure patients. Synthesis and transport important for viral cleaane, whie viral persitce is associated with
of proteins are essenfial. a weak T. response. The omally bioavailable drug tucaesol selecvelyenhances TH response and to assess its uFic potential in HCV
Methods: A human hepatocyte cell line, HHY41 (1.5x10' cells) was infection we investigated the in vtro effects of tuaresol on TH
cultured in the extracapillary space (ECS; 1.4 mis) of a hollow fibre response to HCV proteins.
cartridge (BFC). Culture medium was recirculated (50 mls/min) through Method: Peripheral blood mononuclear cells from 18 patients with
the intracapillary space (ICS) ofhQllow fibres with 0.5 pm pores. HFCs chronic HCV infection were cultured in the presence or wsence of
with polypropylene (pp) fibres were inoculated with cells attached to both tcrsol and HCV proteins - NS3 and core. Polifertive
microcarriers. HFCs with fibronectin (fn)-ooated fibres were inoculated respons was measued using 3H-thymidine uptake andcyto_in
with freshly trypsinised cells. Samples were taken from the medium production (IL-2, IL-4 and IFNy) was measured in the culture
reservoir for ELISAs to determine albumin, al-antitrypsin and supResaats Tucaesoenandld T prolifeation in 17 of the 18
fibrinogen. Cultures were terminated after 30-35 days patientsinsponse toHCVcore(meaninrease94%)andin 10 of the
Results: Data were similar for cells grown either in the presence of 18 to NS3 (mean increase 56%). Tucaresol incrased mean IL-2
fn-fibres or pp-fibres and microcarriers. Albumin (170-200 pg/day) and production in response to HCV core and NS3 (45 to 96 pg/ml, and 42
al-antitrypsin (210-280 pg/day) increased continuously during culture. to 71 pg/ml, respectively). etectable IL-2 was found in the
Fibrinogen appeared in the reservoir within 3 days (20-50 pg) but did lymphocyte culture supennts of all 18 patints in rsponse to NS3
not increase until after 16-20 days (60-100 pg/day). and core whereas IL-4 was found in only 2. In 4 patients background
Cells initially adhered to microcarriers were found to have left the IL-4 production by lymphocytes in the absence of any antigen wasCarriels and aclhered3toimensironalriersctres ofcellsaound andhavelfound and tucaresol reduced the mean IL-4 in these cases from 46 to
carrers and formed 3-dimensional structures of cells around nd5.
bewe th firsel.rw nf-irshdgonaon h 5.8 pg/ml. Low levels of IFNy were found in response to NS3 and
fibret n. thefibres Cels. core in 10 of the 18 patients with a rise in mean values from 12-36heet5. pg/ml and 14-37 pg/ml respectively with tucaresol.Conclusions: Production of proteins such as albumin and al- Conclusions: Tucaresol favours production of a THI cytokine
antitrypsin increased continuously throughout the experiment. profile and enhances lymphocyte response to viral proteins in patents
Fibrinogen was detectable but did not increase until 16-20 days of with chronic HCV infection. These results suggest dtat tucaresol has
culture presumably reflecting fibrin deposition as cells condition their potential as a new treatment forHCV infection.
environment. During this time cells adopted multicellular three-
dimensional structures whether initially adhered to microcarriers or
grown in the presence of fibres coated with fibronectin.
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PROGNOSTIC SIGNLIFCANCE OF HEPATIC VENOUS
PRESSURE MEASUREMENTS IN CIRRHOSIS.
Armonis A, Patch D McCormick PA, Christopoulou K, Greenslade L,
Dick R, Sabin C, Burroughs AKI Liver Transplantation and
Hepatobiliary Medicine, Royal Free Hospital, London, NW3 2QG
Introduction: We wished to examine whether portal pressure
measurements were predictive of survival in cirrhotic patients, and if
there was a height of portal pressure that had prognostic significance.
Method: 132 (81 male, 51 female) cirrhotic patients (Childs A:35,
B:5, C:46) who consecutively underwent hepatic venous pressure
gradient (HVPG) measurement were investigated. Median age was 52
years. (range 21-79) 63% had alcoholic cirrhosis. Prior to admission,
112 patients had bled from oesophageal varices and 40 patients
(30.7%) were on long term treatment for the prevention of rebleeding.
Differences in survival curves using an HVPG of 16mmHg were tested
using the log-rank test.
Results: 41 patients died during the follow up period (median 550
days). Using multivariate analysis, previous long term endoscopic or
surgical eatmnt (p=0.03), prothrombin time (p=0.005), ascites
(p=0.000l) and HVPG (p=-0.001) were found to be the only significant
predictors of survival. Dividing the patients into three groups
according to the time of HVPG meurement in wiation to a vaticeal
bleeding episode (0-7, 8-14, >15 days) the predictive value of HVPG
was found to be much higher if the measurment was taken within the
first (p=0.03) or second (p=0.004) week from bleeding.
Cocusion: HVPG mea ent provides ftr progsic
information in addition to that obtained from the ChildPugh
classification. In patients with a previous variceal bleed, this pdctive
value is higher if the me ment is taken within two week of
bleeding. We advocate the routine use of HVPG me_,rIAIN-A not
only in the management of bleeding, but also in the genel work up of
cirrhotic patients.
PSEUDOMEMBRANOUS ESOPHAGITIS (PME). A K Nayyar, C Royston,
K D Bardhan, Rotherham General Hospitals NHS Trust, Rotherham, UK.
Introuci and Aim PME is an uncommn condition of striking endoscopic
appearance. Here we describe it's feaures, associated conditios & outcome.
Coentrc slough or membrane covers much of the lower
halfor the whole of the esophagus, ending abruptly at a normul squamocolumnarjunctio. Ydelw, orblck with digested blood, the membrane can be peeled away
to reveal fragile esophageal mucosa. These aearancediffer markedly fir
erosive esophagitis. HisaIy The psu rne shows fibrinous exudate,
infiammatoy cells but nobsent memb e (hence "peuo mbaus) am
es u seve im grnu & loss ofepithdium. Bacteia, fungi
& viral inclusions are not identified. Rmu Patenubr From 1952-May
1996 n=42. ThkzWa 36(86%) were in-patients, many alredy seriously ill. 10
had _ d (GI) di s(eg iracablek vomiting, diatiea, maignancy),
9 non-GI (eg stoke, respiratory failure, ote maligat die) and 17 were
ai wilh Gl ble In ca or GI heonag n=27(64%),
dysphagia n=5, pain and/or vomiting n=7, anemia n=2, peptic ulcr follow-up
n=1. Oh Peptic uler n=12; outet stnois n=4; dilated
stomach but without obsuction n=3. lkmgL r Male 26 (6r/.). AVe >65
n=30 (711%); 35-64 n=l 1(26%/). Nil n13536%);
<3wk n=9(21%/9). K 13/42 (31/) had atibotics and 7/42 (17%/)
had NSAIDs. F 7 died shortly der diois & S were stillon
healngtaent when thesd*ended. Most ofde other 30 were re-endosoped
after 3 months tream t with cinetidine 1.6g or oneprazole 20mg. The
pseuclomembranehadceuredi all udtheeosophulookednormal.Lngtbom
outcomw Afterheahng 30 patients wue folowed (man 39 months, range 1-139),
22 on tance tatment (MT) with cinbdine (maily 1.6g) ore o
(20mg). 26 continue in remission inchlding 8 patients off MT. Despite this
treatment 4/22 relapsed, 3 with PME, again associated with sfio iless a at
presentation. Only one patient developederosive sagi. Dim PME
is different from erosive esophagitis and it's cause(s) unk . A poiiity is
U tissue response in th eeldy, with underlying sriou ilnss, resulting
in diffuse esophageal inflammat and sloughing of squams exthelium.
Infectious agents have not been identifid Petic uler, vomaing, anbtics &
NSAIDs may contribute. The role of gastroesophagead reflux in PME is not
known. Cichasim This pobably is the first desriti of idiopathic PME. The
condition is uncommon, ofunknown cause, with dstinc aperce, associated
with severe illness, responds well to treatment, and raely recurs.
A30





ALGINATES ALTER OESOPHAGEAL CELL FUNCTION IN AN
ANIMAL MODEL. W. Hall. P. E. Ross, D. Hopwood. Dept of
Molecular and Cellular Pathology, Ninewells Hospital and Medical
School, University ofDundee, Dundee, DDI 9SY.
Background/Aims: Alginates are used to alleviate symptoms of
reflux in oesophagus. It has been proposed that they act by forming a
barrier to refluxed material. We aimed to develop an animal model to
detennine whether alginates also play a more complex role by altering
cell fimction.
Methods: Pig oesophageal epithelium was mounted in four Ussing
chambers. Fluid phase endocytosis was used as a marker of cell
function, therefore the mucosal surface was exposed to a solution
containing FITC labelled 0.02pm latex microapheres. In addition 0,
0.001, 0.01 or 0.1IpM of alginate A (high m. wt. Laminaria hyperborea
stem) n=6, B (Lessonia nigrescens) n=5, or C (low m. wt. Laminaria
hyperborea stem) n=5, were added to the four chambers. Tissue was
incubated for 1 hr then disaggregated to form single cell suspensions
which were examined using flow cytometry. Measurements were made
before and after the addition ofthe quenching agent trypan blue to
obtain total and endocytosed fluorescence readings.
Results: Values are % differences compared to no added alginate.
EFFECT ON TOTAL
ALG]M A B C
0.001 + 220/o(p<0.05) none none
0.01 - 230/o(p<0.05) none none
0.1 - 23o(p<0.05 -_12% (p<0.1) +63 0.05
EFFECT ON ENDOCYTOSIS
[ALG]M A B C
0.001 none + 200/o(p<0.05) none
0.01 none none none
0.1 none -27% (p<0.05 + 39E 0.05)
Conclusions: Depending on their source and structure, alginates are
capable of upregulating total or endocytosed fluorescence, indicating
changes in cell physiology. At different concentrations the same
alginates may also downregulate these.
FURTHTR EVIDENCE THAT SUMATRIPTAN INDUCED CHEST PAIN
B OESOIHAGEAL IN OIUGN: ONECi ON SOU HAGEALL
VSCZRAL SENSATION. JX1d LA H PJ Whorwell. Dept o5P
Mdicne, Univery Host of Sot M , M cee, UK
We hv woutly _ugebd tha the che p ismod by nlost of the
3-5% ofputisa tshmg som 'Ip- (3) for mrain is el o o o e
dysmotilt e th cmWi. isaamia. Thi is bus on o b ons
I both 16mg md 6mg dou of S _ow moility without
chdagig the ECG. F u ore, these ch _gs motilt tam"d to be
greuteut m those subjet who Si d chest discomfort
compaed with ths who did ot However,we wo uble to show a direct
correlutim betwee tho time of oucomime of cdest discomfrt mid cimages
in moility. Tis could be epiwid by S aetd thed ovisea ssitvity of
the o_sa-ihaus, md it w the puwpou of ths study to amwor this quston.
Sal baloo disemsin of teo_lbaus wa thefore caried out both
befo md a ubo injectio of 16mg sumtiptan or saline
control in 30 nomal hlt r (agod 18-34yrs; 15 male). Tremeants
wer rdomised md doub blind, md ECG was monitored thoughout the
Bank Plecebm Pmtslpm
Velme to demfeut (m):
Pro-injton 28(6,30) 29(3,30)
Post-injecion 27(10,30) 23(7,30)'




Change pro-post inject' 0.01(-0.13,0.34) -0.03(-0.08,0.08)t
(Readls am epressed a neAm (rse); *p<&GS; tp< S)
3 subjects experienced S-induced chat discomfort, but no subject exhibited
any ECG abnormalities.
Codusies Our observation that S increoa viseal sensitivity of the
oesophagus and reduces its compliance provides furh evidence that S-
induced cheat pain is in most insmcoes oesophageal in origin. Furthemore,
it strongly suggests that the role of SHT, receptoDr should be evaluated in
relation to the visceral sensitivity of the gut. 'This research was partially
funded by GlaxoWelicome, UK'
CONCENTRATED (80%) ACETIC ACID INGESTION:
SYSTEMIC AND GASTROINTESTINAL EFFECTS P.D.SiSma,
W.R.Hartmans, J.Dees, and M.van Blankenstein. Department of
Gastroenterology, University Hospital Dijkzigt, Rotterdam, The
Netherlands.
Ingestion of concentrated (80%) acetic acid (CAA) is a form of suicide
practiced by immigrants from Surinam. To compare the effects of CAA
ingestion to other caustic agents and to determine if early endoscopy is
predictive, data on 132 adult patients (44% M/ 56% F), admitted between
1980 and 1994 for ingest ofa caustic agent, were reviewed. All patients
were endoscoped within 24 hours to grade the gastrointestinal lesions
(grade 0: none - grade 3: severe). Clinical severity wasjudged by duration
of admission, ICU admission, systemic and local complications.
Results:
Agent (n) Endosc. grade (%) Hospitalisaion Systemic Sticture Mortlit
0 1 2 3 mean (d) ICU complic. f
CAA(55) 7 18 44 31 7.5 50%/' 13(24%)' 4(7r/) 8(l15%)3
Acid(10) 20 10 30 40 27.0 33% 1(10%/) 6(605/)' 0
Alkali (67) 20 22 28 30 7.0 25% 1(1.5%) 12(lIr/.) 2(3%)
ICAA vs Alkl: p<.0l; 2Acid vs Alai and CAA: p<0.01; CA vs A p<0.05
Systemic complications were only seen in grade 2+3 lesions and included
renal damage in 8, liver damage in 9, diffuse intravascular coagulon in
7, and hemolysis in 10 patients. Ten patients died from systemic (CAA:
8/55 (15%) and alkali: 1/67 (1.5%); p<0.05) or local (alkalu 1/67 (1.5%))
complications. More strictures (mainly oesophageal) developed in grade
3 (32%/) than in grade 2 (7V/) and grade 1 (8%) (p<0.05). Fifteen of22
patients with a stricture underwent 190 endoscopic dilatations (median: 6,
range: 1-84), which were ccesful in only 6. Nine patients needed surgery
for perforation (N=5) or failure (N=4). Six stricture patients underwent
direct surgical reconstruction.
In conclusion: (1) CAA ingestion has a far higher incidence of systemic
complications and mortality than other causfic agents. (2) Early endoscopy
is safe and gives prognostic information. (3) Endoscopic dilatation for
strictures is often unsuccesful and surgery should be considered at an early
stage.
OESOPHAGEAL MOTOR DYSFUNCTION IN PATIENTS WI1H
THE INDETERMINATE FORM OF CHAGAS' DISEASE SM
Almeida, P Martins, DF Evans*, M Sanchez & DL Wingate*. GEN-CAD
Service, Dept of Surgery, UFMG, Belo Horizonte, Brazil, and *GI
Science Research Unit, St Bartholomew's and the Royal London School
of Medicine and Dentristry, London, UK.
Patients with the indeterminate form of Chagas' Disease (CD) are
seropositive, without megaoesophagus and asymptomatic . Small
intestinal dysmotility has previously been found in CD patients without
pseudo-obstruction (GE, 1995, 108: A592). Oesophageal dysmotility may
also be present without dysphagia or dilatation. We used prolonged,
ambulant, oesophageal manometry to test the hypothesis that motor
abnormalities precede clinical manifestations ofCD in the oesophagus.
We studied 19 patients (12M, 7F, age 24-62) seropositive for CD; all were
symptom-free. Recordings were performed for 24 hrs from a manometry
catheter incorporating 3 micro strain gauges 7.5 cm apart positioned in the
oesophagus and connected to a digital datalogger; patients were studied
in hospital but were freely mobile. Data were downloaded for computer
analysis of the incidence, amplitude and type (peristaltic, simultaneous,
incomplete, and retrograde) of oesophageal contractions and compared
with published data on healthy controls (GE, 1996, 110: A624).
74% patients had evidence of impaired oesophageal peristalsis (Median of
abnormal v normal contractions) (33.75% v 64.6%, p<0.001) and
incomplete propagation (49% v 23.5%, p<0.002), but no increase in
simultaneous contractions (13.3% v 7.6%, p=0.07) or retrograde
contractions which were rarely seen (0-3% both groups). Contractile
amplitude, duration and propagation velocity were similar for all patients
and within normal limits and there was no manometric evidence of
dilatation.
The data confirm that impaired peristalsis precedes the clinical
manifestations of oesophageal involvement in Chagas' disease. This is a
useful model for the study of the evolution of oesophageal denervation,
and of the factors that determine progression of oesophageal neuropathy
that has an outcome similar to achalasia. Long term surveillance of
progression of 'non-specific motility disorders' may be desirable in the
light of these findings.
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LOXIGL,UMIDE INHIBITS POST-PRANDIAL TRANSIENT LOWER
OESOPHAGEAL SPHNCTER RELAXATIONS INPAIENT WITH
GASTRO-OESOPHAGEAL REFLUX DISEASE
M D to, Stuat Riley. Northern General
HospitaL Sheffield and Rota Resech Lab tium, Monz, Italy.
Transient lower o_s el p it rx ion TLOSR) frequency
incrses and lower eal hincter (LOS) pressue fls following
a fat meal. We have previously shown that thee ffets are attenuated
in healhy volunwters by the cholecystonin (CCKA) antagonist
loxiglumide. We have therefore studied the effects of loiglde on
po_1prania LOS fimction in paients with refdlux d .
Ninpaes (3M, 33-66 years), with symptomaticreflux disease and
exces acid exposure, were studied on two seprate ocsin. After a
four hour fast, each patient was intubated with a manomneric assembly,
incrporating a Dent sleeve, and a pH probe and studied supine.
Following a 60 minute bsl period, patients were rndomly assigned to
receive intravenous loxiglumide (30g/kg/ho for 10 minutes and then
10mg/kg/hour) or placebo. After 20 minutes, a 300m1, 200 kcal, lng
chain triglyceride meal (Calogen) was infused into the stomach.
Manometric and pH data were recorded for a further two hours.
TLOSRs ccurred more frequently in the post-prandial peiod during
placebo (median 0(range 0-3) to 1(0-15) (p-0.03, Wilcoxon signed rank
test)), but not during loxiglumide (O to 0(0-7)). Postprandial TLOSR
frequency was significantly rduced during loxiglumide (p-0.04 cf.
placebo). Basal LOS pressure fell during the placebo postpdial peiod
from 11(6-27)mmHg to 9(2-29), but not during loxiglumide (14(4-23) to
14(2-50)) (p-0.05 cf. placebo). Fewer reflux episodes occurred during
loxiglumide infusion (1(0-8)) than during placebo infusion (2(0-19)), but
this difference failed to reach statistical significanc.
Loxiglumide inhibits TLOSRs and attenuates the fall in basal LOS
pressure following a fat meal in patients with reflux disease. CCK may
play an imporant role in mediang the post-prandial increase in
TLOSRs and fall in basal LOS pressure, suggesting a therapeutic role for
loxiglumide in the management of reflux disease.
UhTURAL NXSTMRY OF REFLUX ESOPEAGITIS: A 5-YEAR FOLLOW
UP STUDY
F. Pace, G. Manzionna, S. Bollani, G. Bianchi Porro.
Gastrointestinal Unit, L. Sacco Hospital, Milan, Italy.
Data concerning the natural history of reflux
esophagitis (RE) are scarce and conflicting: in
particular, it is not clear whether or not, in the
lohg-term, the majority of patients still require
therapy. Therefore, we investigated retrospectively
the fate of our patients with RE ten years after the
first endoscopic diagnosis. A number of parameters
were assessed by means of a structured telephone
interview, concerning the outcome of the patient,
actual therapy (if a,ny), satisfaction with treatment,
and quality of life, during the last year.'
Results: the records were retrieved for 288 patients
where a diagnosis of reflux esophagitis had been made
during the period 1983/86. Data were available for 133
patients (M/F - 93/40), followed up for a median
duration of 9.8 yrs (range 4.6-15.2); 2 patients had
died in the zeantime (in both cases for reasons
unrelated to RE), and 153 patients were no longer
available. The vast majority of patients (96%) were
still assuming maintenance therapy (in 61% a proton
pump inhibitor [PPI], in 29% a 12-receptor antagonist
(H2-RA], in 10% other therapies, such as prokinetics,
antacids, etc). Only a minority (31%) of patients was
still symptomatic during the last year of follow up.
During the entire follow up period, 21% of patients
had more then three endoscopic relapses, 23% between
two and three, 28% one, and 28% zero, respectively. A
large proportion of patients (79%) was still adopting
non-pharmacological measures (diet, posture, etc.)
suggested by their doctors. Only 2 patients (1.5%) had
been submitted to surgery for the control of their
untractable symptoms/mucosal lesions. Finally, the
quality of life (QoL) appeared to bave been partially
improved by therapy (in particular by PPIs): 64% and
11%, respectively, considered their QoL as good or
excellent, respectively.
Conclusions: contrary to many previous reports, it
appears that the prognosis of RE is not favourable; the
disease shows a marked trend to chronicity, leads to
almost continuous drug assumption for symptom control,
and is associated with a high relapse risk after
treatment discontinuation.
SIMULTANEOUS AMBULATORY OESOPHAGEAL MOTILIrY
AND DUODOGASTRO-OESOPHAGEAL REFLUX
MES UREI ENT . A S , Ngd Bird, Sarah Laban and Alan
Johns. Unversity Depatmut of Surgical and Anaesthetc Sciences,
oyalH ir Hospital, Sheffied
Althg l y mtods for duodeog oesophageal refluX
(DOIR) sad oesopageal ty are available, ous
measar t has not been reported. The aim ofthis work was to canfy
out these _mam ents onagroup ofvohters ding fting, fEd,
supine sad uprght conditos to obta a detailed pictue of
os ge mtilty durig DOOR episodes.
8 vohutes wore die mptoc for oesopageal refux but
who in previous ve-igatios had de d periods ofDGOR
Using a 3 presar trandce aumbly attached to a Gastroscan 11
dat lge ( MIC, Sodou, Switndd) the posiion ofthe gasro-
oesohagea juncto (OJ) was obtained . A sodium ion sdective
lectrode attached to a Nynph daft logger (AIbyn Modical, Scotland)
was placed 5cm above the GOJ, alogide the ditl pres_r
transuer, the two other pr e taduers being postioned at 10
and 15cm above the GOJ, nd sodium ion faareasnt was carried
out to ssess DGOR together with wave propagation cdaateritics.
Sodium io c on could be measured during fsting, fed and
ambulatory periods, and mterfeence from meals was short lived. (Rnge
4-17 namites fiom onset ofmeal). During peiods ofDGOR, motility
patens showed a reducon in the rate ofpropagated perstalic waves
compared to thep g 5 minutes (1.5 ± 0.3 v 2.2 ± 0.3, p= 0.018).
Simultneous waves occured m only 1 out of 17 pre-DGOR 5 mmute
periods but were seen in 5 out of 17 DGOR episodes, but there was no
evidence ofrieogade peristalsis.
Sioneous ambulatory oesophageal motility and sodium ion
measurenut gives a detaied study ofevents during refiux ofduodenal
contents into the oesophagus. The dimbinied actvity during DGOR
may lead to delayed clearance and increased oesophageal damage.
DEPRESSION AND LIFE EVENTS IN PATCiKIT?S REFERRED
WITH GASTRO-OESOPH&GEA REFLUX SYMPTOKS
M c Ali*nn, M Fouweather, P Clarke, I Jones,
ED Srivastava. Gastroenterology Unit, Royal
Gwent Hospital, Newport, South Wales.
Background: Anxiety and depression are
thought to be more common in patients with
reflux than control subjects. We examined
whether recent unpleasant life events could be
contributing to excess psychological morbidity
in such patients.
Methods: We studied 165 patients referred
by general practitioners to our endoscopy
service for investigation of reflux symptoms.
Inclusion criteria were primary symptoms of
heartburn, acid regurgitation and/or burning
retrosternal pain. A control group comprised
79 patients having minor operations under local
anaesthesia. All patients completed self-
report hospital anxiety and depression (HAD)
questionnaires and Brugha threatening life
experience checklists.
Results: Among the reflux group 57 patients
had hiatus hernia only at endoscopy. 37 had
oesophagitis only, 38 patients had both, 8 had
gastritis/erosions/duodenitis and 40 had normal
findings. The reflux patients gave higher HAD
scores than the control group (mean 27.8 vs
24.1, p<O.OOl). Life events during the
preceding year had been no more common among
the reflux group than the controls (median of
one event per person in each group), and life
event severity scores were no different (median
5 per person in each group). There was a weak
but significant correlation between HAD and
life event severity scores in the reflux group
(r - 0.097, p<O.OOl).
Conclusions: This large study confirms that
anxiety and depression scores are higher in
patients with reflux symptoms than controls.
Personality traits, and indeed perhaps reflux
itself, probably contribute more to the excess
psychological morbidity than life events.
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PATHOLOGICAL GASTROESOPHAGEAL RF:FIUX (GER) 1'
PATIENTS WITH A GAIltLBLADDER (GB) ILA SI7U AN.lS
SMALL (;ALLSTONES.
P Portincasa'. A Di Ciaula'. GP asxBcigt-Hnee.Souwein. (2
ralaseaiat. Seu)eiotica Mtedi.a. Dcpt. Intcrtiul & OQcupationa
M%edicin,e (DI)MIL), l!llivei'1i Medical Sc:hovl, Liazi. Ilyi
(zasrointicrology Dept.. UnivTrsiit Htospital I ltreeht. The Netherlands
('holecystectomy inay enhance pathological (UTR in svmpio)n1,li.
gallstone patients (Br J Surg /1993 0) SU-3). Littlc is knov n1. howevei
on gastro-usophuagel pH profiles in gulls'toni paticnt.s with . GE4 if?n ii.:
patcnt cystic duet and small stone burdcnll.
Method: ambulatory 24-h gastroesophageal pl1 monitoring %va;
donme in 23 patients witlh symtpletosmiatic gallstonies (8!l 51-. rimeani agC 4<
yrs [range 21-741. BMI 24- 1 Kg m 2). an opacitied (Min tta.
cholecystogrami) and a gallstonie btirdcn 2'V!l' of fastitng ;ll %nlurn:
tultrasonography) and 21 controls ( I Mt I OFr 44 yrs [range '2-87]. B.13!
24!0.4 Kg iti';. Ileaittburn aoid:ot ricd Iegugitatiuici%,CioICiKllctl h%
75"'.. of patients. Data of pi I wcrc czuuzincd in the fasting pcrlox.l and atc.
a standardi7cd dict.
Results: 80%a of' patients had abnorma.l gastric atnd/or esophageca.
pH irn time faltnig state (CFER ,ii (69°.. of patients) In tIe tfastnig pci oi.
gallsttoni paticiltb lad liglie;t % esopiageal tifmie at p1 1 4 (nt1,Cd1A1iu,igC])
160[0-7.3]J% vs 1.7(0.2-5.51%. P 001)s: more CiEI cpisode .and(idt-
episodcs > 5 mnin (P .0.00) and longer CiER episodes [' 0 (0.0) tthai.
;onitrolb. GER cpiwsdes werc symptomatic (i.e. hcartbum withinl 2Omill. o:
esophageal p1l decrease) in Y)"u ot patients. Postprandially. gallstone
patients had signilficantiv mote (ER th;n controls (J' w1)5). rhe
prcvalcincc of gastric alkalin; shili in the hIsting statc (i.e. proportion of
time at pi 1>4) tended to he highier in patienits thani controls (305", vs 19%.
P A;.). Postprandial gastric pH was coniipatabic bctwvcci paticits alic'
controls.
Conclusions: The; presece oft symptoms evocutive olCGER shouil.
bc inivcstigatd in gallstonc patients with a /inc.Iiining (13 und smndl
gall5tiones sinec they have sigrnficant (1.7-R which might benefit 1rum .
diagnostic/therapeutic approach.
IS H PYLORI PROTECTIVE AGAINST GASTRO-
OESOPHAGEAL REFLUX DISEASE?
L Curtis, I Coutts, B McKaig, A Lloyd, P Hill,
G K T Holmes, B Norton.
Derbyshire Royal Infirmaty, London Road, Derby.
H pylon colonisation of the stomach has been iiminat in a wide
variety of upper GI and non-GI disorders. So far, there is little evidence
to link the presence ofH pylon with gastr-oesophageal reflux disease.
Symptoms of gaslro-oesophageal reflux (GOR) are extremely common
and this study was designed to explore any association between GOR
and infection with H pylon.
Method: Patients with long-standing symptoms of GOR were
recruited. Symptoms of GOR were scored using the DeMeester
questionnaire. All patients underwent upper GI endoscopy and the
pesence of H pylori was determined using antral biopsy and rapid
urease test. Patients with either a normal upper GI endoscopy or
oesophagitis were included in the study. Patients with additional upper
GI pathology or who had received antibiotics and or proton pump
inhibitors within the previous six weeks were excluded. A control
group of 196 patients matched for sex and age were tested serologically
using a Helico G2 kit to determine H pylori status.
Results: 45 patients were studied (24 male, 21 female, mean age
49.6 years). The mean DeMeester reflux score was 5.1 (range 3 to 9)
and symptoms of reflux had been present for a mean of 3 years (range 2
months to 20 years). 32 patients had a normal upper GI endoscopy, 13
patients had evidence of oesophagitis and/or hiatus hernia. Only 3
patients were positive for H pylori and 42 patients were negative. This
gave a prevalence of 6.7% for the presence of H pylon in the study
population. This was significantly (p< 0.01) less than in the control
group (37.5 % positive).
Conclusions: Routine testing for H pylori in patients with
symptoms of GOR is inappropriate and is likely to lead to a positive
result in less that 10% of cases. This study has shown, for the first time,
a very low prevalence of H pylori in patients with GOR. Could the
presence ofH pylori in some way protect against symptoms ofGOR?
THE IMPACT OF BREAST FEEDING, ATOPY AND OTHER FACTORS
ON THE PREVALENCE OF GASTRO-OESOPHAGEAL REFLUX
AlAtia R. Golding J and Sandhu BK
Institute of Child Health,Royal Hospital for Sick Children,Bristol BS2 8BJ
Gastro-oesophageal reflux (GOR) is the involuntary passage of
gastric contents into the oesophagus. It becomes pathological if its
frequency and intensity is increased or if complications arise. A few
studies elude to epidemiology of GOR (Carre 1959) but there are no
paediatric population based studies in this field.
Aims: We have attempted to look at the prevalence of GOR in
children aged 6 months and 18 months and its association with factors
such as breast feeding, social background, atopy, other symptoms and
hospital admissions.
Methods: The study is based on the Avon Longitudinal Study of
Pregnancy and Childhood (ALSPAC), a longitudinal population-based
study starting in pregnancy and following all children to the age of 7
years. A series of self-completion questionnaires have been distributed
to mothers and partners at various set times. For the purposes of this
study GOR was defined as being present if a child "often vomited".
Vomiting was defined as "bringing up most or all of the feed". The
data for this study is based on questionnaires completed at 6 and 18
months.
Results: The prevalence ofGOR in children aged 6 months is 4.3%.
By 18 months the prevalence is reduced to 1.5%. At 6 months breast-
fed infants have a lower prevalence of GOR (4.0%) compared to their
non breast-fed counterparts (5.3%) (p<0.001). Serum IgE is not
associated with GOR but wheezing and family history of atopy are.
Eczema is associated with GOR at 6 months but not at 18 months. Of
children with GOR at 6 months 26.3% were admitted to hospital, the
figure for 18 months is 25.3%.
Conclusions: In this large prospective population based longitudinal
study the prevalence of GOR is 4.3% at 6 months and 1.5% by 18
months. Breast feeding reduces the possibility ofGOR. Wheezing
and family history of atopy are associated with GOR. Children with
symptoms of GOR have a high risk (I in 4) of being admitted to
hospital.
FORCES EXERTED DURING OESOPHAGEAL DILATATION
C A Mosse, T N Mills, D G Bell, C P Swi
Departments of Medical Physics, University College, Ipswich General
and Royal London Hositals.
Aim: An electronic device was designed and built for use during
oesophageal dilatation to allow measurement of the forces exerted on
a bougie dilator during dilatation. Methods: The device featured a
handle designed in the shape of hinged split cylinder which could be
locked around the dilator but could be readily moved up and down the
shaft as the dilatation proceeded if necessary. The handle consisted of
two parts, one that gripped the dilator and the other that was gnpped
by the clinician. One of the members that joined these parts together
contained strain gauges arranged as a Wheatstone bridge so that the
forces transmitted by the clinician's hand could be measured
accurately. The device was designed to measure and also record the
push and pull forces exerted during the examination. The force
measurements were recorded using a computer which stored the data
on disk while in real time it displayed the data graphically as a chart
recorder style trace on the screen. The device was calibrted against
a range of weights exerting force on a bougie dilator using a pulley
system and was shown to give reproducible linear measurements of
force over the range of interest. A series of interchangeable split
cylinders allowed it to be used with different sizes of dilator. The
device was elecronically isolated from the patient. Resuls: This
device was used to measure the forces at dilatation in 10 patients using
2 thermoelastic esophageal dilators of 13 and 18 mm diameter (Savary,
Celestin). Peak forces varied from 0.4 to 3.8 Kg force for the large 18
mm dilator and 1 to 2.2 Kg for the small 13 mm dilator. The mean
peak force for the 18 mm dilator was 2.3 Kg and the mean peak force
for the 13 mm dilator was 1.5 Kg. The force exerted in order to pass
the cricopharyngeus was 0.25 - 1.3 Kg. The length of time dth
forward thrust was transmitted to the patient's esophagus was 10-21
sec. Peak retrograde force on removing the dilator was -0.4 Kg. In
all these cases the clinician felt he was applying only low or modeate
force. Conclusion: These measurements represent the first accurate
measurements of the forces exerted during oesophageal bouginage.
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Gastrooesophageal reflux is a complication of achalasia
therapy.
M Da , JGC Cox, JR Beaaett, Hall Royal Iafirmary, HuHL
Gas(ooesop_aSW reflux is a ecoised complication ofahalasia
therapy, whether by cardio t or by balloon dilatation.
Reflux is ofendI by the patient or the doctor unless it is
very troublesome.
Our seres consists of 176 paients, 38 cases were tt ed surgically
while 138 were tatd with balloon dilatation. The patients were
followed up carefully in one centre over 27 years.
There were 47 cases ofreflux 27 ofthese cases were recognised
by symptoms, by endoscopy or by 24 h pH monitoring and were
satisfactorily teated with medical th py.
There were 20 other cases in which pepfic strictures developed and
required stricture dilatation. There were 10 cases of strictures
among the patients who were treated by balloon dilatation and a
similar number of patients developed stricture among the patients
who had cardiomyotomy. The mean period between achalasia
therapy and the digosis ofstcture was 6.0 + 5.14 years in the
dilatation group and 16.2 + 9.07 years in the surgical group.
The diameter ofthe balloon used did not appear to influence the
likelihood ofsubsequent reflux or stricture. None ofthe patients in
the surgical group who had an anti-reflux procedure performed at
the time ofcardiomyotomy developed a peptic stricture.
Conclusions:
I. A high proportion ofpatients treated for achalasia develop
reflux complications.
2. Anti-reflux procedure at the time of cardiomyotomy may prevent the
development ofa peptic stricture.
REFLUX DISEASL C P Swin, SS d a F Gong, D
Evas. Royal L aon Hospital, Whitehpl, Lono El 1BB, UK
Ahm: Tec aim of dhis study was to peform and record the results
of e ic gas sy in a series of patens. M :
Endocic GstoplIty was performed at flexible ds in 28
patients with sal reflux disease unconbtld by long-
term edical apy and who were offered and declined ainti-reflux
srgery (open or arpic) or were deemed unfit for geneal
anesthesia due to concurrent illness. GORD was conf by pre
operative manomnetr and 24 hour amb ry pH studies. Using a
9mm diamete e sewing nlachine a neo-oesopingus of 1-2
cm was created bdow the cardio-_oOphageal junction by placn
nylon suures and securing the tissue with 4 half-hitches tied
ext poreally. Resuls: The operation was performed as a day-
case procedure under sedation (usually diazemuls 20 mg and
pethidine 50 mg IV) and the median duration of the procedure was
35 minutes. Post-opative ament was made at a median of 12
weeks (8-52) with respect to symptoms, manometry and 24 hour
ambulatory pH sudies. Symptoms assessd by DeMoeser symptom
score imprved from a median of 5 to 1 [p<0.05]. Median lower
_esophaga s cter length increa from 1.9 to 2.9 cm [p<0.05]
and pressure increasd from 5.25 to 8.25 mm Hg [p<0.05J. The
median (range) % time pH <4 decrased from 8.4 (0.5-16.4) to 2.7
(0-8.1) [p<0.05]. Complications included minor haematnes in
one patient, transient dysphagia in 3, in one patet with
thoracogastric adhesions following thoracoplasty the dIc
stitches cut out and a surgical Nissen fundoplicaon was perfornNd.
Repeat pH measurments at 1 year post prcedure in 2 patients
showed no reflux. Conc : In this series, doscopic p y
significantly improved symptoms reduced acid reflux., and increasd
sphincterlength and pressure. Potential advantages of this p ures
include easy.repeatability, reversibility, short opeation time, lack of
need for general anaesthesia. Endoscopic gastroplasty has a short
term efficacy comparable to operative fundoplication, but with a
much lower utilization of health care resources.
Ten-year follow up after forceful balloon dilatation of achalasia.
M Dakkak, JR Bennett Hull Royal Infirmary, Hull.
Achalasia is a condition which occurs infrequently resulting in
relatively small numbers in many series and the tendency to provide
data on short or medium term follow up. 66 new cases ofachalasia
were diagnosed and trated with forceful balloon dilatation in one
centre between 1971 and 1986. Contrast radiological examinations
were performed following each dilatation. Careful clinical and
radiological follow up for more than 10 years has been camed out
(699 patient-year).
Contrast rdiological studies revealed 3 cases of perforation. 2 were
trated conservatively and recovered well, while one patient was
treated surgically and subsequently died.
The long term outcome has been satisfactory in the majority, with 45
(68%) having an excellent result, 13 (20%/) with a modest result and
8 (12%) whose results were less satisfactory.
In most cases one dilatation was sufficient, but 18 (27/o) required
fiurther balloon dilatation.
Long term follow up revealed 18 patients (27/o) with symptomatic
g_g1 ml reflux, 8 (12%) of these developed peptic
strictures. Only 3 of these patients with reflux had more than one
balloon dilatation.
12 patients died during the follow up from unrelated causes.
Conclusion:
Forceful balloon dilatation remains a simple, safe and satisfactory
form oftreatment for achalsia, but long term follow up reveals that
a third ofthe patients suffer from subsequent reflux.
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LONG TERM OBJECTIVE FOLLOW UP AFTER LAPAROSCOPIC
FUNDOPLICATION IN PATIENTS WITH REFRACTORY GASTRO-
OESOPEAGEAL REFLUX DISEASE. J.Rogre, S.S.Kadirkamanathan,
D.F.Evans, S.M.Scott. Academic Surgical Unit and Gastrointestinal Science
Unit, The Royal London Hospital Medical College, London, UK
Laparoscopic fimdoplication (LF) was performed on 166 consecutive
patients (male 100, female 66) with eal reflux disease
(GORD) who were refractory to medical treatment. Diagnosis of GORD was
confirned by 24 hour ambulatory pH studies. Ninety six patients continued to
take proton pump inhibitors and these underwent an additional pH study on
therapy. Median age of patient group was 42 years (range 16-82) and median
symptom duration was 48 months (3-600). LF was perfonned using 3 to 4
sutures to create a 2 to 3 cm floppy wrap. There were no conversions. Median
operating time was 68 minutes (33-330) and the median hospital stay was 2
days (0-5). Post-operative assessment was made at a median of 47 days (26-
76) with respect to symptoms, lower oesophageal sphincter (LOS) fimction on
manometry and 24 hour ambulatory pH studies. To date 52 patients have been
followed up for over 12 months, 14 over 24 months and two up to 36 months.
Symptoms assessed independently using DeMeester symptom score improved
significantly from a pre-treatment median score of 5 (2-8) to 4 (2-9) [p=0.02]
while on anti reflux medication but, LF markedly reduced the symptom score
to 1 (0-6) which was significantly better than both ON and OFF treatment
[p<0.0001 & 0.0001]. The symptom improvement was maintained at 1,2 and
3 year follow up (median symptom score 1). Acid exposure of distal
oesophagus ON medication was no different to that OFF medication. [% time
pH < 4 ON was 4.8 (0.5-58.8) and OFF was 7.6 (1.3-25.1) p=0.06]. LF
produced effective control of acid reflux which was significantly better than
both ON and OFF medication: {% time pH < 4; 0.4 (0-11.5) [p< 0.0001 &
p<0.0001]). The median % time < 4 was 0.6 at one year, 0.3 at two years after
LF confirming that effective control of acid reflux was maintained. LF also
produced significant increases in median LOS pressure from 6 (0-25) to 13.5
(5.5-27.75) mmHg [p<0.0001]) and length from 2 (14) to 3.5 (2-5) cm
[p<O.OOOl]). These data shows that LF is effective in controlling the
symptoms and distal oesophageal acid exposure in patients with refractory
GORD for at least 36 months.
THORASCOPIC ASSISTED TRANSHIATAL
OESOPHAGECTOMY- NEW LAMPS FOR OLD?
MK Lingam. LY Hiew, B Bartley, D Byrne, G Bell (introduced by
Mr G Fullerton), Deparunent of Surgery, Inverclyde Royal
Hospital, Greenock
Surgical excision remains the best chance of long term survival for
patients with oesophageal carcinom. The advent of minimal access
surgery allows accurate disection and thorascopic mobiisation of
the oesophagus without the need for thoracotomy and its associated
complcations. We report our experence of thorascopic-assisted
transhiatal oesophagectomy (TATH) between December 1993 and
June 1996. Forty-two consecutive patients underwent TATH.
Twelve patients required conversion to thoracotomy because of
puonary adhesions, size of tumour, tracheal injuries or ventilation
difficulties. The mean age of the patients was 65.7 (45-80) years.
The sticture length was between 3-1 Icm in the TATH and 5-12cm
in the conversion group. average total operation fime was 308
miutes (235-400) in the TATH, thoracoscopic dissection taking 83
minutes (50-120).One death occurred in each group. The men post
operative hospital stay was 14 days m both groups. The I and 2
year wurvival rates were 71% (30 of 42) and 60% (25 of 42)
respectively. The results of TATH are very similar to those of
conventional surgery. We propose that TATH may offer an
advantage in terms of visualisation of mediastinal structures during
dissection, thus minimising operative complications.
ANOTHER VIEW ON LAPAROSCOPIC ANTI- REFLUX SURGERY
S El Hasani PM Murchan I Chetter B Khan SS Somers
ACJ VHndsor PJ Guilou
Professorial Surgical Unit, St James's University Hospital, Leeds
Aims: Measurement of outcome for aparoscopk antireflux
surgery (LARS) has to date been confined to the technical
feasibilty, its impact on symptomatology and the fnancal
implication of its introduction. As no data are avalable from the
patients' perspective about the quality of life (QoL) folowing its
introduction, this study was designed to obtain prelrminary
infomation in such patients.
Mohods: Al patients selWcted for LARS were requested to
complete QOL questionnaires (SF36, Euroqual) both prior to and
6 months following surgery. Twenty-six patients have been
studied. AN patients had manometric evidence of gross
incompetence at the lower oesophageal sphincter, with deranged
pH profiles (mean De Meester score 58± 18 SEM).
Resuls are shown in table
SF 38 profie Pre LARS Post LARS Vllcoxon
Med (I.Q. range) Med (I.Q range)
Physical function 62 (35 - 84) 75 (55- 95) 0.44
Functional Role 50 (16 - 78) 88 (48 - 91) 0.006*
PainScore 30 (20-60) 72 (61-82) 0.015*
General Health 47 (25 - 65) 74 (49 - 87) 0.096
Vitat 50 (20 -66) 60 (35 - 70) 0.58
Social Function 62 (37 - 87) 87 (62 - 95) 0.14
Emoional role 64 (46- 100) 77 (33- 100) 0.1
Mental Health 60 (48 - 76) 64 (52 -84) 0.84
Life Quality (QoL)25 (0 - 61) 61 (25 -84) 0.02*
Euroqual 40 (25 - 58) 80 (60 - 90) 0.015*
**p <0.01, *p<0.05
Conclusion: No change in the psychoiogical or social domains
was noted folowing surgery, although signIficant improvements
were noted in the physical role, pain scores and overall heakh-
related QoL. Further evaluation of both surgical and medical
therapies of gastro-oesophageal reflux is needed to estabish the
long term benefits as perceived by the patient, rather than by the
dinician in order to compare the value of these two treatmnts.
THE UK NATIONAL BARRETT'S OESOPHAGUS REGISTRY
CPJ Caygill. PI Reed, MJ Hill, A Watson. UK National Barrett's
Oesophagus Registry, Lady Sobell Gastrointestinal Unit, Wexham
Park Hospital, Slough, Berkshire, SL2 4HL.
A UK National Registry of Barrett's Oesophagus (BO) patients
was established in June 1996 as a joint initiative between the
Oesophageal Section of the BSG and the European Cancer Prevention
Organisation (ECP). Since then over 500 patients have been registered
from the first 3 centres and this communication reports the results of a
pilot study of data from two of these centres in adjoining health
districts. The hospitals were Wexham Park Hospital, Slough (WPH),
catchment population 360,000, and Wycombe General Hospital, High
Wycombe (WGH), catchment population 220,000. At WPH the visual
diagnosis ofBO was initially made at endoscopy irrespective of length
of involved segment and confirmed histologically in at least 76%. At
WGH the diagnosis was only considered in segments of approximately
4cm or more, but all ofthese had histological confirmation ofBO.
Between January 1991 and August 1996, 424 BO cases were
registered at WPH. There was a male preponderance of 1.5:1, the
mean age being 65 years for males and 70 years for females. In the
period July 1995 to June 1996 197 BO patients were endoscoped at
WPH (M:F 1.7, mean ages 62 and 71 years respectively) and 71 BO
patients at WGH (M:F 1.7, mean ages 62 and 69 years respectively).
Adenocarcinoma of the oesophagus was diagnosed at WPH in
5/424 (1 in 85) patients between January 1991 - June 1996, of whom
2 were diagnosed in the period July 1995 - June 1996 and in 1 patient
(1 in 71) at WGH in the latter period.
These data confirm the practicality of running a multicentre BO
Registry, establishing comparisons of diagnostic criteria of BO in
different departments and variations with time. The Registry is now
being extended first to the Anglia/Oxford Region and then to the
whole of the United Kingdom.
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INCREASING INCIDENCE OF BARRETT'S OESOPHAGUS:
DIAGNOSTIC ZEAL OR GENUIE OBSERVATION?
A T Prach, T M MacDonald, D Hopwood, D A JdmIan.
Departments of Digestive Diseases, Clinical Pharmacology and
Pathology, Ninewells Hospital and Medical School, Dundee, DDI
9SY, Scotand, UK.
Barrett's oesophagus is the major recognised risk factor for the
development of oesophageal adenocarcinoma. It is well
documented that the incidence of oeophagel adenocarcinoma is
rising, and one miht suspect that this is paralleled by an increase in
the incidence of Barrett's oesopbagus. We have studied the
incidence of Barrett's oesophagus in Tayside to determine whether
there is an increasing incidence in the diag is of Barrett's
oesophagus.
The incidence of endoscopically diagnosed Barrett's oesophagus
was determined by searching the endoscopy dataas for years
1980-1993. This represented 53,433 endoscopies perforned in our
population of 384,000. 961 new cases of endoscopically diagnosed
Barrett's oesophagus were idendfied rep ing 18 new
cases/100,000/year (18 cases/l,000 endoscopies). The incidence
was not constant throughout, but showed a dramatic rise from
1/100,000/year (1.4/1,000 endoscopies) in 1980/81 to
48/100,000/year (42.7/1,000 endoscopies) in 1992/93. When only
cases with histological confirmation were considered, the incidence
for 1992/93 was 18/100,000/year (16.5/1,000 endoscopies).
We have demonstrated a significant rise in the incidence of
Barrett's oesophagus. This may be partially explained by an initial
low incidence, possibly due to a failure to recognise Barrett's
oesophagus endoscopically, combined with a change in endoscopic
referral patterns (possibly more reflux disease) and/or an
overzealous attitude to the endoscopic diagnosis of Barrett's
oesophagus. However, we believe there is a true increase in the
incidence of Barrett's oesophagus in our population. The cause of
this increasing incidence is unknown, but it may be related to the
increasing incidence of oesophageal adenocarcinoma.
PREVALENCE OF SPECLALISED COLUMNAR
EPITHELIUM AT THE CARDIA OF PATIENTS WITH
GASTRO-OESOPHAGEAL REFLUX WITHOUT OBVIOUS
BARRETT'S OESOPHAGUS; COMPARISON WITH NORMAL
CONTROLS. B.T.Cope, M.A.Cox, J.C.Gearty, Gastroenterology
Unit, City Hospital, Dudley Road, Birmingham, B18 7QH, UK.
Previously unsuspected specialised columnar epithelium (SCE) has
been reported in biopsies of the cardia from 18% of unselected
patients undergoing endoscopy (1). This may be relevant in the
increasing prevalence of adenocarcinoma in the distal oesophagus and
at the cardia and raises the question whether Barrett's oesophagus is
much commoner than previously thought. In this study, we have
looked at the prevalence of SCE at the cardia of 54 consecutive
patients with symptoms of gastro-oesophageal reflux (GOR). 15 of the
54 had mild erosive reflux oesophagitis (Savary Miller grades I&2)
and 13 of the 54 had erythema of the distal oesophagus without
erosions. The results were compared with 18 normal controls who had
neither symptoms of GOR nor any endoscopic abnormality of the
upper GI tract. Patients with more severe endoscopic GORD including
Barrett's oesophagus were excluded. The 54 GOR patients (33
females) were aged 23-83 mean 56 years and the 18 controls (II
females) were aged 22-75 mean 45 years. At least 3 large endoscopic
biopsies were taken from below the squamo-columnar junction at the
cardia in each patient, stained with haematoxylin/eosin and alcian
blue/PAS diastase and assessed histologically for the presence of SCE
by one pathologist (JCG) who was unaware of the clinical or
endoscopic features. 29 (53.7%) of the patients with GOR had SCE at
the cardia compared to 4 (22.2%) of the controls (X2=5.38; P<0.02).
There was no correlation between SCE at the cardia and age, sex and
the presence of reflux oesophagitis at endoscopy. We conclude that
SCE is relatively common in both groups but is commoner in patients
with GOR than controls. However it must be doubtful whether SCE at
the cardia has the same significance as Barrett's oesophagus.
1. Spechler et al. Lancet 1994; 344:1533-6.
ACID AND BILE REFLUX IN SHORT SEGMENT BARRETT'S
OESOPHAGUS.
CK MacKay, H Ihmaidat, J Going*, CR Carter, MR Ward, JF
MacKenzie**, RC Stuart.
Departments of Surgery, Pathology* and Gastroenterology**, Glasgow
Royal Infirmary, Glasgow.
Barrett's oesophagus (BO) is a consequence of oesophageal exposure
to severe acid and bile reflux. It has been suggested that Short Segment
Barrett's oesophagus (SSBO) represents an early, metaplastic phase in
the transition from normal to BO. If this is the case, oesophageal acid and
bile exposure in SSBO should be greater than normal. To examine this
hypothesis the aim ofthis study is to compare oesophageal acid and bile
exposure in normal, SSBO and BO patients. Methods: BO is defined as
.3cm columnarisation of the distal tubular esophagus n =21; SSBO is
defined as intestinal metaplasia at an otherwise normal squamocolumnar
junction, n=19; and normal is defined as no BO or SSBO, n=43. Normal
and SSBO patients were all symptomatic patients attending for diagnostic
endoscopy. Ambulatory 24 hour oesophageal pH and bile studies were
performed using a Synectics mark III Digitrapper and Bilitec 2000 system,
10 days after stopping acid suppression therapy. When possible both
studies were performed simultaneously and the probes were positioned
Scms above the lower oesophageal sphincter. A positive pH study is
defined as a DeMeester score >15 and a positive bile study is defined as a
bilirubin exposure >5% ofthe supine period.
Results: Barrett's SSBO Normals
No. of+ve pH studies 18/21* 11/19 24/43
Median DeMeester score 57.2** 17.9 25.6
No. of+vebile studies 11/16 2/10 9/18
Median bilirubin exposure 9.45% 0.1% 4.9%
* p < 0.03 by X2test. ** p < 0.01 by Mann- Whitney U test
Conclusion: Oesophageal acid and bile exposure in SSBO does not
differ from normal but is significantly less than in BO. These results do
not support the hypothesis that SSBO is an early step in the progression
to BO. It is suggested that gastroesophageal reflux is not an aetiological
factor for SSBO.
PATTERN OF EARLY CHROMOSOMAL ALTERATIONS IN
BARRETT'S OESOPHAGUS.
CK MacKay. RC Stuart, J Going**, JN Baxter, WN Keith*
(introduced by JF MacKenzie)
Department ofMedical Oncology*, University ofGlasgow. Depts. of
Surgery and Pathology**, Glasgow Royal Infirmary, Glasgow
Barrett's oesophagus is the major risk factor for oesophageal
adenocarcinoma. The progression to malignancy involves several
genetic events. but little is known about early changes occurring in the
metaplastic epithelium before dysplasia develops. Aim: to identify
chromosomal alterations, consistent with malignant potential in non-
dysplastic Barrett's mucosa. Method: Multiple endoscopic biopsies were
taken from 17 patients with uncomplicated Barrett's oesophagus,
including normal oesophagus and stomach as controls.The frozen biopsies
were sectioned, clustered on slides and subjected to interphase
cytogenetics. Fluorescent In-Situ Hybridisation (FISH) was performed
with probes specific to chromosomes 1,8,9,12,17 & 18. Signals per
nucleus were counted on 200 cells per biopsy,using fluorescent
microscopy. The chromosome index(CI) was calculated (No. of signals
/No.of nuclei). The mean CI for controls(n=77) was 1.58 +0.1 and a
value >3 standard deviations from the mean was regarded as abnormal.
Results:
Chromosome No. biopsies No. patients Chromosomal Changes
1 24 8 No abnormality
8 9 4 1 gain (Patient 2)
9 31 9 2 gains (Patients 2 & 5)
12 15 6 1 loss (Patient 3)
17 16 5 No abnormality
18 33 13 No abnormality
Total 128 17 4 alterations
Condusion: Chromosomal changes occur in uncomplicated Barrett's
oesophagus, at a low frequency, consistent with the hypothesis that
genetic alterations are rare in non-dysplastic disease. Clonal divergence,
reflecting the histological heterogeneity ofBarrett's mucosa, is
suggested, as chans do not occur at all biopsy sites in each patient.
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AMPLIFICATION AND OVEREXPRESSION OF CYCLIN DI
IN OESOPHAGEAL CARCINOMA
R. Mor P. Newcomb, R Barker, R Hardwick, D. Alderson.
University Department of Surgery, Bristol Royal Infirmary, Bristol
BS2 8HW
The cyclin Dl gene encodes a protein which controls the passage of
the cel through the GI/S checkpoint in the cel cycle. Cyclin DI is a
proto-oncogene, since its aberrant expssion could contrbute to
uncontrolled cel proliferation. This study investigaed amlificatin and
overexpression of cyclin DI in oeophageal carCnoma.
Twenty-six oesophageal adenocarcinonas and 19 cel
carcinma were studied. Paird tuowur and noma DNA sampes were
ywsed by Soudtrn blotting with specific DNA probes for cyclin Dl
and for a control gen (ot-lactalbumin) which is present in a singc copy.
Thc cyclin DI gene copy number was caculated for each tunour.
Expression of the cyc}in DI gene was asessed by immunohistochenical
analysis of its protein product, which is usua undetectable by this
medtod in normal tissues.
Cyclin DI gene amplfication (by a factor of between 2 and 6) was
identified in 7 tunours (16%); 5 were squamous cel carcinomas, 2 were
adenocarcinomas. No significant association was identified between
amplification and tumour T stage, N stage, or patient survival.
Overexpression of cycin Dl protein was identified in 8 tumours (6
squamous cell carcinomas and 2 adenocarciomas) and was significantly
associated with gene amplification (p=0.04, Fisher's Exact test).
Overexpression was also significantly associated with eady T stage (Ti
or T2; p=0.01 Fisher's Exact test). No significant associaton was
identified between overexpression and N stage or patient survivaL
There was a trend (non-significant) towards a predominance of both
amphification and overexpression of cyclin DI in squamous cell
carcinomas over adenocarcinomas.
These results indicate that cyclin DI amplfication and overexpression
occur commonly-in oesophageal carcinoma, particularly squamous cell
carcinoma. Cvclin DI overexpression may influence tumour behaviour,
causing the disease to present at an earlier T stage. The mechanism for
this effect is unclear. and warrants fiuther investigation.
RISING INCIDENCE OF OESOPHAGEAL ADENOCARCINOMA:
A 20 YEAR RETROSPECTIVE REVIEW FROM A SINGLE UNIT
BJ Johnston, PI Reed, MS Carpani de Kaski, S Levi. Lady Sobell GI
Unit, Wexham Park Hospital, Slough, Berkshire, SL2 4HL.
It is now recognised that the pattern of oesophageal cancer has
changed dramatically. A previous report from our unit in 1991
revealed that during 1976-1990 49%/ of all oesophageal cancers were
adenocarcinomas (AC). The review of endoscopy records has now
been extended to include the next 5 year cohort, 1991-1995 inclusive.
A total of 37,992 consecutive endoscopy records for the period
1976-1995 were studied retrospectively for mention of oesophageal
cancer, 289 cases were identified. They were subdivided by
histological type, oesophageal location, sex, age and into four cohorts
of five years by year of presentation to the unit. The oesophagus was
divided into two segments, above and below 32cm, by adapting the
criteria suggested by the US National Cancer Institute (1989).
The mean age at diagnosis of both male and female patients with
squamous cell carcinoma (SCC) had increased during the 20 years
study period; in males from 67.4 years in the first, to 74.2 years in the
last quartile and in females from 66.4 to 72.8 years during the same
period. In contrast, whereas the age of males with AC had remained
virtually unchanged (66.7 to 68.3) in females with AC the age had
dropped from 74.2 to 69.9 years between the first and last quartiles.
AC were located predominantly in the lower oesophagus, 132 (83%)
below 32cm and 28 (17%) above 32cm. SCC were more evenly
distributed; 48 (43%) below and 62 (57%) above 32cm. In line with
other published series the numbers of AC had risen from 21 (45%) in
the first quartile to 63 (70%h) in the fourth quartile. Overall the
male:female sex ratio for AC was 3:1 (M120: F40 cases) and 0.7:1
for SCC (M46: F64).
AC now represents the majority of all oesophageal cancers
diagnosed in our unit, especially in males. These findings confirm a
continuing rise in incidence of oesophageal AC to 700/o, the highest
incidence reported to date.
Eur J Cancer Prev 1991; 1: 23-25; Cancer 1989; 64: 526-30
.ADENOC.ARCLNO.M,X OF THE LOWER OESOPHAGUS AND
CARDIA ARE SIMILAR BOTH EPIDEMIOLOGICALLY
.AND ('LINICALLY: A POPULATION BASED SILTDY
FROM 1974 TO 1993.
D)olan K. Walker SJ. Sutton R. *Wvil1iams EMI1.
Departments of Surgery and *Public Health. Royal Liverpool University
Hospital. Liverpool L8 7XP. England.
I here were 5,322. cases of primary oesophageal carcinoma and 10.573
cases of primary gastnc carcinorma reported to the Merseyside and
Cheshire Cancer Registrv (population ' 5 million) between 1974 and
1 1fhe ratio of oevsophageal to gastnrc carcino ma was 1 Calculation
otf the cumulative incidence rates revealed a significant increase in
oesophageal carcinoma in males over the study penrod this was found to
be entirely due to a rapid rise in adenocarcinoma of the oesophagus. the
incidence of which trebled in males and doubled in females. Eighty-six
percent of these adenocarcinomas occurred in the lower oesophagus.
The incidence of gastric carcinoma decreased in both sexes between
I 9'74 and 1993. However, analysis of the subsite-specific incidence rates
indicated that carcinoma of the cardia more than doubled in males, and
almost doubled in females. whereas carcinoma at all other sites of the
stomach decreased wenty percent of all gastric carcinoma occurred in the
cardia
The similar trends in incidence of adenocarcinoma of the oesophagus and
ol the cardia prompted a comparison of the epidemiological and clinical
parametcrs of adenocarcinoma occurning in the middle oesophagus. lower
oesophagus, cardia and subcardia. Adenocarcinoma of the lower
oesciphagus and cardia were very similar in their changing incidence, age at
diagnosis. male female ratio. percentage of patients who smoked and in
their survival. lBoth carcinoma of the lower oesophagus and the cardia
ditlered significantly from tumours of the subcardia. This suggests that
adenocarcinoma of the lowver oesophagus and gastric cardia may be the
same disease, and this has important consequences for the surgical
treatment of carcinoma of the cardia.
PET SCANNING FOR ASSESSING RESECTABILITY OF OESOPHAGEAL
CANCER - Preliminary results
AUTHORS: R.MASON, D.GOLD, N.MAYNARD, D. MANIFOLD,N.BOYLE,
H.TAYLOR, M.MAISEY, AND S.RANKIN.
INSTITUTION: DEPARTMENTS OF SURGERY AND RADIOLOGY,
GUY'S AND ST THOMAS'S HOSPITALS, LONDON
Aim: To determine whether PET scanning improves the
accuracy of pre-operative staging with spiral CT scanning
of patients with primary oesophageal carcinoma.
METHODS: 14 consecutive patients with oesophageal (10 ade
no, 4 squamous) were studied. 3 were excluded due to
distant metastases detected by PET and CT scans. 11
patients with operable disease were scanned pre-
operatively by spiral CT and PET scan, using the positron
emitter 18F fluoro-2-deoxy-D-glucose. The findings of
spiral CT and PET were assessed independently of the
findings at operation and pathological examination of the
resected specimen.
RESULTS: The primary tumour was visualised in 10 cases by
spiral CT and in all 11 cases by PET. CT gave anatomic
information of the extent of local spread which would not
by expected from PET scans. Positive left gastric/
coeliac lymph nodes were found in 7 cases. These were
detected in 4 cases on CT (with 1 false positive) and in
only 1 case by PET because of the lack of anatomical
detail required to separate them from the primary.
Positive mediastinal nodes were found in 5 cases. These
were detected in 3 cases by CT and in 2 of these by PET.
One patient had 4 x 0.5cm subcapsular liver metastases.
These were detected by PET but not by CT.
CONCLUSIONS: The ability of PET scans to detect disease
distant to the operative field suggests its main role may
be in patients with large tumours and borderline
operability. In addition PET may have a role in
predicting response to neo adjuvant chemotherapy.
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DOES PRIOR RADIO- AND/OR CHEMOTHERAPY
PREDISPOSE TO COMPLICATIONS AFTER INTUBATION
FOR MALIGNANT OESOPHAGO-GASTRIC OBSTRUCTION
1Rcu M. van Blankenseus, J.Dees and P.D.Siersemna.
Department of Gastroenterology, University Hospital Dijkzigt,
Rotterdam, The Netherlands.
Endoscopic intubation is an effective procedure for palliation of
dysphaga in patients with malignant oesophago-gastnc obstruction.
Prior radio- and/or chemotherapy may entail an increased risk of
complications following tubation with a rigid prosthmis.
The aim of the study was: (1) to assess efficacy, complications,
recurrent dysphagia and urvival after intubation for paliation of
dysphagia, and (2) to evaluate the relationship between prior radio-
and/or chenotherapy and the occurrence of complications.
From 1988 to 1995, a consecutive series of 307 patients underwent
intubation with a Celestin prosthesis under general anaehesia for
palliation of dysphagia, caused by a mlignant stricture of oesophagus
and cardia. Of these 307 patients, 111 (36.2%) patients had undergone
prior radio- and/or chemotherapy. In 306 (99.7%) patients, a rigid
prosthesis was succesfidly placed. The dysphagia score improved from
2.7 ± 0.6 (grading from 0 to 4) at basedi to 0.6 ± 0.8 at 4 weeks after
intubation. Major complications were registered in 97 (31.7%/) patients
and included: perforation (22), fistula (5), haemnorrhage (9), severe pain
(10), aspiration (8), erosion/ulcer at the end of prosthesis (7), fever (4),
migration (22), malposition (7), and fracture of prosthesis (3). Sixty-
nine (22.6%) patients had recurrnt dysphagia. Median survival was 67
days and hospital stay after placement was 6.6 ± 5.5 days. Prior radio-
and/or chemotherapy increased the risk of perforation, fisla,
haemorrhage and severe pain following intubation (26/1 11 vs 20/195;
p=0.0026). Median survival was not different between patients with or
without prior radio- and/or chemotherapy.
In conclusion: 1. Celestin prostheses are an effective palliative
treatment for malignant dysphagia, however they carry a relatively high
risk of complications and recurrent dysphagia. 2. Prior radio- and/or
chemotherapy predisposes to prosthesis-related complications.
PATENTS' OW PERCEPTIONS OF ENDOSCOPY UNDER
THROAT SPRAY. M Wlsh, GD Smib6 S Smash KR Pala.
E espy Uni%t, W_tsrl General Hospib l Ednbrh, Soi nd.
indoscopy is common canted out i UK
undwr IV sedaton, bt B.S.G gud sugd that thispte is
not ways equd. Unsedatod nos offes advantages of
quick tumover and few sedation rtdc, but pints
own pc ions of such a practice ha not been widely studied. A
nurse led study prom kimi de daftwr colion Of
endoscopy ws usd to asse pat' perceptions holsticaly.
Als: To determine the accptabilIty of diagnosic endoscapy to
patient perfrmed under bcal anahetic spray.
MeSsod: 76 paents who chose to undergo endosopy after throat
spray (M.3, F-40, mein ae 42, ag range 18-70 yas) were
studied using a nurse administered qusior, e d to them
prior to the proacdure. The eoscopyIfWse ind detail
by a nurse. Completed questionnaires w coled prior to
dbdhwge on the same day. The response rate was 100%.
RosuNs: 71 patients (95%) considerd that they had received
sufficint ihnmation about the procedure. 69 patents (91%) felt that
it mtched their expectations. 58 paInts (76%) wer prepaed to
undergo a reped procedure if necessary under throat spray.
Abdomnal pain and boating wer relatively uncommon fokwing
endoscopy (8% and 17% repectivey), but, despit anaestheftc throat
spray (Xybcaine spray, Astra) 38 patients (50%) ai of a
sore throat within 30 minutes of the procedure. 19 (25%) patients
received regular oral suction durng the procedure to avoid the
unomf feeng of drowning in their own sava, and described
it as helpful.
Conlusion: Endoscopy under throat spray was wel accepted in a
selcted group ofpits who chose to have the pmcedure done
unsedated. Patients generally felt weN post-procedure but sore
throat was a common problem desplte lcal anaesthetic spray. The
effectiveness and dose of throat spray may need further study. Pre-
procedure detaied explanation helps to aleviate anxety and match
the expectations with the actual procedure.
QUALITY OF LIFE FOLLOWING STENT INSERTION IN
MALIGNANT OESOPHAGEAL STENOSIS: A RANDOMISED
TRIAL COMPARING METAL AND PLASTIC STENTS.
C Roseveare P Patel, P Goggin, N Simmonds, J Kimble, H Shepherd.
Royal Hampshire County Hospital, Romsey Road, Winchester.
Background: Metal stents are widely used in palliation of oesophageal
carcinoma but their advantage over plastic tubes has yet to be proven.
Aim: To compare the effect of Gianturco metal stents with Atkinson
tubes on quality of life in malignant oesophageal obstruction.
Methods: Thirty one consecutive patients with inoperable malignant
oesophageal obstruction were randomised, patient single blind, to
receive either a modified Gianturco silicone-covered metal Z stent
(n=15) or a plastic Atkinson tube (n=16). Sedation was similar in each
group and patients were given identical dietary advice. Data were
collected by a specialist nurse before insertion, one week after and
thereafter 6 weekly until the patient's death. Quality of life at each time
point was assessed using the Nottingham Health Profile (NHP).
Results: Three stent-related deaths occurred in the first week following
insertion of an Atkinson tube with only one in the Gianturco group.
Complication rates were otherwise similar in the two groups. The table
shows outcome variablos between the groups after insertion.
wks Gianturco Aknson
% change in weight I -0.6(-2.9-+0.8)* 4.5(-7.1-405) * .0'
(fo0na wt) 7 |0.8(-3. 1-+1.9)* --7.3(-1 1.1-+2.)01
%ofpatientswith 1 50%/0 38% 05
no modchagin 7wi89t% 50% 0.00
% of patients with I 5%/o 23% 0.0
improved a te 7 89% t33% 0.0
* Median (inter-quartile range)
Patients in the Gianturco group showed greater improvements in NHP
parameters following insertion of the stent than those in the Atkinson
group. (Energy: p=0.04; emotion: p=0.06; social isolation: p=0.05).
Conclusion: Patients treated with Gianturco stents maintain their
weight for longer, with improved swallowing, appetite and quality of life
when compared to those with Atkinson tubes.
THE COLORECTAL NURSE ENDOSCOPIST - INITIAL
RESULTS Mosha V., Rubanuu&
George Eliot Hospital NHS Trust, Nuneaton
Introduction - Over a one year period a Nurse Endoscopist
was trained in flexible sigmoidoscopy and clinical
coloproctology. Following assessment the Nurse
Endoscopist was able to practice sigmoidoscopy as part of
the colorectal endoscopy service.
Method - Sigmoidoscopy was perfomed in patients referred
directly to the one-stop clinic, from the outpatients
departnent and general surgical wards. Comprehensive
Practice Protocols were followed. Informed consent was
obtained. A video recording of every procedure was taken.
A uSigmoidoscopy Report' was issued to the referring doctor
on completion of each procedure.
Sigm oidpy results were then audited.
Result - 400 procedures were performed over an 8 month
period. 81% of patients were refeed to the ore-stop clinic.
50-80 cm inserion depth was achieved in 70% of patients.
The descending cooplanic fleoxre was reached in 70.5%
of cases. Principle clinical find w :- carcinoma
(4.75%); polyp (17%); inflamaory bol disase (12.75%);
mhoids (31.75%); diverticuli (7.25%) and normal
findings (23%). (*Some patits had > 1 diagnosisffinding).
Biopsy and injection seoeapy was indicted in 38% and
35.75% of cases respectively. Folkw-up inld
outpatients clinic (40.25%); discharge (38%) and
colonoscopy/barium enema (17%). There was no morbidity
or mortality.
Discussion - Audit shows that, following a period of
intensive training and assssment, a Nurse Endorapist is
able to perform independent flexible sigmoidoscopy
competently and safely.
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COMMUNITY BASED OPEN ACCESS NURSE LED FLEXIBLE
SIGMOIDOSCOPY FOR RECTAL BLEEDING
A. Betts, K.P. Nugent, P. Daniels, S. Griffin, H. Smith, D. Mant,
J.N. Primrose.
University Units of Surgery and Primary Care Medicine, F Level,
Centre Block, Southampton General Hospital, Tremona Road,
Southampton. S016 6YD
A direct access nurse led endoscopy service based at 6 community
sites was launched following a 6 month nurse training period.
Patients with rectal bleeding are referred directly to the nurse by
general practioners and an appointment sent by return of post.
Clinics are staffed by a nurse endoscopist and nursing auxillary.
79 patients were endoscoped by the nurse endoscopist (48 female,
median age 63 years [range 23 - 89]). 67 patients complained of
rectal bleeding (81% bright red bood, 19% dark, 48% mixed in with
motions). Other symptoms included abdominal pain (30%), change
in bowel habit (38%) amd weight loss (13%).
One patient had two cancers at endoscopy, 8% had polyps, 8%
diverticular disease and 20% had significant haemorrhoids. 60%
were normal. Median depth of endoscopy 55 cm (range 10-60cm).
Patient satisfaction was recorded using a postal questionnaire.
96% felt the examination was worthwhile, the staff helpful and that
a full explanation of the procedure had been given. 27% found the
examination embarassing and 53% painful, of these 8% required
analgesia and 21% sought medical advice. 94% would be prepared
to undergo the examination again.
In conclusion, a nurse led open access flexible sigmoidoscopy
service is feasible, acceptable to patients and yields pathology in up
to 40% of patients.
Prospective audit ofThoarcoscopk
Splanchuicectomy in the management
of intractable upper abdomisal pain.
MerlezeLN Carter.R, Imrie.C.W.
Royal Infirmay, Glasgow, G31 2ER
AIMS: Methods used for the reliefofintractble
upper abdominal pain have variable success. Anecdotal
reports have suggested that Thoracoscopic
Splanconicectomy (TS) may be associated with
improved response rates. The aim ofthis study was to
prospectively evaluate the short and medium term
response in a consecutve seres ofpaients undergoing
this procedur.
METHODS: AHl patients presented with a clinical
syndrome of intractable upper abdominal pain, most
frequenty from chronic pancreatitis refractory to
standard treatment. Assesmet was
performed by analog pain scores and analgesic
requirements with a minimum follow up of six months.
RESULTS: Six males and five females (median age
41, range(34-69)) underwent TS between June 95 and
April 96. Procedure related morbidity was mild. At
one month, a good response (pain score reduction of
>4 and reduction in analgesia) was achieved in 8 out of
11 patients (73%) and a moderate response (pain score
reduction of>2<4 and reduction in analgesia) in I out
of 11 patients (9%!.). At six months, a good response
was sustained in 6 out of 10 patients (60%), and a
moderate response was seen in one patient (10%h), one
patient having died from disease progression prior to
the six month follow up.
CONCLUSION: Thoracoscopic Splanchnicectomy
would appear to be an effective alternative in patients
with upper abdominal pain refractory to standard
treatment modalitiesFurther prospective evaluation of
this technique are ongoing.
APHTHOUS ULCERATION IN THE TERMINAL ILEUM: WHAT IS THE
SIGNIFICANCE ? D.Sun, B.P. Saunders, J.D. Sanderson. Dept. of
Gastroenterology, Guy's and St. Thomas' Hospitals, London SE1 9RT.
Aphthous ulcerabon is a wel-recognised feature of number of inflammatory
bowel diseases but a parficular hallmark of Crohn's disease (CD). At ileo-
colonoscopy, the finding of ileal aphthous ulcers is not infrequent. In a
previous study, ieal aphthae were demonstrated as the sole finding in 11% of
patients of patients undergoing ieocobnoscopy for chronic diarrhoea or
abdominal pain. The significance of these lesions is, however, uncertain.
We have therefbre studied the charactenstics of 30 consecutve patients in
whom ileal aphthae were demonstrated at ileocoknoscopy. Patients were
aged 23-66 yrs. (median 32.5 yrs.). 19 patients were female. The indicafion for
ileocolonoscopy was assessment of known inflammatory bowel disease (UC
n=3, CD n=8), chronic diarrhoea (n=10), abdominal pain (n=6) and rectal
bleeding (n=3). 2 pabents were taking non-steroidal anti-inflammatory drugs
(NSAID).
Of the 19 patents without known inflammatory bowel disea, 17 had
normal inflammatory parameters (haemogobin, platelets, ESR and C-eactive
protein). 2 patients had a mild rise in ESR, 1 patient had a borderline low B12
level. 4 patents had undergone small bowel banum studies and 2 had had
labelled white cell scans. These tests were all normal
No obvious morphological difences were noted in aphthous ulcers
detected in patients with or wthout IBD or those on NSAID's. Histology of ieal
biopsies showed an inflammatory infiltrate in 13 / 19 patients. Further
sectioning revealed inflammation in 2 additional cases. Granulmas were
absent in all cases.
Ileal aphthous ulceration may be the only abnormality detected in patients
undergoing ileocolonoscopy for the investigaton of gut symptoms.
Morphology, histology, and additional standard investigatons offer no
apparent clues as to the significance of such lesions. Though a smal number
may be due to the use of NSAID's, the majority appear likely to represent a
form of Crohn's disease. Prospective follow-up studies by ilo-coonoscopy
and immuno-pathology are essential to determine the significance and natural
history of these lesions.
COLONOSCOPIC ARGON PLASMA COAGULATION FOR
BENIGN AND MALIGNANT RECTAL TUMOURS
JP Watson, S Jowett, K Oppong, CO Record, K Matthewson.
Gastroenterology Unit, Royal Victoria Infirmary, Newcastle upon
Tyne, NE2 4HH
Endoscopic Nd YAG laser therapy for gastrointestinal tumours
requires large capital expenditure, class 4 containment and carries
a risk of perforation. Endoscopic Argon Plasma Coagulation
(EAPC) is a diathermy based non-contact technique which may
be as effective as laser therapy with fewer side effects.
Methods: All patients with colonic tumours treated by EAPC
between July and Decenber 1996 were studied. After initial
endoscopic and histological diagnosis, patients received EAPC
until satisfactory debulking of the tumour was achieved. The
duration of each treatment, power used and patient tolerance were
recorded for each session. Symptoms were assessed at each
endoscopy session.
Results: 5 males and 3 females (mean age 79.1 ± 7.4 years) with
rectal adenocarcinoma (5) or rectal villous adenoma (3) were
treated. Reasons for non-operability were advanced age, co-
existent medical problems or metastatic disease. The power used
was 50-99W, with each session lasting a mean of 13.6 ± 6.1
minutes. Mean sedation requirements were diazemols 10.0 ± 4.6
mg, in addition to pethidine 50 mg given in 10/15 treatment
sessions. Patient tolerance of the procedure was reported as good
or excellent in all cases. Patients required 1-3 treatment sessions
during the study period, with a mean of 4.3 ± 3.1 weeks between
sessions. The symptoms of rectal bleeding and passage of mucous
improved or resolved in 7 of the 8 cases. 1 patient died from
metastatic disease during the study. No complications were
observed.
Conclusions: EAPC in this group of patients was well tolerated,
safe and resulted in useful symptomatic improvement.
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TECHNIQUE, AND LONG TERM OUTCOME OF ENDOSCOPIC
BALLOON DILATATION FOR PYLORIC STENOSIS.
CPSwain. Royal Lo1don Hospital, Whitchapel, London El lBB.
Aim: The aim of this study was to review the technique, results and
long term outcome of paints with benign pyloric stenosis trd with
balloon diltio. Patent and Methods: Sixteen patets wer
treated over a 7 year period. 15/16 werc of Asian origin. The mean
age was 31 (range 20-49). 9/16 wer Clo test positive, 10/16 wae
taking o rle at prenation and 6/16 had ben tratd with
triple therapy prior to initial endoscopy. Mean follow up of patients
was 36 months (range 7-84). 4/16 had inpatient stays ranging from 2-8
days. 16/16 had e itis and 10/16 had evidence of active
duodenal ulceraton at initial adoscopy. All had food in stomach, 3/16
had gastric dilatato at endosopy. All had mid-bulbar stenosis and
none had true nAdoscopic pyloric stenosis. The exit was found at 7
o'clock in 7/16. Techoque: An 18 mm through the scope (IfIS)
balloon was used to dilat the duodenal stricture. A variety of
techniques were needed to open the stenosis sufficiently to pass the
TTS balloon which is poorly designed for this application. For 14/16
screening was needed. An overtube was passed and a p;ediatric
endoscope used to place a guide-wire into the 2nd part of the
duodenum. Tapered and balloon ERCP dilators were used over the
wire to predilate the stricture prior to the passage of an 18 mm
balloon. A large channel endoscope was used to pass the balloon. In
10 cases the balloon was inflated distal to the stricture an then pulled
through and in 6 it was possible to inflate the balloon inside the
stricture. Result: Eight patients required a single dilatation session,
four needed two, three needed three and one patient needed four
dilataton sessions before an endoscope could reach the second part of
the duodenum. There were no perforations or deaths and no patient
required surgery. Yearly endoscopic follow up indicated that the
dilated stenosis could be crossed with an endoscope, that H Pylori was
eradicated in all, and the symptoms of stenosis were abolished and
none had recurrent ulceration at endoscopy. Conclusion: Although
endoscopic balloon dilatation of pyloric stenosis can be technically
demanding the long-term results are excellent.
FORCES EXERTED BY THE ENDOSCOPIST ON THE
COLONOSCOPE DURING COLONOSCOPY. C A Mosse, T N
Mills, DG ldl, C PSwLin. Dearments of Medical Physics,
University Colege, Ipswich Geneal and Royal Lxndon Hospitals.
Ain: An electronic device was designed and built for use at
colonoscopy to allow measurement of the forces exerted by the
clinician on the endoscope during colonoscopy. Methods: The device
featured a handle designed in the shape of hinged split cylinder which
could be locked around the endosc but could be readily moved up
and down the shaft as the colonoscopy proceeded. The handle
consisted of two parts, one that gripped the scope and one that was
gripped by the colonoscopist. One of the members that'joined these
parts together contained strain gauges arranged as a Wheatstone bndge
so that the forces transmitted could be measured accurately. The
device measured and recorded the twisting forces exerted dunng the
examination as well as the push and pull applied. A computer stored
the data on disk while in real time it displayed the forces graphically
as two chart recorder style taces. The device was calibrated against
a range of weights exerting force on a colonoscope using a pulley
system and was shown to give reproducible linear measurements over
the range of interest. A series of interchangeable split cylinders
allowed it to be used with any size of colonoscope. It was
electronically isolated from the patient. The width of the colonoscopes
used varied from 11 - 16 mm diameter. Results: This device was used
to measure the forces at colonoscopy in preliminary studies in 10
patients. Results: Peak forward force = 4.4 Kg, backward force = -
1.2 Kg, left torque = 0.35 Kg meters, right torque =0.9 Kg meters.
Percentage time force greater than 1 Kg = 5%. Peak anal insertion
force = 270g.
Conclusions: These measurements represent the first accurate
measurements of the forces exerted during colonoscopy. Methods and
developments which reduce the force exerted during successful
colonoscopy are likely to diminish pain and reduce the risk of
perforation. A knowledge of these forces may also help with the
design of new instruments and models for teaching or research.
RANDOMIZED TRIAL OF ORAL SODIUM PHOSPHATZ COMPARED WITH
ORAL SODIUM PICOSULPHATE PREPARATION OF THE COLON FOR
COLONOSCOPY. X Yoshioka; J Bates; D Norton; MRB
Keighley. University Department of Surgery, Queen
Elizabeth Hospital, Birmingham.
INTRODUCTION: Proper bowel cleansing is essential
for colonoscopy. Sodium picosulphate is regarded by
many as the standard preparation for endoscopy and
elective surgery. Some colonoscopic studies suggest
that oral sodium phosphate is superior to most other
agents used for bowel preparation.
AIN: To compare oral sodium phosphate and oral
sodium picosulphate in preparation for colonoscopy.
NETEOD: One hundred and six patients who had
colonoscopy were randomly allocated into two groups:
patients having oral sodium phosphate 45ml twice day
before investigation (n - 51)and those having oral
sodium picosulphate 2 sachets the day before
investigation (n - 55).
RESULTS: Linear analogue scale for patient's
acceptability including abdominal pain, nausea,
embarrassment, fear and fatigue showed that the score of
fear was significantly greater in sodium phosphate group
compared to sodium picosulphate group (p<0.02). Scoring
of'the faecal residue in the colon revealed that sodium
phosphate was more effective in the ascending (p<00S),
descending (p<0.01) and whole colon (p<005) compared to
the remainder. However, no significant difference was
found in the observed area of the mucosa between the two
groups.
COECLUsION: These results suggest that oral sodium
phosphate is well tolerated and a satisfactory agent for
preparation in colonoscopy. In terms of bowel
preparation sodium phosphate is superior to sodium
picosulphate.
THERAPEUTIC SMALL BOWEL ENDOSCOPY. C P Swain.
Royal London Hospital, Whitechapel, London El 1BB
Aim: To asse the indications and outcome of therapeutic small
bowel endoscopy. Patients & methods: From a series of enterscopic
examinations in 207 patients results of therapeutic enteroscopy in 50
cases were assessed. Most cases were performed without overtube or
screening. Indications & results: Blkeding: Angiodysplasiaofjejunum
14 (6 single, 8 multiple), bleeding diverticulum 1, amyloid 2,
inoperable malignancy 2. No further bleeding occurred in 8/14
angiodysplasia and the diverticulum. Bleeding rate appeared reduced
from the malignancies but not the amyloid cases. Bipolar probe was
used for 11 and Nd:YAG laser for 8. The laser fiber was easier to
pass through the scope to use at distal sites. In 15% of patients
referred for entroscopy for bleeding lesions accessible to the
gasroscope had been missed and were treated using the enteroscope.
A bleeding duodenal ulcer, 3 gastric angiomas, linear erosions in
hiatus henia, 2 Dieulafoy ulcers and 3 watermelon stomachs were
treated with bipolar or laser treatment and had no further bleeding.
Polypectomy. 8 hamartomatous polyps were removed from the small
bowel and 14 from stomach in 3 patients with Peutz Jeger syndrome.
A duodenal carcinoid tumour was completely excised. Feedig:
Feeding tubes were placed beyond the ligament of Treitz in 10 patients
using a 0.35 mm, 400 cm guidewire, passing a feeding tube over the
wire and then rerouting it through the nose. Direct puncture
percutaneous jejunostomy with radiological assistance was used in 5
patients with gastric stasis or obstruction. D : Sicture
dilatation with TIS hydraulic balloons was used in 3 patients, 2 for
Crohn's and one for 1 patient with a low grade Iy .
Manoetiy: An enteroscope was used to place small bowel mano
tubes in 4 patients. Intermexdoxal chollangwgphy: a pigtail stent was
inserted via an enteroscopically placed guidewire into a bil-duct
anastomotic stricture joining a Roux en Y loop in 1/2 patients. No
fatalities, perforations or induced bleeding occurred in this series.
Conclusion: TherApeutic enteroscopy offers effective haemostasis for
a subgroup of patients with bleeding found at enteroscopy and can be
used safely for a range of other therapeutic options.
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A PROSPECTIVE RANDOMISED CONTROLLED STUDY OF THE
USE OF RANITIDINE IN PATIENTS WITH GASTRIC CANCER
J Gokhale, GV Miller, SR Preston, NS Ambrose, UM Ward, JG Mills*, RSB
Ehsanullah* B Darekar* JN Primrose and the Yorkshire GI Tumour Group.
St James's University Hospital, Leeds, UK and *GlaxoWellcome Research
and Development, Greenford, Middlesex, UK.
Introduction:-The H, antagonist cimetidine has been shown in one study to
improve the outcome in patients suffering from gastric cancer. In this study
we have examined the use of the more potent H2 antagonist ranitidine
following operation for gastric cancer. Methods:- We performed a multi-
centre, prospective, randomised, double blind, controlled trial on 222 patients
with gastric cancer who underwent radical or palliative resection or who were
deemed inoperable at presentation. The patients received either ranitidine
150mg bd or placebo bd. The participating clinicians were members of the
Yorkshire GI Tumour Group. The principal outcome measures were survival
and survival excluding 30 day mortality. Results:- The median survival
(95% confidence intervals) was 331 (232-393) days in the ranitidine group
compared to 187 (143-269) in the placebo (p=0.225). When patients who died
within 30 days of operation were excluded (21 in placebo group, 15 in the
ranitidine group) the difference in survival remained not significant (p=
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Conclusion:- Although the outcome is better in the ranitidine group and the
difference approaches significance in stage IVa, this study does not
demonstrate significant benefit from the use of ranitidine in gastric cancer.
Further, larger studies may be indicated.
PREDICTION OF RESECTABILITY OF GASTRIC TUMOURS
USING ENDOSCOPIC ULTRASOUND
SAN.orton, D Alderson.
Dept. of Surgery, Bristol Royal Infirmary, Bristol BS2 8HW
The accurate assessment of the resectability of gastric tumours can
be difficult using conventional imaging investigations. Posterior
invasion may not be apparent on computed tomography (CT) and so
patients may be subjected to inappropriate laparotomy. Endoscopic
ultrasound (EUS) can clearly visualise the layers of the stomach wall
and adjacent structures, including regional lymph nodes and so the
locoregional staging of gastric tumours can be determined. This
procedure can be performed immediately following the initial
diagnostic endoscopy.
Twenty four patients with histologically proven gastric cancer
underwent EUS. Eleven patients were deemed to have resectable
tumours on EUS. This was confirmed at operation. Ten patients were
felt to have irresectable tumours using EUS. Of these, five underwent
laparotomy and palliative bypass due to extensive tumour invasion.
Five patients were unfit for surgical intervention or had evidence of
metastatic spread.
CT predicted resectability in 3 irresectable tumours and 5 resectable
tumours but was valuable in providing information regarding
metastatic spread.
Endoscopic ultrasound is more accurate than CT in predicting
irresectability of gastric tumours and therefore has a valuable role in
the assessment of tumours in patients who would not otherwise
require palliative bypass.
TOTAL INTRAVENOUS ANAESTHESIA IN PAEDIATRIC GASTRONMESTINAL
ENDOSCOPY
MLMar.KCJM raall MWhie.HW-M K& _1. JW v KIClee. JG Bovi2.Deps.of Paediatrics' and Anaesthesiolo, University Hospital Leiden, the Nether-
lands.
Gastrointesnal endoscopy (GE) has become a ueful diagnostc method for gsaoin-
testinal disas in childood. In recent years, new developme in the adinistration
of analgesic and anaetetic drugs have greaty facilitad the technique of total intrave-
nous anaeshesia for GE. However, this kind of anaestesia is often asociad with
delay during GE.
Aim of the (pilot) study: To analyse the benefits drawbacks of total intravenous
anaes-thesia during upper GE in children. Paden: 22 chiklren (10 girls), mean age 7.5
years, who underwent GE because diaostc or therapeutic purposes: 19 oesophago-
gastro-duodenoscoPies (GIF), of wich 9 capsule-guided sal bohwel biopsies (DDB),
and 3 percan_eo endoecopic gao mie (PEG). Metbod: Total intravenous
anaesthesia at the discretion of the anaesist was given to the children.
The time-lag from the start of the anaesthsia to the intrduction of the endoscope, the
duration of dte GE and th recovey time fom anaesthesia were assssed. In addition
blood pressure, heart rate, and SaO2 wer non-invasively moniored andu lly
recorded. Anxiety before GE was indepndently assssed, usmg a scorng linear visl
analogue scale from 1 to 5, by the child's parents (P), the endoscopist (E), the
anesthesist (A) and the nurses (N).
Children older than 6 years were asked to assess their own anxiety (Ch). The agitation,
degree of discomfort and quality of operating conditions were assessed too.
Results:
DELAY FROM mmn dumeoag MEASUREMENTS Manrands ANXIETY
SCHEDULEDMME t(mans) CHILD
St mesdasia- 15.59 Syalic RE 96.7 m Hg By A-2.6
introncope
Tma GE 18.33 Heart re l09.0p.m. By N-2.7
GIF (n-19) 12.44 Sa02 96.3% By P-2.9
DDB (n-9) 28.50
PEG tN-3)
Reovery 26.52 Opaerins Oprn By E-3.5
Exta GE-dme 43.45 Physial Not needed B Ch-3.6
Conclusions: Our preliminary results show a total mean extra endoscopy time of 43.45
minutes for total intravenous anaesthesia in paediatric upper GE, of which 15.6 minutes
in the endoscopy room. The operating conditions were optimal. The anxiety before GE
was experienced by the child as more suressful than observed by the adults.
THE SPECTRIUM OF ENTERIC DYSMOTILITY REVEALED
BY PROLONGED SMALL BOWEL MANOMETRY. DL
Wingate, FD Castillo, T Nomura, MF Benson, DF Evans. GI Science
Research Unit, St Bartholomew's and Royal London School of
Medicine, London, UK.
Clinical small bowel manometry (SBM) can identify differences
between grous of subjects, but its diagnostic value remains uncertain
We used computer-analysed SBM in 47 studies in 18 healthy controls
to construct a database ofnormal values of20 variables of the
migrating motor complex (MMC); the diagnostic potential ofthis
technique was supported by a study of Chagas'.disease in Brazil, in
which 21/21 patients had > 2 variables outside the normal range. We
used prolonged SBM as a diagnostic test in 63 UK tertiary referral
patients with suspected dysmotility. Subjects were studied for 24 hrs
with a triple-sensor nasojejunal manometric catheter linked to a digital
datalogger; data from the sensor located at the d-j flexure was used to
calculate the 20 variables. SBM failed in 6 subjects (10%). Motility
was judged to be normal in 17 subjects, with <1 abnormal variable.
The remaining 40 patients with >2 abnormal variables (range 2 - 9,
median 4) included all 14 patients with known pathology - diabetic
neuropathy (5), vagotomy diarrhoea (3), scleroderma (2), enteric
myopathy (3), CNS disease (1) - and 4/4 'irritable bowel' patients with
refractory urgent and frequent defaecation. Abnormal records were
marked by distortion, and, in 5, by abolition of the normal difference
between diurnal and nocturnal activity. In 7, there was marked
attenuation or absence of a motor response to food (not all patients
could tolerate a normal meal). In 4, there were 'Chagas-like' prolonged
Phase 3 and slow propagation of the MMC: another 7 had one or other
of these abnormalities. In contrast, ultra-rapid MMC propagation was
seen in 3/5 diabetics, and 2 others with diarrhoea. Low amplitude
contractions were seen in 3 (scleroderma 2, dilated bowel 1) but Mi in
patients with myopathy. 3 had MMCs by day but not at night, and 3
had excess MMCs throughout. We suggest that computer-analysed 24-
hr SBM is an objective and reproducible diagnostic technique; it
reveals diverse patterns of dysmotility that probably reflect different
pathologies of gut muscle and nerves.
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ANOV LMETHOD OR 24HOUR PANCOLONIC
AMBUIATORY MANOMEIRY
R HaggrI. D Kumarl. M Benson2. A Grundy3. Dept. of
Surgeryl, Div. of Gastroenterology2 and Dept. of Radiology3
St. George's Hospital, London, United Kingdom.
Normal colonic motility patterns have not been clearly
defined. The aim of this study was to establish a new
technique and describe colonic motor patterns using 24 hour
ambulatory pancolonic manometry.
Five healthy volunteers were recruited to the study.
Colonic motlity was measured using two silicon coated
catheters(OD-3mm) with 5 pressure transducers at 15cm
intervals. The proximal catheter was introduced
transnasally and it's tip positioned at the splenic flexure
under fluoroscopic control. The distal catheter was
introduced transanally in an unprepared colon and it's tip
positioned in the descending colon with the help of a
colonoscope. No sedation was used for the colonoscopy. The
tip of the distal catheter was clipped to the colonic mucosa
with a titanium clip. The transducers spanned the bowel
from the terminal ileum to the rectum. Data was recorded
continuously on a portable data logger (MMS Universal
Portable System). All subjects were fully ambulant and ate
their own meals.
Recordings were made for a total of 116 hours in 5 subjects.
The colon exhibited high amplitude propagating
contractions(HAPC), migrating motor complexes(MMC)
and rectal motor complexes(RMC). Mean number of HAPC
was 5.24/24hrs, 16% occurring within 1 hour of waking and
28% preceding defecation. Mean number ofMMC was
11.8/24hrs, 33.5% of which propagated into the caecum.
Mean number ofRMC was 10.6/24hrs, 17.8% propagated
aborally and 9.8% propagated orally.
The human colon exhibits phasic activity which is
propagated from the terminal ileum. The rectum shows
complexes which are propagated in an orad as well as
aborad direction.
GASTRIC ARRHYTHMIAS IN THE FUNCTIONAL BOWEL
DISORDERS.
A.C.B. Leahy, C. Clayman, I Mason, K Besherdas, 0. Epstein. Centre
ofGastroenterology, Royal Free Hospital, London NW3 2QG.
Cutaneous electrogastrography (EGG) abnormalties including
arrhthmias and a postprandial power decrease have been described in
functional dyspepsia (FD). EGG arrythmias have been well correlated
with antral dysmotility. The aim ofthis study was to substantiate EGG
abnonnalities in FD, and to compare FD patients with patients
suffering from irritable bowel syndrome (IBS). Methods: Patients
studied incuded 105 with dyspepsia with a normal endpscopy and
abdominal ultsound scan, 60 with IBS diagnosed by the Rome
criteria and 30 healthy controls. Two cutaneous bipolar eectrodes
were placed over the stomach and connected to an EGG recording unit
(Synectics, Stockholm, Sweden). EGG was perfo daccording to a
standard protocol which included a 2 hour prelpostprandial study.
Bradygastria was defined as 0-2cpm; normal slow wave activity as 2-
4cpm; and tachygastria as 4-9cpm. Postprandial power change was
calculated. Statistical analysis was performed by the Student's t-test.
26 patients had a radiolabeiled gastric emptying study peformed to
correlate EGG abnormalities with gastric emptying. Abnormal EGG
was defined as <700/o normal slow wave activity either preprandially or
postprandially. Results: A postprandial power decrease was observed
in 8 controls and this was not considered to be an abnormality when
present alone. Two controls had <70@/o normal slow wave activity
either preprandially or postprandially. EGG abnormalities were present
in 32 (30%) FD patients and 6 (10%/) IBS patients. 35 IBS patients
also had dyspepsia, including all 6 patients with abnormal EGG. Mean
% normal slow wave activity pre/postprandially were: controls
86.9/90.0; FD 81.6/82.9(p<0.02); IBS 86.6/88.9. No correlation was
found between EGG arrhythmias and delayed gastric emptying.
Condusions: 1. EGG has a high (93%) diagnostic specificity. 2.
Postprandial power decrease is observed in healthy controls. 3. 30%b of
FD patients have abnormal EGG suggesting antral dysmotility. 4. In
IBS, EGG abnormalities only occur when dyspepsia is present.
VOLIIIONAL SWALLOWING MODULATES CORTICAL
SWALLOWING PATHWAYS VIA BRAINSTEM MEDIATED
INTERACTIONS
S. Hamdv Q. Aziz, J.C. Rothwell, D.G. Thompson
Department of Gastroenterology, University of Manchester, and the
Institute of Neurology, London, UK.
Background: Swallowing is an complex process exhibiting both
excitatory and inhibitory influences over the muscles of the upper
digestive and respiratory tracts. Furthermore, the cortex has an
important role in the initiation and modulation of swallowing and
respiration. Despite these observations, the functional interactions
between volitional swallowing and the cortical pathways to human
swallowing and respiratory musculature are unknown. Aims: To
determine how volitional swallowing interacts with the cortico-fugal
pathways to swallowing and respiratory musculature in man. Methods:.
Swallowing musculature (Mylohyoid) and respiratory musculature
(Diaphragm) were studied in 8 healthy volunteers (7 male, age range
24-32 yrs). Mylohyoid and diaphragm EMG responses to transcranial
magnetic stimulation of the cortex were recorded, in maximal
inspiration, at intervals of: 100 msec between 0-1 sec, 2 sec and 5 sec,
after a Sml water bolus swallow or a control task (hand contraction).
Results: When compared to the control task, swallowing facilitated the
mylohyoid responses between 0 and 0.4 sec (swallowing: 670±21V,
control: 565±36pV, p<0.02) before inhibiting them between 0.6 and 2
sec (swallowing:460±20izV, control: 637±261&V, p<0.01). In contrast,
the diaphragm responses were consistently inhibited from 0.4 sec
onwards (swallowing: 150±1 11V, control: 187±101V, p<0.05).
Conclusions: Volitional swallowing modulates the cortical pathways to
human swallowing and respiratory musculature, via excitatory and





Smith V and Milla PJ
Histopathology. Great Ormond Street Hospital for Children,
Great Onrond Steet, London WCIN 3JH, UK
Functional inesinal obsuctio or chronic idiic in l
pseudo-obstruction is due to defects either in the enteric
innervation or in the smooth muscle.
We have stde full-thickness intestinal samples from 27
patients with fnctional intinal obsruction due to enteric
smooth muscle disease, usig rotine histology, electron
microscopy, histochemical and imhemical techniques
to detect changes in the in l smooth muscle.
Two patients presing at the age of 6 months and 18 months
had an acquired intesnal myopethy as a result of an autoimmune
process. In 25 the disorders were congenital, and of tese 7 had
segmental abnmlities limited to the rectm and distal colon and
18 a diffuse disease affecting both the small ad large bowel. We
identified five apparent histological pLnotpes of enteric muscle
disease. Three of these represent abormalibes in morphogenis
resulting in alterations in intestinal muscle layering. Two
probably exemplify intrinsic myocyte defects or changes in the
extracellular matrix.
Phenotyping these patients carefully is important both in
devising optimal treatment and in un g the nderlying
defect. Recognition of the autoimmune smooth muscle disease is
helpful, since making the diagnosis influences the paient's
management. The histological pheotype alludes to probable
aetiology thus allowing investigaion of the possible molecular
and genetic defects.





INTERSTITLAL CELIS OF CAJAL (ICC) INTHE
HUMAN COLON: REGIONAL DENSIrY
VARIATIONS
R Haggas. C Finlayson*. S Gharaie$. and D Kumar.
Dept. of Surgery and Dept. of Histopathology*, St.
George's Hospital, London, United Kingdom.
To determine the regional variation of density of ICC in
the wall of the normal human colon, we have studied 109
colonic tissue blocks.
ICC were identified in the colon by
immunohistochemical staining, using a rabbit
polyclonal anti-c-kit antibody (Oncogene Science).
Normal colonic tissue was defined as non-involved tissue
obtained at surgical resection for a non-obstructing
carcinoma of the colon. The regions of interest were
right, transverse and left colon. Density of ICC was
graded on the basis of the number of ICC per high power
field. Statistical analysis was performed using chi-
squared tests.
In the myenteric plexus the transverse colon (p=0.009)
and right colon (p=0.05) had a significantly higher
density of ICC than the left colon. Although not
statistically significant, there was a trend for the density
of ICC to be higher in the transverse colon than the right
colon in the myenteric plexus. In the circular muscle
layer, the right colon had the highest density of ICC, this
was significant in comparison to the left colon (P=0.02)
but not the transverse colon. No significant regional
variations in ICC density were identified in the
longitudinal muscle layer.
Regional variations in the density of ICC are present in
the colon. The highest density of ICC in the myenteric
plexus was observed in the transverse colon, the proposed
site of pacemaker activity.
GENDER DIFFERENCES ANDREPRODUCIEIITlY OFWHOLE
GUT VISCERAL SENSITIVITY. CYF£ncis, LA Houghton, PJ
Whorwell. Dept of Medicine, University Hospital of South Manchester.
Abnormalities in gut visceral sensation are currently regarded as being
important in the pathophysiology of functional bowel disorders.
However, its inter-subject variation, its reproducibility (or intra-subject
variation) and the effect of gender on these parameters has received little
attention. Repeat studies on 8 healthy female (aged 20-37 yrs; median
23 yrs) and 10 healthy male (aged 20-57 yrs; median 22 yrs) volunteers
were carried out to assess the sensory responses of the oesophagus 10),
duodenum [DI, jejunum (JI, ileum X1L, colon ICI and rectum [RI to
isovolumic balloon distension. The order in which these regions were
distended was randomised, and there were 3 to 47 weeks (median 9
weeks) between studies.
Results Female subjects tended to be more sensitive than male subjects
to distension of the 0 [vol to discomfort (ml): females 15 (7.5-20)
geometric mean (range) v males 24 (10-110); p=0. 16], D [73 (40-110)
v 99 (50-150); p=0.08], J [58 (40-70) v 70 (30-170); p=0.32], 1
[55(30-100) v 92 (40-150); p=0.029], C [177 (110-280) v 235 (150-
500); p=0.23] and R [191 (100-400) v 211 (150-325); p=0.58].
Furthermore, it can be seen from the above ranges that the inter- (or
between-) female variation was less than the inter-male variation; this
difference reaching significance in the 0 (p=0.05) and J (p=0.0015).
However, the intra- (or within-) female variation was not apparently
different from the intra-male variation in the 0 [difference from 1st to
2nd study: 2.5 (0-7.5) median (range) v 5 (040)], D [10 (0-30) v 20 (0-
50)], J [20 (20(0-30) v 30 (0-90)], 1 [40 (10-40) v 10 (0-70)], C [40 (10-
140) v 60 (20-220)] and R [70 (0-125) v 65 (0-125)]. These male-female
differences were not related to differences in anxiety between the female
[HAD score, 4.5 (0-8) median (range)] and male [5.0 (3-9); p=0.41]
volunteers.
Conclusion Because males are less sensitive and have a wider inter-
subject variation than females, they may be less prone to abnormalities
in visceral sensation following exposure to noxious stimuli. This might
help to explain the preponderance of female to male patients with
functional bowel disorders.
TACHYODDIA INDEPENDENT FROM THE DUODENAL
MIGRATING MOTOR COMPLEX MAY BE A PART OF
SPHINCTER OF ODDI DYSFUNCTION. EA Stoner CC Ainley,
DF Evans, V Kulhalli, AJK Piotrowicz. St. Bartholomew's and the
Royal London School of Medicine and Dentistry, London..
Manometric measurements of the sphincter of Oddi (SO) have
enabled a better understanding of its physiology and recognition of the
condition of sphincter ofoddi dysfunction (SOD). Presently SOD is
only reliably diagnosed by an elevated basal pressure. Previously SO
phasic activity has been shown to closely follow the migrating motor
complexes(MMCs) with maximal frequency during phase 3 of the
MMC. A raised frequency of contractions (>8cpm) has been termed as
tachyoddia however it is not regarded as clinically significant.
Aims I)To determine the incidence oftachyoddia.2) To look at the
relationship between tachyoddia, duodenal activity. and SOD
Methods SOM was performed using a triple lumen catheter
Wilson-Cook, USA), the central channel being continually aspirated. A
station pull through technique was employed. The duodenal motility
was measured using a single lumen 5 French catheter taped to the
outside of the duodenoscope.
Results 65 patients with post cholecystectomy pain, idiopathic
pancreatitis or biliary pain underwent SOM. 15 of the 65 (23%)
p tients had at least one episode of tachyoddia.
Tachyoddia Tachyoddia
Basal synchronous independent Total
pressure with MMC ofMMC
Raised 1 4 5
Normal 9 1 10
Total 10 5 15
A raised basal SO pressure is significantly associated with independent
tachyoddia ( Fisher's exact test p< 0.05.)
Conclusion. The SO may have its own pacemaker which is
dissociated from the control of the MMC in patients with SOD.
Tachyoddia independent of the MMC should now be regarded as part
of sphincter of Oddi dysfunction.
GASTRIC EMPTYING (GE) AND GASTROINTESTINAL
REGULATORY PEPTIDES (GRP) IN CHILDREN WITH
RECURRENT EPIGASTRIC PAIN (REP)
A Papadopoulou. A Vazeou, E Kitsiou',A Papadimitriou2, C Bartsocas
" P & A Kyriakou" Children's Hospital,' Laiko" Hospital, and
2'Nevy's" Hospital, Athens, Greece
Recurrent epigastric pain is often of uncertain aetiology and it is
therefore attributed to psychological causes. Gastrointestinal motility
disorders have been implicated in the pathogenesis of abdominal pain
and regulatory enteropeptides, in the pathogenesis of intestinal
dysmotility. However, the incidence of gastric dysmnotility and the role
ofGRP in children with REP are poorly defined. We therefore, carried
out a prospective study in 36 children (mean age 10.4 years, 18 males)
with REP of uncertain aetiology, in order to detect the incidence of
gastric dysmotility and the role of serum motilin. In 28 patients, REP
were associated with non-ulcer dyspepsia: early satiety, postprandial
abdominal bloating and/or distention. In 8, REP was paroxysmal,
precipitated by prolonged fasting. Seventeen patients (47"!%) were
found to have abnonnal gastric emptying assessed by gastric
scintigraphic studies : 12 (43 %) of the 28 patients with dyspepsia
(mean age 9.4 yrs) were found to have delayed emptying of a solid
meal (mean T,,2 of 50% of 9mTC-phytate in stomach was 147.2
minutes); 5 of the 8 (62 %) patients with paroxysmal pain (mean age
13.4 yrs) had rapid gastric emptying (mean T,,2 of 50%/. of '9MTC-
phytate in stomach was 55 minutes). Fasting serum motilin
concentrations were lower in the patients with REP compared with 26
healthy controls (p<0.00001). However, no significant correlations were
found between serum motilin concentrations and the duration or the
severity ofREP or gastric emptying time. The treatnt with cisapride
and/or erythromycin was associated with resolution of symptoms in all
of the patients with delayed gastric emptying. Similarly, dietary
modifications were associated with a relief in symptoms in children
with rapid gastric emptying. In conclusion, GE abnormalities are
common in children with REP of uncertain aetiology. The role of GRP
in children with REP should be further investigated.
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THE USE OF RADIOTRANSMITTING CAPSULES TO MEASURE
INTE INAL TRANSIT Sl 1wis and KW Heaton. Depanment of
Medicine, Bristol Royal Ifmary, Bristol BS2 8HW.
Because luminal pH increases as the duodenum is entered then falls on
entry into the caecum, the pH radiotanamittng capsule can be used to
measure small bowel transit-time. It can also be used to measure whole-
gut transit-time (WGIT) and, by subtraction colonic transit-time.
However the latter is a valid exercise only ifWGIT is not itself altered by
the capsule.
We set out to see if WGTr measured by the pH radiotransmiting
capsules differed from WGfT measured simultaneously using the
traditional barium imprepated plastic pellet methodL
13 healthy volunteers had their WGIT measured using plastic marker
pellets of different shapes, then coilecting two stool samples and x-raying
them. At the same time a pH radiotansmitting capsule was swallowed
and tracked. These measurements were then repeated with the volunteers
taking in order wheat bran, senna then loperamide in maximally tolemted
amounts.
No significant differences were seen between the two sets of
measurements on baseline diet or if the intestinal tansit was altered using
wheat bran, senna or loperamide.
Median WGTI7 (h) and lerange i h tic p a a capule
n Peiets Capsule 95% CI
Baseline 37 63 43, 73 55 36, 76 -3, 10
Wheatbran 13 39 32, 76 42 31, 58 -4, 22
Senna 13 41 31, 50 42 36, 57 -16,4
Loperamide 11 74 61, 97 78 67, 113 -22, 18
We found no systematic difference in measured WG1T between results
with the traditional plastic marker pellets and with the pH
radiotransmitting capsule. This was true even if WG1T was artificially
increased or decreased. In addition the pH radiotransmitting capsule gives
information on small bowel transit and caecal anal transit-times, thus
negating the need to use separate techniques for each or the use of
radioactive isotopes. This pH radiotransmitting capsules may be a useful
method of assessing small and large intestinal transit-times.
ALOSETRON SWWS COLONIC TRANSIT IN PAlTS WlTH
RITA3IZ DOWEL SYNDROME (13) 1M 1.w LA loughton, PJ
Whorwell. D eatofM odici, University Hospita ofSouth M er,
M20 2LR, UK
The slcive SHT, dos,oseton du abdomin d fort
in patets wilh IBS (Bwdhan at d, GCasoenrol 1996;110:630) ad slows
whole got d coloic trnit in heay vohabs (Hg et al,
G_1troenterol 1995;108:84). However, its effoct on gastrointstin transit
in patiets with IBS ha n been previously invest . Tweve BS patients
(aged 23-56 yrs) diagnosed by the Rome critaw e theefore entd into
a randomised, double blind, cro ver study, compn the effect of oral
akoer (2mSg bd x I day) with placebo on whole gut (mouth to anus),
mail bowel (mouth to cacm) ad colnict Mean whole gut transit
(MWGT) wa determined by the number ad time of excretio of 3 diffent
radio-opaque madkm geedW on 3 co ve ds (dys 2, 3 and 4).
Small bowel tnit (SBT) ws meard a the time fiom ingesion of a
standard mea of mash potdo, sasuag ad boes (non-absorbable
carbohydrae) to a rise in brewh hydrogen of 3 ppm sosined for 30 min (day
5). Colonic (CT), left colonic (LCT), right colonic (RCT) nd rectosigmoid
(RST) trant weo evaluaed by abdominal X-y (day 5).
Bmi
Plaebe Aleseisu P
WGT (marker 1; hrs) 68(21-125) 82(14-159) 0.09
WGT (marker 2; hra) 67(16-137) 73(24-14) 0.07*
WGT (marker 3; bra) 52(16-119) 54(13-120) 0.47
MWGT (bra) 59(18-114) 72(20-141) 0.13
SBT (min) 335(190-490) 330(200-510) 0.51
CT (hra) 38(1-67) 49(1-72) 0.07*
LCT (hrs) 12(0-23) 23(0-52) 0.006*
RCT (hrs) 7(1-23) 7(0-31) 0.57
RST (hrs) 8(0-24) 5(0-23) 0.38
Results expressed as median (range)
Conclion Aloseton delays colonic transit by prolonging left colonic transit.
These results add further to the body of evidence that dosetron may have a
therapeutic role in irritable bowel syndrome. 'This reseaoch was funded by
GlaxoWellcome, UK."
SUMATIPAN AT A THERAPEUTIC DOSE ALTERS
OESOPHAGEAL MOlITY. JM Foste, LA Houghton, PJ
Whorwell. Dept of Medicine, University Hospital of South Manchester.
3-5% ofpatients taking the 5HTI, agonist sumatripan (S) for migraine
experience chest discomfort, potentially suggesting a cardiac origin.
However, we have recently suggested that the oesophagus may be the
cause of this chest discomfort, as a supratherapeutic dose ofS (16mg, sc)
significantly alters oesophageal motility without affecting the ECG. The
aim of this study was to investigate whether a therapeutic dose of S
(6mg, sc) also affects oesophageal motility. Lower oesophageal sphincter
(LOS), oesophageal body (4 sites), gastric and pharyngeal (to monitor
swallows) pressures were recorded using a perfused manometric catheter
with sleeve sensor in 16 healthy volunteers (aged 19-32 yrs; 9 male)
before and after administration of S or saline control. Sequences of 6
consecutive 5ml water swallows with a minimum interval of 20 soc
between each swallow, were carried out -15, -5, 5, 15, 30, 45, 60, 80,
100, 120, 150 and 180 min post-injection. Treament order was
randomised and double-blind; throughout the study ECG and symptoms
were monitored. milts S significantly increased the amplitude of
oesophagealcontractions (mean increasefrompre-injection: S4.SmmHg,
placebo -4.SmmHg; difference 9.3mmHg, 95%CI 4.1-14.SmmHg,
p=0.002); an effect that was maintned throughout the whole of the 3
hr recording period. In addition, S induced a transient increase in LOS
pressure immediately after injection (S 10.9mmHg, placebo 5.lmmHg;
difference 5.8mmHg, -0.7-12.3mmHg), although it had no overall effect
on LOS pressure over the time period studied (S 1.9mmHg, placebo
2. lmmHg; difference 0.2mmHg, -3.9-4.2mmHg). S, however, did not
affect the duration (S 0.3s, placebo -0. ls; difference 0.4s, 0.2-0.5s) or
velocity of propagation (S -0.09 cm/s, plaebo -0.12cm/s; difference
0.03 cm/s, -0.15-0.21 cm/s) of oesophageal conons. Chest
discomfort was only experienced in one subject and although this subject
did show a change in oesophageal motility, there was noColaon with
the degree of change. No subject exhibited any ECG abnormalities.
Conclusion At therapeutic doses S also has an effect onoesophageal
motor function, and this provides further evidence of a possible
oesophageal cause of S-induced chest symptoms.
GASTRIC EMPTYING IN HUMAN IMMUNODEFICIENCY VIRUS
(HIV) INFECTED INDIVIDUALS: RELATIONSHIP TO SYMPTOMS,
AUTONOMIC FUNCTION AND GASTROINTESTINAL (GI)
PATHOGENS. PJ Neild. R Jewkes, BG Gazzard. Chelsea and
Westminster Hospital, London, U.K.
Symptoms suggestive of delayed gastric emptying are common in
HlVseropositive (HIV+) individuals, as is autonomic neuropathy, though
often subclinical. We tested the hypothesis that GI symptoms may be
related to objective delay in gastric emptying and that this mav be
associated with autonomic dysfunction and/or the presence of
opportunistic G1 pathogens. Methods: 19 HIV+ subjects with enteric
infections (HIV/P) and 37 HIV+ subjects with no identifiable pathogens
(HIV/NP) were compared with 12 presumed HIV-ve healthy controls
(cont). Subjects completed a symptom score and underwent a series of
autonomic function tests (aft), and a scintigraphic solid gastric emptying
test, using a single headed gamma camera with anterior and posterior
views. Results:. Gastric half emptying time (ti/2) was increased in HIV+
subjects and significantly so in those with GI pathogens, though lag
phase (th.) and the proximal emptying component (pt1/2/ t1/2) were less
affected. GI symptoms and autonomic dysfunction were significantly
increased in HIV+ subjects compared with controls but did not correlate
with gastric em ing(r2=0.02l and 0.012 respectively). t,2 was related
to CD4 count (r1=0.13, lsO.06)and .21,p0.0004).
results exp as mesSEM coat K INP HIV+/P
symptom scoreXIS 0.08*0.08 5.54*0.63** 6.9*0.86**
SD ofR-R intevals (SDRR) (m) 661.56i4.12 39.95*3.8' 33.29*4.3 1
gstric t,2(min.) 66.95. 16 92.38*8.04A 158.3*20.9**
t,.,(min.) 22.03*f3.54 29.08*3.02 48.5*9.42
pti,21 t4, 10.75*0.05 0.63*0.03 0.60*0.03
'p<0.05, *p<0.01, **p<0.001 wrt cont. AAp<0.001 wrt HIV/P
Conclusions: Gastric emptying is disturbed in a number of HIV+
subjects, particularly those with small intestinal GI pathogens, but
neither gastric symptoms or autonomic dysfunction can predict those
with abnormalities. Delay may result from local production of cytokines,
eg tumour necrosis factor alpha, or duodenal dysmotility causing reflex
inhibition of emptying.
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